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Background: Being born very premature (i.e. before 32 weeks’ gestation) has an impact on survival and
quality of life. Improving care at birth may improve outcomes and parents’ experiences.
Objectives: To improve the quality of care and outcomes following very preterm birth.
Design: We used mixed methods, including a James Lind Alliance prioritisation, a systematic review,
a framework synthesis, a comparative review, qualitative studies, development of a questionnaire tool and
a medical device (a neonatal resuscitation trolley), a survey of practice, a randomised trial and a protocol
for a prospective meta-analysis using individual participant data.
Setting: For the prioritisation, this included people affected by preterm birth and health-care practitioners
in the UK relevant to preterm birth. The qualitative work on preterm birth and the development of the
questionnaire involved parents of infants born at three maternity hospitals in southern England. The medical
device was developed at Liverpool Women’s Hospital. The survey of practice involved UK neonatal units.
The randomised trial was conducted at eight UK tertiary maternity hospitals.
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Participants: For prioritisation, 26 organisations and 386 individuals; for the interviews and questionnaire
tool, 32 mothers and seven fathers who had a baby born before 32 weeks’ gestation for interviews
evaluating the trolley, 30 people who had experienced it being used at the birth of their baby (19 mothers,
10 partners and 1 grandmother) and 20 clinicians who were present when it was being used; for the trial,
261 women expected to have a live birth before 32 weeks’ gestation, and their 276 babies.
Interventions: Providing neonatal care at very preterm birth beside the mother, and with the umbilical
cord intact; timing of cord clamping at very preterm birth.
Main outcome measures: Research priorities for preterm birth; feasibility and acceptability of the trolley;
feasibility of a randomised trial, death and intraventricular haemorrhage.
Review methods: Systematic review of Cochrane reviews (umbrella review); framework synthesis of ethics
aspects of consent, with conceptual framework to inform selection criteria for empirical and analytical
studies. The comparative review included studies using a questionnaire to assess satisfaction with care
during childbirth, and provided psychometric information.
Results: Our prioritisation identified 104 research topics for preterm birth, with the top 30 ranked. An
ethnographic analysis of decision-making during this process suggested ways that it might be improved.
Qualitative interviews with parents about their experiences of very preterm birth identified two differences
with term births: the importance of the staff appearing calm and of staff taking control. Following a
comparative review, this led to the development of a questionnaire to assess parents’ views of care during
very preterm birth. A systematic overview summarised evidence for delivery room neonatal care and
revealed significant evidence gaps. The framework synthesis explored ethics issues in consent for trials
involving sick or preterm infants, concluding that no existing process is ideal and identifying three
important gaps. This led to the development of a two-stage consent pathway (oral assent followed by
written consent), subsequently evaluated in our randomised trial. Our survey of practice for care at the
time of birth showed variation in approaches to cord clamping, and that no hospitals were providing
neonatal care with the cord intact. We showed that neonatal care could be provided beside the mother
using either the mobile neonatal resuscitation trolley we developed or existing equipment. Qualitative
interviews suggested that neonatal care beside the mother is valued by parents and acceptable to
clinicians. Our pilot randomised trial compared cord clamping after 2 minutes and initial neonatal care, if
needed, with the cord intact, with clamping within 20 seconds and initial neonatal care after clamping.
This study demonstrated feasibility of a large UK randomised trial. Of 135 infants allocated to cord clamping
≥ 2 minutes, 7 (5.2%) died and, of 135 allocated to cord clamping ≤ 20 seconds, 15 (11.1%) died (risk
difference –5.9%, 95% confidence interval –12.4% to 0.6%). Of live births, 43 out of 134 (32%) allocated to
cord clamping ≥ 2 minutes had intraventricular haemorrhage compared with 47 out of 132 (36%) allocated to
cord clamping ≤ 20 seconds (risk difference –3.5%, 95% CI –14.9% to 7.8%).
Limitations: Small sample for the qualitative interviews about preterm birth, single-centre evaluation
of neonatal care beside the mother, and a pilot trial.
Conclusions: Our programme of research has improved understanding of parent experiences of very
preterm birth, and informed clinical guidelines and the research agenda. Our two-stage consent pathway
is recommended for intrapartum clinical research trials. Our pilot trial will contribute to the individual
participant data meta-analysis, results of which will guide design of future trials.
Future work: Research in preterm birth should take account of the top priorities. Further evaluation of
neonatal care beside the mother is merited, and future trial of alternative policies for management of cord
clamping should take account of the meta-analysis.
Study registration: This study is registered as PROSPERO CRD42012003038 and CRD42013004405.
In addition, Current Controlled Trials ISRCTN21456601.
Funding: This project was funded by the National Institute for Health Research (NIHR) Programme Grants
for Applied Research programme and will be published in full in Programme Grants for Applied Research;
Vol. 7, No. 8. See the NIHR Journals Library website for further project information.
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Plain English summary
Babies born before 32 weeks’ gestation (very preterm) may have poor health or they may not survive.Our research focused on care at the birth, with close co-operation between parent representatives,
clinicians and researchers.
We interviewed parents who described their experience of very preterm birth as a ‘rollercoaster of emotions’,
and said that touching their baby helped bonding. About one-third of parents see and touch their baby for
the first time on the neonatal unit. Parents were mostly positive about care during the birth, but some
women felt that they had not been listened to or had not been believed; in addition, some fathers felt
excluded. Parents found it helpful when staff were calm and took control. We developed a questionnaire to
measure parents’ satisfaction with care during preterm birth.
We designed a small trolley so that immediate care for the baby could be beside their mother, and also
showed that this care could be done using existing equipment. Parents and clinicians were largely positive
about this care.
We do not know when is best to clamp the umbilical cord at birth. Our randomised trial at very preterm
birth found that cord clamping after ≥ 2 minutes and initial care for the baby with the cord intact may
be beneficial, compared with immediate clamping and care after clamping. A brief process for offering
participation in the trial (consent) when birth was imminent, with a detail explanation later, was acceptable
to women and clinicians. We will pool our data with other trials to help find out the best way of managing
cord clamping at preterm birth.
Through involving parents, the public and health-care professionals, we identified 104 unanswered research
questions around care for preterm birth, and ranked the top 30.
Our work has improved understanding of parents’ experiences, provided research ideas and developed a
consent process and ways of caring for babies at birth beside their mother.
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Scientific summary
Background
Preterm birth has major impact on survival and quality of life, psychosocial and emotional stress for the
family, and costs for health services and society. Mortality and morbidity are highest for infants born very
preterm, before 32 weeks’ gestation, and impairment may persist into early adulthood. This programme
focused on care in the delivery room at very preterm birth.
Aims
Our aims were to improve the quality of immediate care at preterm birth, enhance family-centred care,
and improve outcome for babies born very preterm and their families.
Methods
Our range of methods were delivered through five interconnected work packages.
l Work package 1: James Lind Alliance Priority Setting Partnership between service users and health-care
professionals to identify and prioritise the top research questions in preterm birth –
¢ with an ethnographic analysis of partnership working.
l Work package 2: two systematic reviews –
¢ umbrella review to identify effective interventions in the delivery room for babies born very preterm
¢ framework synthesis addressing ethics issues in recruiting preterm or sick babies to clinical trials.
l Work package 3: strategies for providing initial neonatal care beside the mother at preterm birth,
with umbilical cord intact –
¢ survey of neonatal care
¢ qualitative interviews with parents: (1) comparative review of tools to assess experiences of care at
birth; and (2) developing a new questionnaire for use after very preterm birth
¢ measuring umbilical cord flow before cord clamping
¢ developing and evaluating a mobile trolley to support neonatal care at birth beside the mother,
with cord intact: (1) service evaluation; and (2) qualitative interviews with parents and clinicians
l Work package 4: pilot randomised controlled trial evaluating timing of cord clamping, including –
¢ qualitative interviews with women and clinicians about consent
¢ 1-year follow-up of women
¢ 2-year follow-up of children (corrected for gestation).
l Work package 5: protocol for an individual participant data meta-analysis.
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Results
Work package 1
We identified and distributed for public voting 104 unanswered research questions. The 30 most popular
were ranked at a workshop. The top 15 were:
1. Which interventions are most effective to predict or prevent preterm birth?
2. How can infection in preterm babies be better prevented?
3. How best to prevent necrotising enterocolitis in premature babies?
4. What is the best treatment for lung damage in premature babies?
5. What should be included in packages of care to support families when a premature baby is discharged
from hospital?
6. What is the optimum milk-feeding guidance for premature babies?
7. What is the best way to judge whether a premature baby is feeling pain?
8. Which treatments are best to prevent early-onset pre-eclampsia?
9. What emotional and practical support improves outcomes for premature babies and their families?
10. Which treatments are most effective for preterm premature rupture of membranes?
11. When is the best time to clamp the umbilical cord in preterm birth?
12. What support is most effective at improving breastfeeding for premature babies?
13. How best to treat necrotising enterocolitis in premature babies?
14. Does specialist antenatal care for women at risk of preterm birth improve outcomes?
15. What are the best ways to optimise the environment (such as light and noise) to improve outcomes?
Future prioritisations should endeavour to anticipate potentially differing perspectives, mitigate any
imbalance where possible, and report voting by ‘service users’ and health-care professionals separately.
Work package 2
Our systematic review (umbrella review) identified 18 Cochrane reviews covering four topics:
1. Delivery room interventions for airway management, respiratory or circulatory support (four reviews).
Two reviews found no eligible trials and one included one small trial. The fourth concluded that there is
no evidence that routine endotracheal intubation reduces mortality or morbidity in vigorous term babies
with meconium staining, compared with standard resuscitation.
2. Surfactant replacement therapy for preterm infants with or at risk of respiratory distress syndrome (eight
reviews). The strongest evidence supported type and timing of surfactant administration: for very preterm
infants surfactant reduced the risk of death by about 40%, and natural surfactant was more effective
than synthetic. Early surfactant administration with brief ventilation reduced mechanical ventilation, but
delivery room administration was no better than delayed selective administration. Uncertainty remains
about the comparative effects of newer synthetic surfactants, and novel non-invasive administrations.
3. Supplemental oxygen or other drugs for infants compromised at birth (five reviews). There was insufficient
evidence for reliable recommendations about using air or 100% oxygen for newborn resuscitation, about
using adrenaline or sodium bicarbonate, and about using naloxone for infants exposed in utero to opiates.
Various measures for keeping newborn very preterm infants warm reduced the risk of hypothermia, but
effects on morbidity and mortality remain unclear.
4. Strategies for influencing placental transfusion (one review). Deferring cord clamping for between
30 and 120 seconds, rather than clamping before 30 seconds, possibly reduced blood transfusions and
intraventricular haemorrhage. Effects on death and long-term neurodevelopment remained unclear.
Our framework synthesis addressing ethics issues in recruitment identified two types of study:
1. Empirical (49 studies). Revealed themes about parents’ attitudes, clinicians’ attitudes, validity of consent,
different consent processes and miscellaneous topics. Empirical research confirmed that there are
difficulties for some parents giving valid consent.
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2. Analytical (30 studies). Revealed themes about the ethical basis of parental informed consent for
neonatal research, parental consent validity, other options for seeking consent, risk and the double
standard between consent for treatment versus research.
There was agreement that it is important for parents give or decline consent for neonatal trial participation.
However, none of the existing consent processes reviewed was satisfactory. Clinicians have concerns that
research participation is dropping because of problems with consent, and they may face ethical difficulties in
discharging conflicting duties to research, neonates and parents.
We identified three important gaps:
1. evaluation of a process for obtaining emergency consent in perinatal research
2. studies on trials where both the mother and the fetus or neonate are participants
3. studies that report the views of bereaved parents on the consent process.
We developed a two-stage oral assent consent pathway and included this in our pilot trial (work package 4),
which addressed the first two research gaps. The third research gap has been addressed elsewhere.
Work package 3
Our survey showed variation in delivery room practice for infants born very preterm. In tertiary units, the
care provided was more consistent with current international guidance than in non-tertiary units. There
was variation in how policies for cord clamping at very preterm birth were implemented, both between
and within units. No unit provided neonatal care with cord intact, and staff were anxious about this
practice. Implementation of deferred cord clamping seemed more successful if there was strong local
interdisciplinary support, with agreement on a single technique and the eligibility criteria. Clinical
leadership and training in the practical techniques also appeared helpful.
Parents’ views and experiences of very preterm birth
Almost half of the parents interviewed described difficulty remembering aspects of the birth. The anticipation
before seeing and touching their baby for the first time was characterised by contrasting and rapidly changing
emotions. Parents who talked about touching and holding their baby described immediate bonding. Visiting
the neonatal unit was initially overpowering, especially for those who had not been before or were seeing
their baby for the first time. Parents referred to the awkwardness and exclusion felt by fathers.
Overall parents’ experiences of care were positive. We identified four determinants of parents’ experience:
staff professionalism, staff empathy, involvement of the father, and the birth environment. These are
consistent with research on term births. Two factors unique to very preterm birth were the importance
of staff appearing calm and staff taking control during the birth. Two areas where parents felt that care
could have been improved were staff not believing the women, or appearing not to listen to them, and
fathers not being involved.
Our comparative review of measures of parents’ satisfaction with care during childbirth identified
nine questionnaires, none of which evaluated care at very preterm birth. Therefore, we developed a
questionnaire to measure this. There were 17 items, with subscales on ‘staff professionalism and empathy’,
‘information and explanations’, ‘confidence in staff’ and ‘involvement of the partner’. The total scores may
be useful to compare satisfaction across hospitals, whereas individual aspects of care can be evaluated
using the subscales. We used this questionnaire in our pilot trial. Further research should explore whether
or not there is variation in experiences for parents from different backgrounds and in different settings.
Neonatal care at birth beside the mother
We developed a small trolley to support newborn resuscitation at birth beside the mother, marketed as
LifeStart™ (Inditherm Medical, Rotherham, UK), and conducted a service evaluation within a busy tertiary
hospital. Common delivery room resuscitation procedures were performed successfully on the trolley,
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including with cord intact. Compared with conventional resuscitation equipment, for most aspects of care
clinicians rated the trolley as ‘the same’, ‘better’ or ‘much better’. Reported problems included difficulty in
getting close to the operating table at caesareans and trip hazard from gas hoses.
When interviewed, parents said that they liked having their baby close and they felt reassured knowing
what was going on. Some felt that their watching helped staff communicate with them. Others said that
they would have liked more explanation. No parent whose baby received intensive intervention, such as
intubation and cardiac massage, expressed regrets about watching.
Clinicians interviewed were also largely positive about care beside the mother, and felt that allowing parents
to see and touch their baby at birth was especially important if the baby was subsequently admitted to the
neonatal unit. They reported positive comments from parents about being close to their baby, and none
mentioned negative comments. Most clinicians had no reservations about parents watching them, but some
thought that staff with less experience might feel insecure. Practical challenges at caesarean sections were
that parents were sometimes unable to see their baby, scrubbing for the sterile field took time and the
trolley controls were under sterile drapes.
We also showed that neonatal care can be provided beside the mother using standard resuscitation
equipment. This has advantages of being already available and staff being familiar with its use. Further
research should assess experiences in other hospitals, using a trolley or standard equipment, and including
parents from more diverse backgrounds and babies requiring advanced resuscitation.
Work package 4
This pilot trial assessed the feasibility of conducting a large UK multicentre randomised controlled trial
comparing deferred cord clamping (after at least 2 minutes) and immediate neonatal care with the cord
intact, with immediate clamping (within 20 seconds) and immediate neonatal care after cord clamping
for very preterm births. Initially, recruitment was for 1 year but, as feasibility was demonstrated, the study
continued while funding for the main trial was sought, but it closed when the application was unsuccessful.
Recruitment was above target, largely because of the two-stage consent pathway that allowed women to
be offered participation when birth was imminent. Overall, 261 women were randomised and gave birth to
276 babies. Randomisation was across the range of gestation. Compliance with the allocated interventions
was good. Fewer babies allocated to cord clamping after at least 2 minutes died than those allocated to
cord clamping within 20 seconds, but the difference was not statistically significant. Three-quarters of
deaths were in infants born before 28 weeks’ gestation. For live births, there was no clear difference in
intraventricular haemorrhage, or other outcomes at discharge for baby or mother.
Women’s experiences of the two consent pathways were similar. Those recruited following oral assent
reported having less information about the trial, but felt that it was sufficient to make their decision.
Irrespective of the consent pathway, there were gaps in women’s understanding. Clinicians were supportive
of the two-stage consent pathway in time-critical situations and thought that providing information on a
‘need-to-know’ basis was an advantage over the usual process. They emphasised the importance of a team
approach to inviting participation, regardless of the consent pathway. In the questionnaires at 1 year,
women were largely positive about the trial. Suggestions about what could have been improved included
being approached earlier in labour and better communication about the study from staff.
At the age of 2 years (corrected for gestation at birth), we found no clear difference in the composite of
death or adverse neurodevelopment between the allocated groups after adjusting for missing data using
multiple imputation.
Work package 5
A key challenge here was unpredictability of the time scale for analysis. The number of new trials has
increased (29 registered in the past 2 years) but many are small and had begun data analysis before being
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contacted. Therefore, we expanded the protocol to include a retrospective individual participant data
meta-analysis. Currently, we know of 53 trials involving 11,811 infants (3020 for long-term outcomes).
This meta-analysis will inform future trial design.
Conclusions
Central to the success of the programme was service user representatives being equal partners
throughout. Parent experiences were heard and explored throughout. This allowed us to tackle emotive
issues at very preterm birth, such as neonatal care in the delivery room and seeking consent for
participation in an intrapartum trial.
Our work on neonatal care beside the mother brings family-centred care to the delivery room and has
major implications for maternity services. Although this is a relatively simple change in practice, it requires
a change in culture to multidisciplinary teamworking. Both parents and clinicians felt that this improved
communication. The trolley was important in providing ‘proof of concept’ for care beside the mother,
but existing equipment can be used. Hospitals can use the questionnaire we developed on parents’
experiences.
Limitations of our work include participants in the prioritisation process not being representative of those
most affected by preterm birth, the small sample for the qualitative interviews about preterm birth,
evaluation of neonatal care beside the mother being conducted at a single hospital, and the randomised
trial being a pilot.
Key implications for future research for funders and researchers:
l Consider the top 30 research priorities, ranked by those affected by preterm birth and by health-care
professionals.
l Improve understanding of parent experiences at preterm birth through further research involving
parents (including fathers) from a wider range of backgrounds and settings.
l Evaluate neonatal care beside the mother in a wider range of settings, using standard equipment or the
mobile trolley (e.g. in a multicentre randomised controlled trial).
l Evaluation of interventions around the time of preterm birth in large multicentre NHS trials is feasible
and should be considered.
l The two-stage consent pathway should be included in future intrapartum clinical research trials, and
merits evaluation in other emergency or time-critical trials.
l Design of future clinical research trials comparing alternative policies for cord clamping should take
account of results from our trial and the planned individual participant data meta-analysis.
Study registration
The study is registered as PROSPERO CRD42012003038 and CRD42013004405. The Cord pilot trial is
registered as ISRCTN21456601.
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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SYNOPSIS
Background
Being born too early (preterm birth) has a major impact on survival and quality of life for the child, on
psychosocial and emotional stress on the family, and on costs for health services and society.1–3 Mortality is
highest for infants born very preterm, before 32 weeks’ gestation. In the UK, infant mortality (deaths in the
first year of life) for babies born very preterm is 144 deaths per 1000 live births, compared with 1.8 deaths
per 1000 live births at term.4 Although only 1.4% of live births in the UK are very preterm, these babies
account for 51% of infant deaths.4
The costs of neonatal care for infants born very preterm are high. For those born before 28 weeks’ gestation,
duration of hospital stay is 85 times that for term births and hospital inpatient costs are £15,000 higher.
For those born at 28 to 31 weeks, duration of hospital stay is 16 times that for term births and hospital
inpatient costs are £12,000 higher.5 Morbidity among children born very preterm who survive is also higher
than those born at term.3 Of very preterm infants who survive, around 5% develop cerebral palsy and those
without severe disability have a twofold or greater increased risk for developmental, cognitive and behavioural
difficulties.1,2 These impairments may persist into adolescence and early adulthood.6,7 Even modest improvements
in outcome would be of substantial benefit to the children, their families and the health services.
Aims and objectives
The aims of this programme were to improve the quality of immediate care at very preterm birth, enhance
family-centred care, and improve outcome for infants born very premature and their families.
Specific objectives were to:
l Develop a James Lind Alliance (JLA) Priority Setting Partnership (PSP) between service users and clinicians to
identify and prioritise treatment uncertainties relevant to preterm birth (work package 1; Figure 1) and to:
¢ identify and prioritise research gaps for preterm birth, using the methods developed by the JLA
¢ describe how service users and clinicians interact when making collective decisions about research
priorities, and how they communicate when deciding research priorities together.
l Develop strategies for providing initial neonatal care at birth beside the mother, rather than away from
the mother, for preterm or sick babies by:
¢ conducting a survey of current practice for initial neonatal care with the cord intact at NHS hospitals
(work package 3.1)
¢ describing parents’ experiences and views of care at very preterm birth, and developing a
questionnaire tool to assess their views of care at very preterm birth (work package 3.2)
¢ improving understanding of the physiology of transition from fetal to neonatal circulation by measuring
umbilical flow at preterm birth and assessing how it varies with gestation (work package 3.3)
¢ conducting systematic reviews and overviews (umbrella review) to assess the evidence for delivery
room transitional assessment and support, and to identify research gaps (work package 2.1)
¢ developing a mobile Bedside Assessment, Stabilisation and Initial Circulatory Support (BASICS) trolley to
support providing newborn life support beside the mother, and with the cord intact (work package 3.4)
¢ describing parents’ and clinicians’ experiences and views of neonatal care at birth beside the mother,
and of the BASICS trolley (work package 3.5).
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l Generate information that will inform the design of a high-quality large multicentre UK trial comparing
a policy for very preterm births of deferred cord clamping and initial neonatal care with umbilical cord
intact, against immediate clamping and initial neonatal care after cord clamping, by:
¢ conducting a narrative systematic review (framework synthesis) to identify the ethical challenges
and their potential solutions in consent to recruitment of preterm or sick infants to clinical trials
(work package 2.2)
¢ conducting a pilot randomised trial comparing deferred cord clamping and initial neonatal care
with the cord intact, against immediate clamping and initial neonatal care after cord clamping
for very preterm births, including follow-up of the women for 1 year and until 2 years of age
(corrected for gestation at birth) for the children (work package 4)
¢ establishing a collaborative group to conduct a prospective meta-analysis of trials evaluating
alternative strategies to influence placental transfusion at preterm birth, and developing the protocol
for this analysis (work package 5).
The prioritisation process ran in parallel to other work packages. It was added to the programme in
response to feedback from the funding board at stage 1 of the grant application process. Hence, other
work packages were not dependent on its outcomes. Although cord clamping did emerge as a top
priority, we had already identified this as a priority via an informal process.
WP 4.0
Cord pilot trial
WP 2.1
Evidence-based immediate
care of the very preterm
infant
WP 2.2
Ethics issues in recruitment
of preterm or sick infants to
perinatal trials
WP 3.1
Neonatal care at birth,
a survey of current practice
WP 3.2
Parents’ view of care at
preterm birth
WP 3.3
Measuring placental
transfusion
WP 3.4
Developing the BASICS
trolley
WP 3.5
Evaluating parents’ and
clinicians’ views of neonatal
care beside the mother
WP 1
Identifying and prioritising research gaps relevant to preterm birth: a James Lind Alliance
Priority Setting Partnership
WP 5.0
A prospective meta-analysis
FIGURE 1 Overview of work packages. WP, work package.
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Priority setting for future preterm birth research
In the past, the health-care research agenda was determined primarily by researchers, and the processes
for priority setting in research lacked transparency.8 Often, research does not address the questions about
treatments that are of greatest importance to patients, their carers and practising clinicians.9,10 Many
research questions have not been investigated and for many more the existing evidence is incomplete.
The JLA (www.lindalliance.org/; accessed 24 January 2019) has developed methods for bringing patients
and clinicians together to establish PSPs that then identify and prioritise ‘treatment uncertainties’ to inform
publicly funded research.11 This approach has been used successfully for a wide range of topics including
asthma,12 urinary incontinence,13 vitiligo,14 prostate cancer15,16 and schizophrenia.17 For urinary incontinence,
of the top 10 priorities, five came from clinicians, four from patients and one from researchers.13
When uncertainty about the effects of treatments relates to preterm birth, it seems particularly pertinent
that research should address the most important priorities, and the most pressing needs, of these vulnerable
children and their families and clinicians. Failure to identify and prioritise these uncertainties may result in
suffering and death.18 Examples in perinatal care where this failure to identify and prioritise important
uncertainties has happened include the use of caffeine, which was shown to reduce the risk of cerebral
palsy and developmental delay, and so was widely taken up in clinical practice, but only 30 years after being
suggested for prevention of apnoea in premature babies.19,20 In addition, the use of magnesium sulphate,
which, after 60 years of controversy, was finally shown to be better for women with eclampsia than either
diazepam or phenytoin.21–23 Although the importance of women and their clinicians contributing to the
perinatal research agenda is well established,8 we proposed the first PSP in the perinatal field.
To establish a PSP required bringing together representatives of women and their families and of clinicians
and other health-care workers. Understanding of how people interact and make collective decisions in
groups or committees with members from diverse organisations comes from health research, and from
social psychology and business administration.24 Larger groups may increase membership diversity,25 although
this may be offset by a reduction in reliability of decision-making. The chairperson is crucial for establishing
inclusiveness, openness and trust in the discussion.25–28 If time is short, less knowledge is shared and evaluated
and then decisions result more from judgement based on prior preferences than problem-solving,29 which
may mean that they are more influenced by an individual’s status within the group.25
When we planned the Preterm Birth PSP, evidence about how service users and clinicians make joint
decisions on research priorities was lacking.24 Improved understanding of how such partnerships work
(e.g. if expertise based on qualifications, experience or problem-solving skills influences decisions30 or if the
way arguments are framed changes as consensus develops) may offer insight into how the process could
be improved.
The Preterm Birth PSP published a list of the top 15 research priorities,31 which is being used by the National
Institute for Health Research (NIHR) and by researchers in planning new research. Study of the groups’
working processes has also led to recommendations about how decision-making might be improved.
Parents’ views and experiences of very preterm birth
Very preterm birth and subsequent hospitalisation of the baby can be an extremely distressing time for
parents.1,32 There has been little research into parents’ experiences at the time of very preterm birth, or
their satisfaction with their care during the birth. In addition, previous work has often failed to include
fathers. Women’s views and experiences during labour and childbirth are increasingly important to
health-care providers and policy-makers,33 and may have an impact on subsequent health and well-being
for the woman and her baby.34,35
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To ensure a strong parent focus throughout our programme, we planned qualitative interviews to explore
parents’ experiences of very preterm birth and their first moments with their baby.36–38 Regular multidisciplinary
project meetings to plan these interviews, and to discuss the emerging themes and verbatim transcripts, were
immensely valuable for subsequent work packages. These were particularly valuable for developing strategies
for neonatal care beside the mother, and for planning the pilot trial. Our experience in conducting these
interviews also contributed to further qualitative work exploring the views of both parents and clinicians of
neonatal care at birth beside the mother,39,40 and of the new two-stage consent pathway in our pilot trial.41,42
A number of instruments have been developed to assess women’s satisfaction with care during childbirth.
When planning our programme we were not aware that any of these were designed to be used following
very preterm birth, which is usually a different experience from giving birth to a healthy term baby. To
confirm this we conducted a systematic review of available measures to assess parents’ satisfaction with
care during labour and birth.43 Having demonstrated there was not a suitable tool for very preterm birth,
we developed a 20-item questionnaire called Preterm Birth experience and Satisfaction Scale (P-BESS) for
use in this situation.44 We used this questionnaire for the follow-up of women recruited to our pilot trial.
It has been translated into Spanish and Portuguese.
Placental transfusion and neonatal transition
At birth, if the umbilical cord is not clamped then blood flow between the baby and the placenta may
continue for several minutes.45–48 This umbilical flow is part of the physiological transition from fetal to
neonatal circulation, which, for very preterm infants, may improve resilience during this transition.49–51
‘Placental transfusion’ refers to the net transfer of blood to the baby between birth and cord clamping.
Cord clamping before umbilical flow ceases may restrict neonatal blood volume and red cell mass, and/or
disrupt transition from fetal to neonatal circulation. For term births, umbilical flow usually continues for
2 minutes, but may continue for over 5 minutes.46,48 The mean volume of placental transfusion at term
is 100 ml, which is 29 ml/kg birthweight and 36% of neonatal blood volume at birth.48 For preterm births,
umbilical flow may continue for longer than for term births52 and is incomplete if the cord is clamped in
30–90 seconds.53 This corresponds with development during gestation; at term, two-thirds of the fetoplacental
circulation is in the infant, whereas for those born below 30 weeks’ gestation, a greater proportion of the
fetoplacental circulation is in the placenta.45 In addition, the preterm umbilical vein is smaller than at term,
and uterine contraction less efficient; therefore, transition from the fetal to the neonatal circulation may
be slower. Cord milking or ‘stripping’ seems to be an attractive option for preterm births, as potentially it
increases neonatal blood volume without the need to defer cord clamping.54 However, cord milking
over-rides the infant’s physiological control of its own blood volume and blood pressure, and it interrupts
transition to the neonatal circulation.55
To improve understanding of the physiology of placental transfusion and assess when might be the best
time to clamp the cord for preterm births, we measured umbilical flow at preterm birth. Although this
proved to be more challenging than we had anticipated, the resulting data helped to inform the decision
to wait at least 2 minutes before clamping the cord in the pilot trial.
Neonatal stabilisation and resuscitation at birth beside the mother
In the UK, about one-third of all newborn babies are attended at birth by neonatal resuscitation staff.
For most, all that happens is an assessment, stimulation, thermal care and simple airway management.
However, around 15% of these babies receive active stabilisation and/or resuscitation at birth, such as
mask ventilation, intubation, cardiac massage or drug administration.
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Transition to the neonatal circulation begins at birth when pulmonary vascular resistance falls as the lungs
expand and fill with air, pulmonary blood flow increases and ductal blood flow declines as peripheral
resistance falls.56 Stabilisation at very preterm birth aims to assist this transition, and recommendations for
newborn life support for very preterm infants are to prioritise establishment of respiration and a resting
lung volume.57 Traditionally, this was facilitated by immediate cord clamping, allowing the baby to be
transferred quickly away from the mother for interventions such as airway opening manoeuvres,
continuous positive airways pressure (CPAP) and tracheal intubation with or without prophylactic
surfactant administration.
Providing initial neonatal stabilisation and resuscitation for very preterm or sick infants beside the mother
would potentially allow newborn life support to be provided with the cord intact, facilitating a longer
period before cord clamping than was possible at the time when we were planning this programme. It
would also allow the woman and her partner to share the first moments of their child’s life, a more family-
centred approach to care at birth.58,59 Family-centred care in neonatal units, with improved communication
and involvement of parents in their baby’s care, appears to benefit babies, is welcomed by parents60 and
has been prioritised by the NHS.61 Providing initial neonatal care beside the mother also has parallels with
family presence during resuscitation of adults and children, an approach that is preferred by families and
clinicians, and that appears to be beneficial.62–65 Should the baby subsequently die, this time spent with
the parents may prove to be an important factor in their experience of the life of their baby, and could
potentially be of benefit in bereavement.
At the start of our programme, information about neonatal care beside the mother within the UK was
anecdotal.53,66 Therefore, we began by describing current practice at that time for care at birth67,68 and by
assessing the evidence from randomised trials for delivery room neonatal interventions. We then developed
and piloted strategies for providing initial neonatal care beside the mother, and assessed whether or not
this was acceptable to parents and clinicians. This included both developing a new mobile trolley designed
specifically for this purpose69 and adapting the existing equipment.70 Our work demonstrating that
providing newborn life support beside the mother is valued by parents and clinicians,39,40 and that care
with the cord intact is feasible, contributed to the success of the Cord pilot trial.71 Providing neonatal care
beside the mother, with the cord intact, compared with after clamping and cutting the cord, has growing
interest nationally and internationally.72,73
Ethics issues in recruitment of preterm or sick infants to perinatal trials
Recruitment of preterm or sick infants to clinical trials requires approaching parents at a particularly difficult
time, often with a tight time scale for making a decision. This raises challenges for obtaining informed
consent to such research, especially issues regarding competence for consent, understanding of complex
issues, insufficient time for parents to consider participation, and voluntariness if parents have a sense of
obligation or feeling of debt to the clinician-researcher who is caring for their child.74 On the other hand, if
the problem of consent is not successfully addressed, this risks becoming an ‘orphan’ area of research. That
is, if ethically permissible research cannot be designed, then this area of medical research will be abandoned.
Earlier work has explored these difficulties, specifically in the neonatal context.74 Discussion of both the
nature and the importance of consent, as well as empirical work on methods of obtaining consent and
parental experience of those methods, has continued.75–77 Hence, when we planned our programme it
seemed timely to review understanding of these ethics issues in the light of this expanding literature, and
of both the changing regulation for clinical trials and the increased public expectations of the conduct
of research. Our overall aim was to identify a way of conducting ethical neonatal research in those
circumstances where obtaining valid consent from parents has proved to be a significant challenge. The goal
was to identify both the challenges to an ethically defensible consent process and their potential solutions.78,79
This led to the development of a two-stage pathway for consent used and evaluated in the Cord pilot trial.
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This pathway accounted for almost one-third of recruitment to the trial, and was viewed positively by both
parents and clinicians.41,42 It was rapidly included in updated guidance for intrapartum research from the Royal
College of Obstetricians and Gynaecologists.80,81 The same two-stage approach has also been adapted for use
in an acute stroke trial, for which randomisation is within 8 hours of the stroke.82
Systematic review of timing of cord clamping at very preterm birth
Thirty years ago, it was first suggested that immediate cord clamping for preterm babies might increase the
risk of intraventricular haemorrhage (IVH).83 Postulated mechanisms for this increase were hypovolaemia or
increased fluctuation in blood pressure during the abrupt transition from fetal to neonatal circulation.
At the time that we planned this programme, the Cochrane review of timing of cord clamping and other
strategies for influencing placental transfusion at preterm birth included 10 trials, with 454 mother–infant
pairs largely recruited before 33 weeks’ gestation.84,85 In these trials, deferred cord clamping ranged from
31 to 120 seconds and immediate cord clamping ranged from 5 to 20 seconds. Many outcomes were
reported by only a few studies, with potential for reporting bias. Immediate clamping was associated with an
increased risk of transfusion for anaemia [relative risk (RR) 1.57, 95% confidence interval (CI) 1.14 to 2.16; four
trials, 183 infants] or hypotension (RR 1.94, 95% CI 1.06 to 3.54; 3 trials, 90 infants) compared with deferred
clamping. The risk of IVH on ultrasound scan was also higher for babies allocated immediate clamping
(RR 1.90, 95% CI 1.27 to 2.84; seven trials, 329 infants), but for severe IVH (grade 3 or 4), a more reliable
predictor of long-term outcome, there was no clear difference (RR 1.17, 95% CI 0.27 to 5.02; five trials,
269 infants). There was no clear difference between the groups in temperature on admission to a neonatal
unit, but only three trials (143 infants) reported this outcome. One study had reported follow-up at a median
age of 7 months for 58 out of 67 surviving infants, with no clear differences between the groups.86
Alternative policies for timing of cord clamping at very preterm birth
In previous trials for deferred clamping, the decision about when to clamp the cord was usually a balance
between allowing some umbilical flow and what was perceived as an acceptable delay in transferring the
baby to the neonatal team. As standard practice was for the neonatal team to be located either at the side
of the room or in a room nearby, this necessitated early clamping and cutting of the cord, particularly for
infants requiring stabilisation or resuscitation at birth. Therefore, providing initial neonatal care at birth
with the cord intact would make it feasible to defer cord clamping for longer than had previously been
possible, including for high-risk infants who have the most potential for benefit.
Our programme to improve the quality of care and outcome at very preterm birth focused on care at the time
of birth. We reviewed evidence from systematic reviews 36–38,67,68,70,78,79,87 relevant to delivery room neonatal
care, surveyed current practice, described parent experiences, measured umbilical blood flow, developed
strategies for providing newborn life support beside the mother, and reviewed ethics issues in recruitment of
preterm and sick babies to clinical trials. These work packages all contributed to the design and conduct of
the Cord pilot trial, a pilot randomised trial to assess the feasibility of conducting a large UK trial comparing
alternative strategies for cord clamping. To provide adequate power for long-term follow-up of the children
and inform the design of a large definitive trial, we planned a prospective meta-analysis of similar studies.
This focus on the time of birth and cord clamping was identified as a priority by informal discussion with
parent representatives,88 and parent representatives worked in partnership with clinicians and researchers to
develop the application and conduct the research. The topic had also been identified as a research priority
by researchers,58,84,85,89 obstetricians,90 midwives,90 neonatologists (Duley L, Farrar D, McGuire W, Oddie S.
Survey of the Extended Neonatal Network to Assess Views on Timing of Cord Clamping and Placental
Transfusion: Report Prepared for the Extended Neonatal Network. 2009. Unpublished), the National Institute
for Care Excellence (NICE),91,92 and the Royal College of Obstetricians and Gynaecologists.59 Therefore, it was
unsurprising that this uncertainty was included in the list of top priorities from our JLA Preterm Birth PSP.31
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Changes from the original programme plan
The phrase ‘preterm birth’ is broad. Our programme had a specific focus on care around the time of birth,
and our intention was that this would be reflected in the scope of our JLA PSP (work package 1). However,
from the initial scoping meeting, it was clear that both service users and clinicians had a different view and
the discussion ranged from risk factors to prognosis and the grandparent perspective. This continued at the
first meeting of the partnership steering group. As the partnership was between service users and clinicians,
the researchers agreed that their views should determine scope. The challenge of too wide a scope led to
delays in progressing the priority setting, and the process progressed only once it was agreed that this
should be narrowed. This delay and the resource demands of the priority setting process meant that it was
not possible to conduct the planned work on outcomes.
Although our sampling frame for the qualitative interviews with parents (work package 3.2) included
one hospital where deferred cord clamping was in routine practice for very preterm birth, no parents
interviewed had experienced neonatal care beside the mother. It was, therefore, not possible at that time
to assess their experiences of this type of care. Instead, we did this by assessing parent and clinician
experiences of neonatal care beside the mother using semistructured interviews, rather than the planned
focus groups (work package 3.5). This was in order to gain more detailed accounts of the events and
experiences than would be available in a focus group. In addition, because in focus groups individuals
might be reluctant to disagree with the dominant view, you get a socially constructed view rather than
people’s individual views and experiences.
Measuring placental transfusion at preterm birth proved to be far more challenging than our earlier work
at term birth.48 This was primarily because of the unpredictability of preterm birth, which made it difficult
for the research team to be present and with the equipment set up in time for the birth. As we secured
funding to assess feasibility of a similar trial in low and middle income countries, this study was replicated
successfully in India.47
The Cord pilot trial was conducted as planned. Added value of this multidisciplinary programme led to
several additional elements. First, innovative methods for consent to participate in emergency perinatal
trials was identified as a research gap by the ethics framework review. This led to the development of a
two-stage oral assent pathway used in the trial when birth was imminent, which boosted recruitment.
Second, to evaluate this pathway we used our experience of semistructured interviews with parents and
clinicians (work packages 3.2 and 3.5) and of the framework analysis of ethics issues (work package 2.2)
to design and conduct qualitative interviews with women and clinicians who had experience of consent
in the Cord pilot trial. Finally, excellent recruitment contributed to the Trial Steering Committee (TSC)
assessment that feasibility had been demonstrated and that we should seek funding to progress to the
definitive trial. The TSC also recommended that recruitment continue while funding was sought, to avoid
‘stop/start’. Hence, recruitment was extended and only closed when the funding application was rejected.
To maximise the value of this additional recruitment, follow-up of both women and children was also
extended and data for all those randomised are presented here.
For the prospective meta-analysis, the first cycle of analysis had been planned within the programme.
However, as data from the two largest studies (Cord pilot trial93 and the Australian Placental Transfusion
Study94) were not available within the time scale of the programme, this analysis has been postponed.
In addition, the collaborative group of triallists has agreed to expand the protocol to a retrospective
individual participant meta-analysis with nested prospective meta-analysis.
Programme management
The co-applicants formed a programme steering group to oversee implementation of the research programme
as well as integration and timely delivery of the work packages. This group met every 4 months for the first
3 years, and every 6 months thereafter. A project management group of coinvestigators supported each work
package. In addition, the JLA Preterm Birth Priority Setting Partnership (PSP) formed a steering group from
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membership organisations and stakeholders, and independent oversight of the Cord pilot trial was by an
independent TSC and Data Monitoring Committee.
Patient and public involvement
Throughout this report, we use the term ‘service users’ to describe patient and public involvement. Because
having a baby is a physiological event, pregnant women and parents are not ‘patients’. The topic of when to
clamp the umbilical cord at very preterm birth was identified through discussion with parent representatives,
including Gill Gyte, offering perspectives from the National Childbirth Trust (NCT). Consultation with parents,
through Bliss, quickly made clear that parents viewed change in practice at this difficult time with considerable
caution. A strong parent perspective throughout the planning and conduct of our research was clearly
essential to ensure relevance, quality and a timely delivery. This was achieved through partnership with
representatives of the NCT (https://www.nct.org.uk/) (GG) and Bliss (https://www.bliss.org.uk/) (Jane Abbott
and Zoe Chivers). Their input included being co-applicants in the grant application, membership of the
programme steering group, membership of most project management groups, co-authorship of many
programme publications, and active dissemination of outputs through their organisations. Success of this
collaboration was reflected in a Bliss ‘Advancing care through research’ award for the programme.
Additional patient and public involvement contributed to the JLA Preterm Birth PSP, which involved both
service user organisations and service users (parents and adults born premature). A personal reflection
from one service user member of the steering group demonstrates both the value and the challenges of
such involvement (Box 1). In addition, the TSC for the Cord pilot trial included two independent parent
representatives, and parents commented on information for participants.
BOX 1 Personal reflections from a parent member of the steering group for the JLA Preterm Birth PSP
In the early part of 2012, I received an e-mail in my work capacity at the charity KIDS. Attached to the
introductory e-mail was a survey about preterm birth research, which I circulated to my caseload of parents in
the London borough of Camden. I then completed the survey myself, as I also happen to be a parent of a
daughter who was born 11 weeks prematurely.
I was at the time just completing a Master’s degree and my research dissertation regarded an aspect of preterm
birth and the development of Cerebral Palsy. With this added interest, I contacted the researcher who had sent
out the survey in order to discuss the research further. During our meeting, she mentioned that a fundamental
part of this project was for service users and health-care professionals to come together to set priorities and
that my involvement, as a parent, within the steering group would be most welcome.
The journey that followed was both fascinating and rewarding. There was a steep learning curve about a
process like this – which saw the identification of unanswered questions about causes, care and treatment of
preterm birth through to the prioritisation by service users, clinicians and researchers of the Top 15 issues for
future research. There was also great validation in being a respected and involved participant of the steering
group throughout the process, culminating in my presentation of the parent perspective on this piece of work
at the European Congress of Perinatal Medicine in Florence (where our work won a prize in the top 6)!
Having felt incredibly held and supported during steering group meetings where my contribution was
encouraged and valued, there were times, particularly during group conference calls or in the e-mail rounds,
when I wondered whether my input was necessary or appropriate and I often felt quite overwhelmed by the
scientific complexity of the overall process and project. This seems pertinent to acknowledge in a field that has
patients at its centre, but often has to go beyond their sphere of understanding or comfort.
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Initially it felt that my value was to bring in my personal experience, and I was often called on to reflect my
perspective as someone who had been impacted by preterm birth. However, at times it was hard to know how
to pitch this within the high level of theoretical rhetoric, both from a medical and a research position. I did
often wonder at how the personal voice can be lost in the higher level of complexities and detail.
All of that said, the overarching feeling has been one of being embraced and encouraged, with the reminder
that this sort of collaborative work brings together individuals with very different skills and experience for a
reason. The process as a whole felt empowering and the knowledge that my personal experience was playing
a vital part in bringing fresh understanding was validating.
Bev Chambers
Reproduced with permission from Bev Chambers.
BOX 1 Personal reflections from a parent member of the steering group for the JLA Preterm Birth PSP (continued)
DOI: 10.3310/pgfar07080 PROGRAMME GRANTS FOR APPLIED RESEARCH 2019 VOL. 7 NO. 8
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Duley et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
9

Work package 1: identifying and
prioritising research gaps relevant to
preterm birth – a James Lind Alliance
Priority Setting Partnership
See Appendices 2–4 for the published and unpublished reports of this work.
Research aims
Our aims were to:
l identify and prioritise research gaps relevant to preterm birth that are most important to people
affected by preterm birth and health-care practitioners in the UK
l describe how service users and clinicians interact when making collective decisions about research
priorities, and how they communicate when deciding research priorities together.
Identifying and prioritising research gaps relevant to preterm birth
Prioritisation process
Using methods established by the JLA,95 we first identified unanswered questions about the prevention
and treatment of preterm birth from people affected by preterm birth, clinicians and researchers. Then
we prioritised those questions that people affected by preterm birth and clinicians agreed are the most
important (Figure 2).
Initiation of the partnership
The Preterm Birth PSP was initiated in November 2011, following an earlier introductory meeting of potential
stakeholders. The 29 participating organisations were asked to complete a declaration of interests, and a
steering group was convened that included members from nine of these organisations. At the introductory
workshop it was clear that many participants felt that the scope of the partnership should be wider than
was initially envisaged, for example including uncertainties about the causes of preterm birth, the prognosis
following being born preterm, and interventions long before birth.
Consultation
As widening the scope too far risked making the prioritisation unachievable, the steering group restricted
the scope to uncertainties about treatments and to interventions during pregnancy and around the time of
birth or shortly afterwards (taken up to the time of hospital discharge for the baby after birth).
Research questions were gathered from people affected by preterm birth, clinicians and researchers using
methods developed by the JLA.95 This included a survey completed online by 349 people, and in paper
format by 37 women attending specialist preterm birth antenatal clinics at two tertiary level hospitals and
parents visiting two neonatal intensive care units. These 386 responses contained 593 potential research
questions. In addition, 540 potentially relevant research questions were identified from systematic reviews
of existing research and from national UK clinical guidelines.96–107
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Collation
All questions were screened to identify those sufficiently similar to either merge or group into broader
questions and to remove any that were out of scope, unclear or being answered by a subsequent or
in-progress randomised trial. This left 70 unanswered questions from the survey, 28 from systematic
reviews and 24 from clinical guidelines remaining in the process. Of these 122 questions, 18 overlapped
with other questions and were merged to give a final ‘long list’ of 104 unanswered research questions.
Prioritisation
This was a two-stage process. First, the long list of 104 questions was sent out for voting on the top
10 questions, online and in paper format, using a modified Delphi survey. The steering group reviewed
ranking by the 507 people who voted, overall and by stakeholder group. They removed remaining overlap
or repetition between questions, before agreeing the shortlist of 30 questions to go forward to the second
stage: a prioritisation workshop. This workshop had 34 participants, including representatives from people
affected by preterm birth and clinician organisations as well as parents of babies born preterm and adults
who were born preterm. At the workshop, nominal group technique95 was used to achieve consensus on
ranking the 30 questions.
Online and paper format
uncertainties survey with
386 responses, yielding
593 potential questions
Top 15 research priorities
Steering Group removes out-of-scope and duplicate
questions, and merges overlapping questions
Questions in prioritisation survey,
online and paper format
(n = 104)
PaPB
priorities
HP
priorities
PaPB and HP
priorities
Top 30 priorities ranked at final workshop
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o
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Accessing partner organisations
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FIGURE 2 Flow chart of the JLA Preterm Birth PSP. HP, health professional; PaPB, people affected by preterm birth.
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Key findings
We identified 104 unanswered research questions (Oliver S, Duley L, Uhm S, Crowe S, David A, James CP,
et al. Top Research Priorities for Preterm Birth: Results of a Prioritisation Partnership Between People
Affected by Preterm Birth and Healthcare Professionals. Unpublished). Consensus was not achieved on a
top 10, and so a top 15 research priorities was agreed (Box 2).31 This top 15 had significant differences to
the ranking following public voting. The most noticeable were two questions ranked 18 (How do stress,
trauma and physical workload contribute to the risk of preterm birth, are there effective ways to reduce
those risks and does modifying those risks alter outcome?) and 26 (What treatments can predict reliably
the likelihood of subsequent infants being preterm?) at the workshop. These were outside the top 15 but
had been ranked 3 and 4, respectively, in the public vote.
Describing how service users and health-care professionals interact when
making collective decisions about research priorities
Methods for data collection
The study sample comprised attendees at 13 meetings of the Preterm Birth PSP: 12 steering group
meetings (three conference calls, nine face to face) and the final prioritisation workshop. These were all
recorded and transcribed. An ethnographical approach108 was adopted with participant observation109 and
discourse analysis110 of the recordings, field notes and analysis of documentary records of meetings and
steering group activities.
Analysis
Transcribed data were coded using an analytical framework based on the Elaboration Likelihood Model111–113
using NVivo 10 (QSR International, Warrington, UK) software. We coded discussion as using either a central
route (rational argument with evidence) for persuasion or a peripheral route (relying on emotional responses
BOX 2 Top 15 UK research priorities for preterm birth.
1. Which interventions are most effective to predict or prevent preterm birth?
2. How can infection in preterm babies be better prevented?
3. Which interventions are most effective to prevent necrotising enterocolitis in premature babies?
4. What is the best treatment for lung damage in premature babies?
5. What should be included in packages of care to support parents and families/carers when a premature
baby is discharged from hospital?
6. What is the optimum milk-feeding strategy and guidance (including quantity and speed of feeding and
use of donor and formula milk) for the best long-term outcomes of premature babies?
7. What is the best way to judge whether or not a premature baby is feeling pain (for example, by their face,
behaviours or brain activities)?
8. Which treatments are most effective to prevent early-onset pre-eclampsia?
9. What emotional and practical support improves attachment and bonding, and does the provision of such
support improve outcomes for premature babies and their families?
10. Which treatments are most effective for preterm premature rupture of membranes?
11. When is the best time to clamp the umbilical cord in preterm birth?
12. What type of support is most effective at improving breast feeding for premature babies?
13. Which interventions are most effective to treat necrotising enterocolitis in premature babies?
14. Does specialist antenatal care for women at risk of preterm birth improve outcomes for mother and baby?
15. What are the best ways to optimise the environment (such as light and noise) in order to improve
outcomes for premature babies?
Reprinted from The Lancet, Vol. 383, Duley et al.,31 Top 15 UK research priorities for preterm birth, pp. 2041–2,
© 2014, with permission from Elsevier.
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to cues such as authority, commitment, consistency, liking, reciprocation, social proof or scarcity). For example,
prioritising a treatment because the speaker ‘wanted to know if there would be better outcomes’ was coded
as ‘central’ because of its rational approach. Asserting ‘I think this topic has to be number one because that is
sort of nice’ was coded as ‘peripheral’ with a ‘liking’ cue.
To investigate decision-making based on values, transcripts were coded into three types of discussion:114
informational (facilitator encourages participants to speak, defers controversy and lets participants know
their ideas will not be evaluated), problematical (participants consider the information and/or values
needed to address the issue intelligently) and reflexive (participants discuss their own discussion to learn
from the process).
To understand the process of consensus development, the JLA approach was compared with the ‘Group
Development Model’115 (Figure 3), which argues that every group experiences these five stages before
becoming a self-reliant unit. At each stage, the dynamics of the group change from periods of inefficiency
and uneasiness through to a period of high performance.
Key findings
Throughout their meetings, steering group members used a central route pathway (281/502, 56%) more
often than a peripheral route (221/502, 44%), and the peripheral cues they used most were ‘commitment’
and ‘consistency’. During the final workshop, ‘social proof’ (i.e. peer pressure, ‘we do this in our group’)
was used most frequently. Health-care professionals used the central route (n = 33) more than service users
(n = 15), and service users used the peripheral route (n = 23) more often than health-care professionals (n = 17).
The main types of discussion were ‘informational’ and ‘problematical’, with ‘problematical’ increasing
over time. For the first 18 months (up to compiling the long list of uncertainties) there were no ‘reflexive’
discussions, and these remained less frequent (n = 9) than ‘informational’ (n = 104) and ‘problematical’
(n = 169). For both ‘informational’ and ‘problematical’ discussion, speakers used central routes more often
than peripheral ones. When they used peripheral routes, for ‘informational’ discussion they used all the
peripheral cues. For ‘problematical’ discussion, cues used the most were ‘consistency’ during steering
group meetings, and ‘social proof’ during the final workshop. ‘Scarcity’ was more common later in the
process when there was more time pressure. Participants were less likely to accept peripheral route
messages, although when supported by a central route message from another speaker it became
more persuasive.
Group development model
Forming
Storming
Norming
Performing
Adjourning
JLA stages of partnership working
Initiation
Identification
Collation
Prioritisation
Reporting
FIGURE 3 Group Development Model versus JLA stages of partnership working.
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Four questions ranked in the top 10 after public voting were outside the final top 15. These were stress
and physical workload, preventing subsequent preterm birth, screening in the first trimester and multiple
birth. The last three moved down the ranking based on the argument that they were included in the
overarching top ranked question ‘Which interventions are most effective to predict or prevent preterm
birth?’. Arguments against ‘stress and physical workload’ were that it was similar to another question and
that it is not a conventional treatment and would be difficult to define or change.
There were similarities between the Group Development Model stages and the JLA PSP process, in
particular that ‘forming’ (or team building) was comparable with ‘initiation’, and ‘adjourning’116 was
comparable with ‘reporting’. At ‘storming’, team members were comfortable expressing discontent and
challenging other opinions, and at ‘norming’ they had a common goal and shared responsibility for
achieving it. In the PSP, these two stages were difficult to distinguish because the group repeated
‘storming’ after ‘norming’. At ‘performing’, team members were competent, autonomous and able to
handle the decision-making process, which was similar to ‘prioritisation’ in the PSP. However, when new
members joined for the final workshop, this returned the group to an early development stage (‘forming’),
as they needed to get to know each other and define their roles and tasks. Only then could the group
begin to ‘perform’ and prioritise the research questions. This discrepancy in terms of group development
between steering group members and the new participants may have influenced the quality of the final
consensus.
Strengths
Strengths of this Preterm Birth PSP include the large numbers of participants in the process and the range
of stakeholders involved. Although several of the top priorities are already well recognised as important,
such as what is the optimum milk-feeding regimen for preterm infants, others are indicative of areas
previously under-represented in research (e.g. packages of care to support families after discharge and the
role of stress, trauma and physical workload in the risk of preterm birth). This is in keeping with findings
from previous JLA partnerships and highlights the value of shared decision-making.117
Challenges
Preterm birth is associated with factors such as lower socioeconomic status, ethnicity and maternal age.118
Despite implementing strategies to reach a representative population, our respondents remained primarily
white and with a relatively high proportion of homeowners and so were not representative of those most
affected by preterm birth. This may limit the relevance of these priorities to other populations.
The JLA PSP process uses a modified Delphi with individual voting, followed by a face-to-face workshop
using Nominal Group Technique. Combining these two methods aims to maximise the advantages of both
while minimising their disadvantages. The ‘lost priorities’ demonstrate that merging the two methods may,
in some instances, weaken the benefits of each method. Large changes in ranking between individual
voting and the final workshop appeared to be related to difficulty in the perspective of people affected by
preterm birth being heard in the large group session, and a difference in the priorities of two key groups
of health professionals (neonatologists and obstetricians).
Maintaining balanced representation between people affected by preterm birth and the different groups
of health professionals for the final prioritisation workshop was challenging, and may have influenced the
final ranking. The difficulty in achieving consensus underlines the complexity of priority setting for research,
particularly for preterm birth. Pregnancy is not an illness or disease, and it involves at least two people
(mother and child); preterm birth can have lifelong consequences for them and their families, as well as for
the health services and society. This complexity and the differing priorities of different stakeholders make
it important to consider the top 30 list, and the long list of 104 questions (Oliver et al., unpublished),
as well as the top 15 priorities, when planning and funding new research.31
DOI: 10.3310/pgfar07080 PROGRAMME GRANTS FOR APPLIED RESEARCH 2019 VOL. 7 NO. 8
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Duley et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
15
Implications for future research
These 15 top priorities provide guidance for researchers and funding bodies to ensure that future preterm
birth research addresses questions that are important both to service users and to clinicians. Although
people affected by preterm birth and health-care professionals had many shared priorities, they had
different perspectives on some questions. Priorities may also change over time and in different settings.
Therefore, when planning and funding research it is important to consider not only the top 15 priorities
but also the top 30 ranked by those affected by preterm birth and the top 30 ranked by health-care
professionals.
Future prioritisation processes, particularly those with a similar wide range of health-care professionals,
should endeavour to anticipate potential different perspectives and mitigate any imbalance where
possible, and should report voting separately by ‘service users’ and health-care professionals. Health-care
professionals who are also researchers should declare this potential conflict before participating in the
prioritisation workshop, so that it can be taken into account.
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Work package 2.1: evidence-based
immediate care of the very
preterm infant
Newborn infants who have delay in establishing independent respiratory effort after birth may requiretransition support in the delivery room. To support development of guidance for providing initial
neonatal care beside the mother, and also to provide a context for determining how deferred cord clamping
might be integrated with evidence-based transitional assessment and support practices in the Cord pilot
trial, we conducted an overview or ‘umbrella review’ of relevant Cochrane reviews.
See Appendix 5 for the unpublished report of this work.
Research aims
Our aims were to identify Cochrane reviews of delivery room transition support interventions, appraise
review quality and identify important gaps in the evidence.
Methods for data collection
We undertook a systematic overview (umbrella review) using the standard methods of the Cochrane
Collaboration and the Centre for Reviews and Dissemination.119,120 We registered the overview on
PROSPERO (registration number CRD42012003038). We searched the Cochrane Database of Systematic
Reviews121 (Issue 6, 2015) for reviews evaluating any intervention for delivery room support of newborn
infants. We excluded reviews of interventions that are more usually or feasibly delivered following
admission to the neonatal unit, and those administered to all infants as part of routine practice.
Analysis
For each review, two reviewers independently extracted information on review quality characteristics, and on
the participants, treatment and control interventions, and outcomes. Review quality was assessed using the
11-item AMSTAR (A MeaSurement Tool to Assess systematic reviews) tool.122,123
Key findings
Eighteen Cochrane reviews were identified. Broadly, these reviews assessed delivery room interventions for
airway management, respiratory or circulatory support (four reviews); surfactant replacement therapy for
preterm infants with or at risk of respiratory distress syndrome (eight reviews); supplemental oxygen or other
drugs for infants compromised at birth (five reviews); and strategies for influencing placental transfusion
(one review). The overall quality of reviews was good, but methodological quality of the included trials
varied greatly. Four reviews had no included trials. The most commonly prespecified primary outcomes were
death, incidence of chronic lung disease and neurodisability. Two reviews prespecified surrogate outcomes,
such as physiological measures, rather than clinically important primary outcomes. There are few data on
long-term neurodevelopmental outcomes.
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Of the four reviews that assessed interventions to support the infant airway and breathing, two did not find
any eligible trials and one included only a single small trial.124–126 The fourth review assessed delivery room
airway support for infants at risk of meconium aspiration (four trials, 2884 participants) and concluded that
there is no evidence that routine endotracheal intubation reduces mortality or morbidity in vigorous term
babies with meconium staining compared with standard resuscitation.127
The strongest evidence supported type and timing of surfactant administration for preterm infants.
Two reviews, originally published in 1997, provided strong evidence that for very preterm infants, surfactant
replacement reduced the risk of death by about 40%.128,129 A related review concludes that natural
surfactant is more effective than synthetic surfactant for reducing the risk of death.130 These reviews are
now regarded as ‘complete’, as further trials would be unlikely to change their conclusions. Subsequent
reviews found evidence that early surfactant administration with brief ventilation reduces the need for
mechanical ventilation and associated morbidity, but that prophylactic (delivery room) administration is
not more effective than delayed selective administration when infants have prophylactic nasal continuous
positive airway pressure support.131,132 Uncertainty remains about the comparative effects of newer synthetic
surfactants that contain surfactant protein mimics, and of novel non-invasive routes for administering
these.133,134
Five reviews assessed supplemental oxygen or other drugs for infants compromised at birth. One
compared using air rather than 100% oxygen for newborn resuscitation at birth.135 Five trials were identified
(three were quasi-randomised), but the review concluded that there was insufficient evidence to support a
recommendation for using either intervention. Three reviews assessed other drug interventions.136–138 Of these,
two assessed adrenaline or sodium bicarbonate during resuscitation and found insufficient evidence for reliable
conclusions.136,137 The third review assessed naloxone for infants exposed in utero to opiates and identified nine
trials, but none assessed clinically important outcomes.138 The fifth review examined interventions to prevent
hypothermia in newborn very preterm infants,139 and it concluded that various measures, including plastic
wraps or bags and warming mattresses, reduce the risk of delivery room hypothermia, but found insufficient
data to assess effects on infant morbidity and mortality.
One review assessed timing of cord clamping and other strategies for influencing placental transfusion at
preterm birth.140 This review found evidence that deferring cord clamping for 30–120 seconds, rather than
clamping before 30 seconds, probably reduced the need for blood transfusion and possibly reduced the
risk of IVH. Data from 13 out of the 15 included trials did not identify a statistically significant effect on risk
of death. Long-term neurodevelopmental outcomes were not reported.
Implications for research
Some reviews identified key evidence gaps. These were mainly related to pharmacological intervention for
transition support or resuscitation of newborn infants, and the effectiveness of new, less invasive forms of
airway management (and related issues regarding surfactant delivery).
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Work package 2.2: ethics issues in
recruitment of preterm or sick infants
to perinatal trials
The recruitment of very preterm or sick infants to clinical trials requires approaching parents at a difficulttime, often with a tight time scale for making a decision. This raises challenges for obtaining valid
informed consent to such research.
See Appendices 6 and 7 for the published reports of this work.
Research aims
We aimed to synthesise:
l Observational and qualitative studies that explored the process of recruitment and consent, and
reported parents’ and clinicians’ views and experiences.
l Analytical (or philosophical) studies that have examined the pertinent ethical questions. These concern
the validity of consent, the proper understanding of the parental role in giving or withholding consent,
varied possible methods of seeking consent, the best interests of those involved, issues of risk, and the
parallels between consent processes in relevant research and clinical contexts.
The goal was to identify both the challenges to an ethically defensible consent process and their potential
solutions. Ideally, these solutions would include strategies that we could implement to improve the consent
process in the Cord pilot trial.
Methods for data collection
The methods used for this review conformed to those set out for a framework synthesis.141 The first stage
was the development of a tentative initial conceptual framework based on prior knowledge of the existing
philosophical literature on informed consent, including in neonatal research.142,143 This initial framework
informed the criteria for including studies and it suggested terms for the literature searches. After refining
the framework in the light of the literature from the first searches, the second searches were developed.
All searches were updated (for examples of search strategies, see Appendices 6 and 7).
Analysis
Empirical studies
For the empirical studies, the conceptual framework was modified to focus on specific questions prioritised by
the authors, and further searches devised, guided by bioethics review methods studies.144,145 We screened
abstracts of the papers from identified citations for inclusion, using the five criteria from the modified framework:
1. parents’ views of neonatal trials
2. clinicians’ views of neonatal trials
3. parents’ and clinicians’ views of parental consent/decision-making in clinical practice if the articles
concerned the validity of the consent in an emergency situation, or during or soon after labour
4. validity of consent
5. other options for gaining consent.
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Analytical studies
For the analytical studies, discussion of the initial themes that were identified confirmed the conceptual
framework. Further searches were informed by this framework and by bioethics review methods
studies.144–146 We screened abstracts of papers from identified citations for inclusion, using the five criteria
from the confirmed framework:
1. consent, participation or recruitment for neonatal research (relevant to clinical trials)
2. parental decision-making for treatment of, or research with, sick or preterm neonates
3. parental decision-making for birth and/or labour
4. methodology in emergency/urgent neonatal research
5. alternative ways of gaining consent for neonatal research.
Overall, we ‘included’ 49 empirical papers and 30 analytical papers (Figure 4). All studies met the quality
assessment criteria. For the empirical papers, we identified five themes: (1) attitudes of parents, (2) attitudes
of clinicians, (3) validity of consent, (4) different consent processes and (5) miscellaneous topics. For the
analytical papers we identified four themes: (1) ethical basis of parental informed consent for neonatal
research, (2) validity of parental consent, (3) other options for gaining consent, and (4) risk and the double
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FIGURE 4 The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram for
the framework synthesis. Derived from Wilman et al.79 [© Wilman et al., 2015. This article is distributed under the
terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate
credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated] and Megone
et al.78 [© The Authors, 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available
in this article, unless otherwise stated].
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standard between consent for treatment and consent for research. We coded articles and tabulated them
against these themes.
Key findings
Empirical research
Our review found that the stated motivations for parents to consent were altruistic: the benefit entering
the trial might bring to others; the possibility of some benefit for their baby, or themselves; or the trial
bringing some hope in a hopeless situation.79 Motivations to decline participation in research were
inconvenience to parents, burden to their child, or worries about risks, particularly for the baby. Some
parents felt that they did not have enough time to decide. Severity of illness of the infant did not appear
to affect trial participation.
Parents felt that formal consent for research was necessary and protected their child. Most parents felt
that they ought to make the decision about whether or not their child participated in research. They
wanted to feel informed and involved, and considered it their responsibility to make this sort of decision.
However, many parents also wanted input from others before making the decision, including family and
their doctor. Some parents did not want to make the decision. Others felt that being approached about a
trial added to their stress and anxiety, particularly if they were approached at an inappropriate time.
Clinicians respected parental authority and largely felt that parental consent was necessary for trials.
Reasons for this were that it respects ‘parental rights’, parents are best placed to act in the best interests
of their child, and parents must live with the long-term outcomes of their decision. On the other hand,
some clinicians felt that clinicians are the best decision-makers for sick babies, and some wanted to spare
parents the burden of making this decision.
Clinicians felt that consent forms protected researchers (by providing confirmation that information was
given), and aided communication with parents. However, clinicians also worried that too much information
added to parents’ burden, and noted barriers to effective communication (e.g. intimidation of parents, and
lack of care and support for them). Clinicians raised concerns about balancing their responsibility to the
trial with their responsibilities to the parents. Some considered these ‘equal responsibilities’ and felt that
it was possible to discharge both. Others saw the possibility of ‘divided responsibilities’ causing anxiety to
clinicians, or saw the need for ‘prioritised responsibility’ in which clinicians put parents’ interests before the
interests of the trial.
Interviews with parents who had given consent for neonatal trials suggested that this consent was valid
for only 59% in terms of voluntariness, competence and informedness. Some parents reported feeling
pressure to participate, whereas others felt no pressure. Competence, or capacity, to give valid consent
may be affected by factors such as emotional state, understanding and time available to decide. Parents
reported being calm when they made the decision, but some felt that they had been anxious or stressed.
Some parents reported not making a proper decision because of the pain or anxiety, others reported
making considered decisions despite pain, time pressure or anxiety. Some parents had clear understanding
of a trial, but others reported problems with understanding a trial about which they were asked for
consent. Some parents felt that they could make a genuine decision even with suboptimal understanding.
Communication skills of the clinician affected understanding. Although parents largely felt that they had
adequate time, in the circumstances, to make the decision, a significant minority did not. Parents made
rapid decisions regardless of how much time was available, and they needed more time if there was a
greater risk. Parents largely received satisfactory information; however, some parents reported problems
with the information that they were given. The information sheet was often unread, although in some
studies parents remembered being given the sheet and used it when making their decision.
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In general, mothers acknowledged the difficulties for researchers in finding the ‘right time’ to approach them
for consent for perinatal research. Some parents would prefer antenatal consent rather than consent during,
or after, labour, and would like information earlier in pregnancy even if not recruited then. However, parents
were not completely comfortable with antenatal consent as they reported not seeing the relevance of the trial
at that time, and felt greater anxiety if told about the trial earlier in pregnancy. Some parents were comfortable
with consent in labour, but some were not. Parents were not comfortable with waived consent.
Opting out is when consent is presumed unless the parent explicitly opts out of the trial. Although some
parents were comfortable with opting out, others were not. For continuous consent, there is initial
agreement to participate with further discussion and information after recruitment. Validity of the later
‘continued’ consent improves when discussion continues after recruitment. Some parents approve of
continuous consent, but some have concerns about receiving further information at a later stage when
that might have affected their original decision. One study reported a staged consent process in which
consent (oral or written) is sought antenatally and the consent is sought again at the point of intervention.
However, at present this is only reported, not discussed.
The main conclusions are that:
l there is widely held agreement that it is important that parents do give or decline consent for neonatal
participation in trials, but that
l there is evidence that existing consent procedures are unsatisfactory, and that
l none of the proposed alternative consent processes reviewed by the research is satisfactory
l there are some significant gaps in the empirical research in this area.
Analytical research
The analytical research addressed the justification for seeking consent from a parent (or parents) to
neonatal or perinatal trials.78 This issue arises because it may be thought that it is not sensible to seek
consent when the most affected party is unable to give consent, in which case the focus should simply
be on that individual’s best interests. Hence, it is relevant to query the basis for consent being given, or
declined, by the parent. Justification for parental consent includes the importance of autonomy, such as
parental autonomy, or the parents’ own rights to make decisions about their child. A similar claim holds
that parenting decisions are part of deciding how to conduct one’s own life, while another defence
suggests that fetal rights are part of maternal autonomy. However, others have rejected any defence of
parental consent that appeals to autonomy, arguing that a parent’s interest in autonomous parenting may
not outweigh the child’s interests, or that parents do not ‘own’ their children.
A second claim in defence of parental consent is that parents should be seen as surrogate or proxy
decision-makers, where ‘proxy’ means not simply someone who acts on behalf of another but one who
represents another’s views. Some suggest that there might be reason for a parent to give consent even
if an appeal to autonomy or rights is rejected. Thus, it is held that it is not appropriate to think of the
‘autonomy’ of a neonate and, therefore, it is not appropriate to think of ‘informed consent’ for a child.
Another line of argument is that consent in the neonatal context is a case of ‘family decision-making’,
because it is not appropriate to consider the child’s decision in isolation. In addition, it is suggested that
parents should give consent because they will bear the consequences of the decision. However, some
claim that the requirement for parental consent rests on the value of beneficence; as the purpose of
informed consent is protection of the best interests of the child, it is the responsibility of parents to make
decisions as a way of promoting their child’s best interests, so they should give consent. Some have argued
that parents should be allowed to make the decision only when it is in the best interests of their child.
In reply to this, it is argued that the protection of the child’s best interests should not rest entirely or even
mainly on informed consent. It is the responsibility of the researcher or the ethics review process to protect
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the participant’s best interests (therefore, it is inappropriate to defend parental consent by an appeal to the
protection of those interests). In addition, the concept of parental consent is a misnomer; for neonates,
what should be discussed is parental permission (or authorisation).
An important theme was whether or not, in the neonatal and perinatal context, parental consent is valid,
and to what extent validity matters. Potential barriers to obtaining valid consent in these circumstances
include time limitations, which adversely affect the amount and quality of the information given; stress,
anxiety or pain of the parents; and the mother’s sedation. However, some writers have claimed that these
features can also contribute (positively) to an autonomous decision process. Parental desperation or fear
may affect the voluntariness of any consent given. Parents may also see the researcher as a figure of
authority, which may affect the voluntariness of their decision. A more indirect problem for gaining valid
consent is that the consent process itself increases parental anxiety.
Barriers to informed consent in this context have implications for respect for the principle of autonomy,
if that is the basis for seeking parental consent. Some argue that parental autonomy will be violated if
there is a defect in the consent process, whereas others suggest that parents are being used as a means to
an end in a consent process that may be flawed. A further argument is that the principle of beneficence
(acting for the benefit of the child and/or mother) becomes a more important ethical principle in research
with neonates because informed consent is not possible. Another response to the difficulties with and
barriers to consent is that we must strive for improvements in what we do to seek consent, and attempt to
get the best possible consent even when perfect informed consent is not possible.
The analytical research has examined a cluster of issues around risk in medical research and clinical
treatment. There are disagreements about the nature of the risks involved in research. One claim is that
if the context for the clinical trial is a potentially life-threatening condition, and the outcome of the
intervention is unknown, then the trial intervention should itself be viewed as a significant risk for the
participant. An opposing claim in this situation is that this is a risk of the disease and/or the situation,
and not of the trial, so it should not be viewed as a risk of the trial intervention. Another view is that fully
informed consent is not possible for clinical trials because the very information needed for fully informed
consent is that which is uncertain and under investigation.
Other ways of addressing the consent requirement include a claim that defends the idea of a waiver of
consent in emergencies. The suggestion is that consent can be waived, but that provisional assent must be
given at the time of being invited to participate, and there should be community involvement at the design
stage. The aim is to make research possible for the benefit of patients, so this waiver should not be used
to make research easier for researchers. Another approach defends a method by which consent is achieved
through giving women antenatal notification of the intended clinical trial, and then seeking consent if they
meet the criteria for trial entry. A third option discussed is that of deferred or continuing consent. This is a
process in which, if the parents are absent or affected by situational incapacity, they are assumed to give
initial consent and then provide consent when they are capable of taking in the information and making
the decision. However, this leaves open the possibility that consent is not given, in which case the trial
intervention would have constituted assault. Retrospective consent is argued to be ‘logically incongruent’
and, if consent is retrospectively withheld, the researcher is left in the position of never having had
consent. Another option is the Zelen method, in which parents are not informed if the novel ‘intervention’
will not be offered to the child. This final suggestion is the opt-out method for giving consent. This may
lessen the burden on parents, increase recruitment and increase understanding, but autonomy may be
overridden, for example if a participant fails to exercise their opt-out right by default rather than opting
out autonomously. All of these approaches involve a parent giving (or waiving) consent, but a final
alternative is to have a consent process in which an independent proxy gives consent for the child.
DOI: 10.3310/pgfar07080 PROGRAMME GRANTS FOR APPLIED RESEARCH 2019 VOL. 7 NO. 8
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Duley et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
23
These results reveal five key points about the consent process and highlight one important gap in the
research. The key points are as follows:
1. There is a variety of possible defences for seeking parental ‘consent’ to neonatal and/or perinatal trials,
and these are consistent with the strongly and widely held view that it is important that parents do give
(or decline) consent for such research, as found in the empirical literature.
2. In giving parental ‘consent’ in a perinatal context, parents are authorising infant participation, not
giving ‘proxy consent’.
3. There are philosophical reasons for supposing that at least some parents will fail to give valid consent in
a neonatal context. These support concerns about the consent process raised in the empirical literature.
4. None of the existing consent processes reviewed by the research is satisfactory. This matches the
findings of the empirical research.
5. There are reasons for giving weight to both parental ‘consent’ and the infant’s best interests in both
research and clinical treatment, but also reasons to treat these factors differently in the two contexts,
and this may be partly attributable to the differing relevance of risk in each case.
The significant gap in the philosophical literature is the lack of any detailed discussion of a process of
emergency and/or urgent assent followed by later full consent. This matches a gap found in the empirical
literature.
Successes
This is the first review focusing on the ethics issues around consent to neonatal or perinatal research.
Other reviews have focused on methods for increasing recruitment or improving how information is
conveyed, but none has focused directly on the ethics issues.61,147–151
Challenges
The key challenge lay in this project being a relatively novel departure for systematic review methods, as it
involved reviewing systematically across the disciplinary boundaries between philosophy, social science and
medicine. To address this, the multidisciplinary team included expertise in philosophy, clinical practice,
social science, information science and advocacy for parents. For the philosophers, the systematic review
methods were somewhat different from those that are conventionally adopted in work on ethics. The
notion of a systematic review is uncommon, indeed almost unknown, as a method for conducting research
in philosophy, both in philosophy as a whole and in philosophical medical ethics in particular.144,152 On the
other hand, for the social scientists and clinicians the standard philosophical means for resolving ethics
problems were unconventional. As a result, the whole process of developing a systematic review in ethics
through interdisciplinary collaboration has given rise to considerable reflection in its own right.
Implications for future research
We identified three important gaps relevant to consent for perinatal trials:
1. Studies on a new process for obtaining urgent or emergency consent in perinatal research where
there is little time in which to seek consent to participation. This process involves seeking ‘assent’ to
participation in the trial from parents, accepting that there is insufficient information for fully informed
consent at that point, but then providing further information over time which allows the parents to give
full consent (or an informed withdrawal).
2. Studies on fetal–maternal research, that is, trials in which both the mother and the fetus or neonate are
participants and thus in which both fetal/neonatal interests and maternal interests are in question.
3. Empirical studies that report the views of bereaved parents on the consent process.
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This review provided part of the rationale and justification for including a two-stage consent pathway in
our Cord pilot trial (see Work Package 4), as part of the feasibility assessment for a large trial. Participation
by parent representatives (members of NCT and Bliss) in the ethics review, in the development of the pilot
trial protocol and in the programme steering group contributed to robust discussion about development of
this pathway. They focused on how it should be presented to women and their partners and how it should
be evaluated. Endorsement of the trial protocol from these organisations was important in securing ethics
committee approval and in communication with parents. Hence, this programme has contributed to filling
the first two research gaps identified in our review.
At the time of our research, empirical studies had almost completely excluded views of parents whose
sick child participated in research and died. Since then, however, the Bereavement and RAndomised
ControlLEd Trials (BRACELET) study addressing this gap has been published.153
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Work package 3.1: neonatal care at
birth, a survey of current practice
There are guidelines for initial resuscitation and stabilisation of preterm or sick babies at birth. To assesscompliance with these guidelines and determine if any units were providing initial neonatal care beside
the mother, we conducted a survey and interviewed selected sites.
See Appendices 8 and 9 for published reports of this work.
Research aims
This study aimed to describe current practice for providing neonatal care in the delivery room, and for
providing neonatal care at birth beside the mother.
Methods for data collection
We surveyed all neonatal units in the UK using a short online questionnaire to ask about neonatal care
in the delivery room at very preterm births. Units reporting they were using deferred cord clamping or
cord milking were selected, using purposive sampling, to participate in semistructured interviews. Two
researchers interviewed experienced practitioners either in person or by telephone. Interviews were
recorded and transcribed.
Analysis
Overall, 197 survey responses were received from 199 hospitals, of which 186 (94%) were fully completed.
Seven units participated in the semistructured interviews: five tertiary hospitals, and one large and one
small district hospital. Overall, 33 staff members were interviewed: seven midwives, seven neonatologists,
two paediatricians, six neonatal nurses, seven obstetricians and four managers. Constant comparative
analysis identified five core themes: (1) variability in guidelines and practice, (2) assessing eligibility,
(3) competing priorities, (4) anxiety about timing and (5) persisting uncertainty.
Key findings
There was variation in delivery room stabilisation practice for infants born very premature, and in tertiary
units the care provided was more consistent with current international guidance than in non-tertiary units.68
For example, tertiary units administered more surfactant in the delivery room (93% vs. 78%), were more
likely to provide CPAP (77% vs. 50%) or positive end-expiratory pressure in the delivery room (91% vs.
69%), and were more likely to start resuscitation in air or blended oxygen (91% vs. 78%) than non-tertiary
units. Routine out of hours consultant attendance at very preterm birth was also more common in tertiary
units (82% vs. 55%).
Our interviews suggested that variation in how deferred cord clamping and other strategies to influence
placental transfusion at very preterm birth were being implemented, both between units and within the same
unit.67 For example, there was variation in when the cord was clamped, position of the baby with the cord
intact, timing of the prophylactic uterotonic drug, and which babies were seen as eligible for this intervention.
Deferring cord clamping was felt to require multidisciplinary agreement because of the perceived conflict
between waiting to allow placental transfusion and a wish to ‘get on’ with keeping the baby warm and
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providing newborn life support interventions. In some units, whether or not this happened depended on
which staff members were present. No unit was providing neonatal care with the cord intact, and there was
staff anxiety associated with this practice.
Implementation of deferred cord clamping, or cord milking, appeared most likely to be successful if there
was strong local multidisciplinary support, with agreement on a single technique and the eligibility criteria.
Clinical leadership and training in the practical techniques, combined with audit, also appeared to be helpful.
Successes
Use of telephone reminders for the online survey helped us achieve a high response rate. A strength of our
interviews was the inclusion of all the relevant professional groups, and that the prior survey allowed us to
identify units with relevant experience.
Challenges
Both the survey and the interviews relied on reported practice rather than direct observation. The interviews
were based on a small sample and, as at that time deferred cord clamping was not widely practised, may not
be representative of all UK units.
One of the reasons this study was included in the programme was to identify UK units where neonatal
care was being provided with the cord intact, so that we could learn from their experience. No such unit
was identified, although introducing neonatal care with the cord intact was being discussed at one unit.
Implications for future research
Since this work was completed,154 both the timing of cord clamping for very preterm births and providing
neonatal care with the cord intact have become increasingly topical. This has been fuelled by new research,
including the work conducted within this programme. A change in culture is leading to a shift away from
the previous practice of immediate cord clamping at very preterm birth. In the UK, waiting at least 30 seconds,
but no longer than 3 minutes, before clamping the cord of preterm babies is now recommended if the
mother and baby are stable.155 Hence it would be timely to repeat a survey of practice for timing of cord
clamping and immediate neonatal care.
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Work package 3.2: parents’ views of
care at preterm birth
There has been little research looking at parents’ initial experiences and reactions to very preterm birth,or into their experiences and satisfaction with care during very preterm birth.
See Appendices 10–12 for the published reports of this work.
Research aims
The aims of this work package were to:
l Explore parents’ experiences of very preterm birth, and their first moments with their baby, through
three separate analyses to explore:
1. mothers’ and fathers’ initial experiences of the birth of their very preterm baby
2. parents’ experiences and satisfaction with their care during very preterm birth, and to identify the
domains associated with positive and negative experiences of care
3. parents’ views and experiences of the care for their very premature baby on a neonatal intensive
care unit (NICU).
l Systematically review available measures of parents’ satisfaction with care during labour and
giving birth.
l Develop a questionnaire to measure parents’ satisfaction with care during very preterm birth (P-BESS).
Methods for data collection
Parents whose baby was born before 32 weeks’ gestation during a 6-month period at three NHS hospitals
in the south of England were sent letters of invitation to participate in the qualitative interviews (see
Appendices 10 and 11 for full details). Of 123 eligible parents, 39 (32%) agreed to be interviewed
(32 mothers and 7 fathers).36 Two babies died shortly after birth. Interviews contained 13 open-ended
questions and lasted about 45 minutes. They were conducted by one psychologist and took place at the
participants’ home, or in a private hospital room. Interviews were recorded and transcribed. Reporting
complied with COREQ (Consolidated criteria for reporting qualitative research).154
For the comparative review, studies were included if they reported use of a questionnaire that was a
multi-item scale of satisfaction with care during labour and birth, and provided psychometric information
(about questionnaire construction, reliability or validity) for the satisfaction measure.43 To identify potentially
eligible studies we used the search terms (Birth or Childbirth or Lab*r or Intrapart*) AND (Satisfaction or
Perception or Evaluation) AND (Questionnaire or Measure* or Scale or Instrument). We searched Scopus,
PsycArticles, PsycINFO, PubMed and Web of Science from inception to 30 July 2011, and checked reference
lists in reports of included studies for additional studies. Duplicate citations were removed. Finally, Web of
Knowledge and Scopus were searched for all reports that cited the final questionnaire measures; no new
citations were identified. Data extraction was by two reviewers.
Initially we developed the questionnaire using data from the interviews and studies identified in the
comparative review. We identified seven areas of satisfaction with care during preterm birth: (1) information
and explanations, (2) emotional support, (3) encouragement and reassurance, (4) staff being confident
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and in control, (5) staff being calm in a crisis, (6) involvement of the partner and (7) birth environment. Thirty
questions were included, both positively and negatively phrased, and responses scored on a Likert scale; we
made minor changes following feedback from nine parent representatives. The questionnaire was then posted
to parents of babies born very preterm during the previous 12 months at five tertiary care centres in England.
Analysis
We used inductive systematic thematic analysis to identify themes across interviews. Data were managed
using NVivo software. For the systematic review, we assessed psychometric quality of each questionnaire
using questionnaire construction (item generation, pilot study), reliability (internal consistency, test retest
reliability) and validity (content, face, criterion and construct).
For the questionnaire, a factor analysis was conducted to explore whether questions could be combined
into subscales that represent different aspects of satisfaction with care during very preterm birth. Three
questions asked about partner’s involvement so, as they were not relevant for all women, they were
excluded from the initial analysis. Hence, 27 questions entered into the factor analysis. The number of
factors to be retained was determined using the scree plot and eigenvalues > 1. Questions that loaded on
a factor at > 0.4 were considered significant and were retained. Questions that loaded on more than one
factor ≥ 0.3 were removed and the analysis was rerun. To check whether questions and subscales for the
women were applicable to partners, we conducted a confirmatory factor analysis.
Content validity is evident through the systematic series of steps taken when designing the questionnaire.
Convergent validity was explored by examining the relationship between the total score (and associated
subscales) with two questions assessing overall satisfaction with care during the birth, and reliability by
looking at indicators of internal consistency.
Key findings
Parents’ experiences of very preterm birth and their first moments with their baby
Following very preterm birth, almost half of parents had difficulty remembering aspects of the birth.36
Two-thirds saw their baby at birth and one-third saw their baby for the first time in the neonatal unit. The
anticipation before seeing their baby for the first time was characterised by contrasting emotions, with some
parents eager and excited, whereas others, while wanting to see their baby, nevertheless felt scared and even
dreaded the experience. For example, one father (2, caesarean section, delayed card clamping) said ‘They
rang down and said “do you want to come up and see little one?” We went ”yeah course we do, you know,
brilliant”’, one mother (27, caesarean section, delayed card clamping) said ‘I was very scared of seeing him’,
and another mother (24, vaginal birth, delayed cord clamping) said ‘I thought I’ll go onto the ward and,
thoughts running through my mind of what I was, what I was gonna find, how many tubes was he gonna
have, was he gonna be OK, what colour was he gonna be, did he have everything, 10 fingers 10 toes,
and I found myself sitting by the incubator counting and making sure he had 10 fingers and had 10 toes’.
Similar contrasting emotions were described about touching their baby, for example one mother saying
‘You don’t want to hurt them. You’re so on edge, and you want to care for them and touch them if you
can, or whatever, but also you just feel terrible if you think you’ve done something wrong’.
First contact with their baby was characterised by turbulent emotions, described as a ‘rollercoaster of emotions’.
Parents spoke about the confusion of feeling both elated and devastated, and others felt guilt about the
preterm birth. One mother said ‘. . . I was all prepared, arms out and they give her to me, and it was wonderful,
absolutely wonderful’, and another commented ‘you just feel guilt, the guilt is overwhelming, you know you do
kind of go through aah, not feeling sorry for yourself, it’s just the guilt, it’s not “oh why’s this happened to
me?” it’s “why’s it happened to her?”‘. Half of parents who talked about touching and holding their babies
described immediate bonding with the first touch.37 Visiting NICU was initially overpowering, especially for
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those who had not been before or who were seeing their baby for the first time. This was described as ‘a little
hidden world, full of poorly babies’.38 Parents described awkwardness and exclusion felt by fathers, particularly
during emergency caesarean section, one comment being ‘It’s different being a man . . .’. Nevertheless, fathers
often saw their baby first, and typically experienced this alone.
Overall, the parents’ experiences of care during the birth were positive.36 Our study identified four determinants
of parents’ experiences of care during very preterm birth: (1) staff professionalism, (2) staff empathy,
(3) involvement of the father and (4) the birth environment. These are consistent with previous research on
term births. However, two factors unique to very preterm birth were the importance of the staff appearing
calm during the birth, and staff taking control during the birth. Parents felt that care could have been improved
in two areas: staff could listen more to what women said, and believe them; and the father could be more
involved in the birth.
Comparative review of measures of parents’ satisfaction with care during labour and birth
Nine questionnaires measuring satisfaction with care during labour and birth were identified (Figure 5). For
seven of these questionnaires, how the items were selected was described. Eight of these questionnaires
Records identified
(n = 17,823)
• Database search, n = 17,759
• Other sources, n = 64
Records inspected
(n = 12,365)
Excluded
(n = 11,912)
Duplicates removed
(n = 5458)
Full text retrieved and assessed
for eligibility
(n = 453)
Studies included
(n = 14)
With nine questionnaire 
measures identified
Full-text articles excluded
(n = 439)
• No measure of satisfaction with care, n = 105
• Not specific to birth, n = 80
• Qualitative, n = 71
• Not relevant after full inspection, n = 55
• Not in English, n = 41
• Single item, n = 24
• Discussion/opinion paper, n = 22
• Not for postnatal women, n = 9
• Dissertation, n = 7
• Fathers only, n = 5
• Insufficient information, n = 5
• Unavailable, n = 5
• Data repeated, n = 4
• No psychometric information, n = 4
• Conference abstract, n = 2
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FIGURE 5 The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow chart for the
comparative review. Reproduced from Sawyer et al.43 © Sawyer et al.; licensee BioMed Central Ltd 2013. This article
is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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had tests of internal consistency, but only one reported test–retest reliability.43 At least one aspect of
validity was reported for all questionnaires, but none reported criterion validity.
Only two questionnaires assessed satisfaction with different aspects of care, as well as the perceived
importance of these aspects of care. Three questionnaires were designed for particular types of births,
two for operative births and one for uncomplicated vaginal birth. None of the nine questionnaires
evaluated care for specific populations, such as parents of sick or preterm babies, or whose baby was
stillborn. Parent experiences in these situations may be substantially different from giving birth to a
healthy, term baby.
Preterm Birth experience and Satisfaction Scale questionnaire to measure parents’
satisfaction with care during very preterm birth
Based on the qualitative interviews with parents, the review and discussion with relevant experts, we
identified 97 potential questions in seven domains. Following screening by two experts, 30 items were
chosen (27 in the maternal section and three in the partner section) for the draft questionnaire.44 To check
face validity, content validity and ease of comprehension the P-BESS was sent to nine parent representatives,
following which minor changes were made to the wording.
We posted this 30-item questionnaire to 458 couples/single parents, and 147 were returned completed
(32% of couples/single parents, 147 women and 107 partners). Of these 24 were excluded, largely as they
were completed by partners who were not present at the birth, leaving 145 women and 85 partners. Initial
screening removed three questions that were not performing well. Another three were removed because
they did not significantly correlate with other questions. The remaining 21 questions in the maternal section
were entered into the factor analysis and a further four questions were removed (see Appendix 12). The final
factor analysis identified three factors with 17 questions for the maternal section: ‘staff professionalism and
empathy’ [seven questions, mean 29.2, standard deviation (SD) 5.1], ‘information and explanations’ (seven
questions, mean 27.9, SD 5.7), and ‘confidence in staff’ (three questions, mean 12.4, SD 2.5) (Table 1). The
mean score for the total scale was 69.5 (SD 11.6), out of a possible range of 17–85. Rerunning the factor
analysis with the addition of partner involvement questions confirmed that the three factors remained, with
the addition of a fourth factor with the partner involvement questions.
The total scale and subscales had good reliability and individual items correlated well with the total scale.
Reliability for the ‘partner involvement’ subscale was 0.72 but this increased to 0.91 with deletion of one
question, which was therefore removed. Convergent validity was explored by comparing the scales with
the two questions measuring overall satisfaction with care and the need for improvement. The total scale
and three subscales were all moderately to strongly correlated with these items. A confirmatory factor
analysis to check applicability to fathers showed that the scale was reliable (α = 0.93), but the three
subscales in women’s responses were not applicable to partners and the three factor solution did not fit
the partner’s data well. One possible explanation for this is that fathers’ experiences of preterm birth differ
from mothers’.44 We recommend that only the total score on satisfaction with care is used for partners.
Total scores were related to higher levels of overall satisfaction and less need for improvements, indicating
convergent validity for partners.
Successes
We achieved a good response to the invitation to be interviewed. The use of qualitative methods provides
an in-depth insight into the experiences of parents who have had a very premature baby. The inclusion of
fathers and bereaved parents also provides a valuable and unique perspective. Our data underline the
importance of listening to women during preterm labour and of encouraging fathers to feel involved during
the birth. Whenever possible, parents should be encouraged to visit the NICU before birth. If this is not
possible, parents could be provided with a photograph of their baby in the neonatal unit before they visit.
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Parents who are worried about touching their baby should be reassured and taught to recognise infant
behaviour in response to touch.
Having identified only two existing questionnaire measures of satisfaction with care during labour and
childbirth, both designed for term birth, we developed a new tool for use by both parents following very
preterm birth. This tool is the first specific to preterm birth. The total score may be useful to compare
satisfaction with care during very preterm birth across hospitals and differing practices, and individual aspects
of care can be evaluated using the separate subscales. We used this tool to measure satisfaction with care
in the Cord pilot trial (seeWork Package 4), and it has been translated into Spanish and Portuguese.
TABLE 1 The P-BESS questionnaire: maternal section with 17 items and partner involvement section with two items
During the birth
Strongly
agree Agree Neutral Disagree
Strongly
disagree
1 The staff explained everything really well
2 There was a pleasant atmosphere in the room
3 The staff made me feel cared for as an individual
4 The staff took control of the situation
5 I was given all the information I needed
6 The staff put me at ease
7 The staff were encouraging
8 I understood what was happening
9 The staff were reassuring
10 I did not have confidence in the staff
11 The staff explained to me what would happen during
the birth
12 The staff did not listen to what I had to say
13 The staff kept me informed of what was happening
14 The staff did not understand how I was feeling
15 The staff explained to me what would happen to my
baby when he/she was born
16 There were occasions when no one explained to me
what was going on
17 The staff were warm and friendly
18 The staff encouraged my partner’s/my involvement
19 The staff involved my partner/me in what was going on
Instructions were provided as follows: this questionnaire asks you about your experiences and satisfaction with care at the
birth of your premature baby. Please read each statement carefully and indicate the extent to which you agree or disagree
with each question. If you had a caesarean section under general anaesthetic then we understand that some of these
questions may be difficult to answer but please complete as best you can.
Subscales: Staff professionalism and empathy – items 2, 3, 4, 6, 7, 9 and 17; information and explanations – items 1, 5, 8, 11,
13, 15 and 16R; confidence in staff – items 10R, 12R and 14R; and partner involvement – items 18 and 19.R, reverse-scored items.
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Challenges
Although the response rate for our qualitative interviews was good for this type of study, we received responses
from parents whose baby was born only from two of the three hospitals, reducing the generalisablity of our
data. In addition, participants were mainly white, married women, which is not typical for very preterm birth.
In common with other studies of satisfaction, parents may have been reluctant to criticise the professionals
who took care of them and their preterm baby. This ‘halo effect’ may be even more pronounced for parents of
premature babies, as the staff have been looking after their baby for many weeks.44 Similarly, if women do not
know what care during birth should be like they may just evaluate the status quo.156,157 Our study used in-depth
interviews by a researcher not associated with the hospital, which should have helped to pick up relevant
negative experiences.
The response rate for development of the questionnaire was relatively low, although again this is a good
response for studies of this kind. The sample size was relatively small for a factor analysis, which limits the
validation process. In addition, the sample was not representative of all parents who have a very preterm
birth, as it included largely white, highly educated, married/cohabiting women and their partners. Finally,
as the same factor structure was not identified in partners as in women, only the total score is recommended
for use with partners, which means that the individual factors of care cannot be explored for them.
Implications for future research
Further research is needed to replicate our findings about parent experiences at very preterm birth, and to
explore whether or not there is variation for parents from different backgrounds. For the P-BESS, further
studies are needed to test the refined instrument in a larger, more representative sample of parents. Fathers
of preterm or sick babies are a difficult group to recruit into research.158 Our work highlights the importance
of including them in research studies to ensure that their perspective is represented.
Our experience in conducting semistructured interviews with parents following very preterm birth also
contributed to the design and conduct of an evaluation of parent and clinician experiences of neonatal care
beside the mother (see Work Package 3.5), and of women and clinicians’ experiences of the two-stage
consent pathway in the Cord pilot trial (see Work Package 4).
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Work package 3.3: measuring
placental transfusion
P revious research into the physiology of placental transfusion has largely involved term births. It remainsunclear how the volume and the duration of placental transfusion vary with gestation at birth, and
what the optimal timing is for umbilical cord clamping for preterm births.
See Appendix 13 for the unpublished report of this work.
Research aims
The aim of this work package was to measure the volume and the duration of placental transfusion for
preterm births by weighing babies with the umbilical cord intact.
Methods for data collection
Recruitment was at three maternity units in England. Women likely to give birth to a live baby before 36
completed weeks’ gestation were offered participation. At each site, research staff undertook an initial training
phase recruiting women giving birth at term. At birth, the baby was placed on the weighing platform and
wrapped in warm towels with the umbilical cord intact. We used high-quality pharmacy scales (Excellence XS
Precision Balance Model XS8001L, Mettler Toledo, Im Langacher, Switzerland), which calculated an average
weight twice every second, with data stored in a linked computer. Before the birth, scales were zeroed to allow
for towels, probes and any other equipment. To ensure that the baby was no higher than the level of the
woman’s abdomen, the woman’s bed was raised or lowered if necessary. The baby was monitored throughout
weighing using saturation monitors.
Analysis
Characteristics of the women, events during labour and mode of birth were described for all women.
Placental transfusion was assessed by change in weight over time, as 1 ml of blood weighs 1.05 g. For
each birth, two authors (JD and SO) independently assessed the weight change by inspecting the graphs
of weight against time, using information on the time of cord clamping and when the baby was touched.
Differences were resolved by discussion. Owing to the small numbers recruited, data are described only as
summary statistics were inappropriate.
Key findings
Of 97 women approached, 33 gave consent, of whom six had their baby weighed. Reasons why the baby
was not weighed for the remaining 27 with consent were: term birth (n = 10), research staff not available
as out of working hours (n = 6), birth too rapid (n = 5), cord too short (n = = 2), consent withdrawn (n = 2),
hardware problem (n = 1) and clinician decision (n = 1). For the six babies who were weighed, gestation
was from 34+4 weeks to 36+5 weeks (Figure 6). Three were vaginal births and three were caesarean. The
time of cord clamping ranged from 2 minutes to 3 minutes 57 seconds. For two babies, drying and
applying probes led to a poor recording of weight for the first minute. An initial 10 seconds ‘hands-off’
period to give a baseline weight was therefore adopted. Weight change ranged from a 20-g decline to a
128-g increase. For one baby, weight change was continuing when the cord was clamped at 120 seconds;
for another, weight change ceased at 2 minutes, and for the remaining four babies weight change
appeared to continue for at least 3 minutes.
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This study is small; nevertheless, as with term births, there appears to be variation in the volume and
duration of placental transfusion and, for some, net flow is to the placenta rather than the baby. For
preterm births, umbilical flow may continue for more than 3 minutes. As placental transfusion may have a
role in stabilising the cardiorespiratory circulation during transition from the fetal to neonatal circulation,
the duration of time that the cord is left unclamped and umbilical flow continues may be as, or possibly
more, relevant than the volume of any net flow.49,159
Challenges
Major challenges were recruitment and, when appropriate women were recruited, having enough time for
research staff to arrive and prepare the equipment, made even more challenging as births were often out
of hours. Despite considerable effort at each site, these challenges were only partly overcome.
Implications for future research
Despite the small numbers, these data contributed to evidence supporting the decision to wait at least
2 minutes before clamping the cord for the intervention arm in the Cord pilot trial (see Work Package 4).
These data also suggest that the effect of delayed cord clamping may not simply be to allow more blood
to reach the baby from the placenta, but rather to allow the changes from an in utero placental circulation
to an ex utero lung one, to occur more gradually. Improved understanding of the physiology of placental
transfusion at very preterm birth would help identify the optimal strategy for cord clamping. Better
methods for assessing placental transfusion are required.46,72
2400
2380
2360
2340
2320
W
ei
g
h
t 
(g
)
2300
2280
2260
2240
2220
2200
0 60 120 180
Time from birth (seconds)
240 300
Artefact as baby handled until 47 seconds,
except for initial weight measurement from
8 to 14 seconds
Last accepted weight at 230 seconds;
cord clamped at 237 seconds
FIGURE 6 Caesarean section at 35+6 weeks, weight gain estimated at 51 g.
WORK PACKAGE 3.3: MEASURING PLACENTAL TRANSFUSION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
36
Work package 3.4: developing a
Bedside Assessment, Stabilisation and
Initial Circulatory Support trolley
Newborn resuscitation with an intact cord had been described previously,53,160 but with no agreedstrategy for how to do this and little apparent uptake in clinical practice.67 In 2010, a 1-day meeting
led to the idea for a small mobile resuscitation trolley, the ‘Bedside Assessment, Stabilisation and Initial
Cardiorespiratory Support’ (BASICS) trolley,69 extending the concept of a simple platform.53 This work
package describes its subsequent development into a commercially available medical device.
See Appendix 14 for the published report of this work.
Research aims
The aims of this work package were to develop a mobile trolley to provide newborn life support beside the
mother, and with the umbilical cord intact, and to identify a commercial partner so that the trolley could
be made more widely available.
Methods
A multidisciplinary team including clinical engineers, neonatologists, obstetricians, midwives and parent
representatives met regularly to discuss and develop the design, using a prototype device based on an
overbed hospital table with piped gasses, suction and a timer. Two simulated resuscitations provided
assessment of functionality and practicality for both vaginal and caesarean births, following which the
prototype was modified further.
A ‘second-generation’ prototype was developed in collaboration with Inditherm Medical (Rotherham, UK),
a company specialising in the development and sale of neonatal equipment and devices. Following a third
simulation to refine the design further, and certification with the Conformité Européenne (CE) logo, this
was subsequently marketed as LifeStart™.
Key findings
The first prototype trolley was adapted from an overbed hospital table, which has a long base directly below
the platform that slides under the bed, providing stability. However, modern operating tables and delivery beds
have pedestal bases with little room beneath them. Therefore, the next prototype used a circular base, with
larger wheels and enough weight to provide stability. This then led to the first commercially available
trolley (Figure 7). The design struck a balance between trolley stability and reach of the platform. The
platform is widest at the proximal end, allowing space for the baby’s shoulders and to access the head.
The distal end is narrower, allowing the platform to get close to the mother. The baby is kept warm with
an electric heated mattress produced by Inditherm; the company already produced the CosyTherm©
(Inditherm Medical) mattress for neonatal cots, and this was reshaped to fit the trolley platform. To allow
the platform height to be adjusted to be level with the mother, the central pillar adjusts up and down via
an electronic mechanism. The trolley also has a battery driven digital timer with alerts at 1 minute and at
5 minutes, for use during resuscitation.
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Medical gases for newborn resuscitation (air or oxygen) usually come from wall sockets; hoses connecting
these sockets to the usual resuscitation equipment are short and tuck in against the wall. For a mobile trolley,
long hoses connected to wall sockets create a trip hazard. Using small gas cylinders attached to the trolley
was not possible at the time we developed the trolley, as the smallest size available for medical air was too
large to attach to the trolley. Gasses are blended and the pressures are regulated using a Tom Thumb Infant
Resuscitator© (Viamed, Keighley, UK) and an oxygen blender (Inspiration Health Care Ltd, Leicestershire, UK)
attached to the back of the trolley, along with a suction bottle (Oxylitre Ltd, Manchester, UK). Other
equipment is attached, as required, using two medical equipment rails on the central pillar.
Successes
This is the first mobile neonatal resuscitation unit designed to facilitate newborn resuscitation beside the
mother, and with the umbilical cord intact. Our initial prototype was entered into the Medical Futures
Innovation Awards in 2011 (www.medicalfutures.co.uk/) and awarded ‘Best Redesign in Cardiovascular
Medicine’. Further development has led to a successful commercial product, LifeStart, marketed in the UK
and internationally, and cheaper than the usual equipment (around half to one-third of the cost). Regardless
of timing of cord clamping, the trolley has a role in supporting neonatal care beside the mother and allowing
her to share her baby’s first moments.
Challenges
Feedback to the manufacturer led to further modifications. For example, the platform was lengthened to
extend its reach, an important development as premature babies tend to have shorter cords than those
born at term.
The trip hazard caused by piped gas from wall sockets has reduced acceptability of the trolley in clinical
care. A medical air gas cylinder small enough for the trolley is now available and can be used following
a local risk assessment (as it is not covered by the CE mark). A disadvantage of this solution is that the
cylinder requires frequent refilling. Another less practical option is to put the large cylinder on a second
trolley and move this to the bedside with the resuscitation trolley.
FIGURE 7 First commercially available LifeStart trolley, October 2012. Reproduced from Thomas et al.161
© 2014 The Authors, licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License 4.0 (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons
Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made
available in this article, unless otherwise stated.
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Resuscitation can be provided without a pressurised gas supply, using a bag, valve and mask system, and
room air. Disadvantages of this method for preterm resuscitation are the inability to control inspiratory
time or provide positive end expiratory pressure, and also that oxygen would not be available for those
babies who fail to respond to resuscitation with air.
Implications for future research
Once a trolley was available for use, we introduced it into clinical service and conducted a service
evaluation161 followed by qualitative interviews to explore the experiences and views of parents and
clinicians of neonatal care at birth beside the mother, and of their experiences and views of the trolley
(see Work Package 3.5).39,40 We also developed strategies for providing neonatal care beside the mother
using the usual resuscitation equipment.162 As discussed in Work package 3.5, further research is needed
to evaluate the clinical and psychological impact of neonatal care beside the mother and of providing care
with the cord intact.
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Work package 3.5: evaluating parents’
and clinicians’ views of neonatal care
beside the mother
See Appendices 15 and 16 for the published reports of this work.
Research aims
Our aims were to provide proof of concept that the trolley could be used in clinical practice, then to assess
whether or not the trolley could be used as part of routine care within a busy tertiary care hospital, and
whether or not it was acceptable to parents and to clinicians. Therefore, we aimed to conduct:
l a case study of first use of the trolley in clinical practice
l a questionnaire-based service evaluation
l qualitative semistructured interviews with parents and clinicians about their experiences.
Methods for data collection
First use of the trolley in clinical practice was for a baby born by caesarean section at 37 weeks’ gestation
who required an EXIT (Ex utero Intrapartum Treatment) procedure163 at Liverpool Women’s hospital. We
delivered the baby’s head and shoulders, while the chest and abdomen stayed inside the uterus, and
administered tocolytics to maintain placental perfusion. Once a safe airway was achieved (by endotracheal
intubation), the baby was born and the umbilical cord cut.
Following this the LifeStart trolley was introduced into clinical service at Liverpool. We conducted a service
evaluation from March 2012 to October 2013.161 The trolley was available at births for which hospital
policy required attendance of an advanced neonatal nurse practitioner or a paediatrician. As this was the
first time that the trolley was available for routine clinical practice because its use was initially restricted to
‘low-risk’ births. This was extended to high-risk births after review of data from the first 20 births, which
was satisfactory. Babies were assessed and resuscitated at birth according to hospital guidelines. Overall,
78 births were included in the evaluation. Data were from the clinical notes, including demographics,
temperature of the baby after resuscitation, care provided on the trolley, whether or not there was a need
to move the baby to a standard resuscitation platform, and any problems experienced. For 61 of these
births, clinicians completed a questionnaire asking their views of care beside the mother and of using the
trolley, and any views expressed by the women or their partners. This questionnaire was not completed for
17 births, as the women were recruited into the Cord pilot trial.
For the qualitative interviews, we recruited parents and clinicians between November 2012 and January
2014. Interviews were conducted by a female psychologist or one of three midwives trained in qualitative
methods, using a standard schedule of open-ended questions. They were recorded and transcribed, and
reporting complied with COREQ.154
Fifty-six women and their birth partners who had initial neonatal care beside the mother were invited to
participate, of whom 30 were interviewed (19 mothers, 10 partners and one grandmother).39 We conducted
19 interviews, as 11 women chose to be interviewed with their birth partner. Five of the babies required
advanced neonatal resuscitation at birth. If their baby had not received intervention at birth, it was explained
to parents what this might involve, and they were asked about how they might feel about being so close if
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this had been necessary. Interviews lasted approximately 30 minutes, and took place either in a private
hospital room (17 women) or at the woman’s home (two women). We extracted demographic data from
the clinical notes.
Using purposive sampling, 26 clinicians who were present at a birth where initial neonatal care was beside
the mother were invited to participate. All initially agreed to be interviewed; as six later declined, 20 were
interviewed.40 Most were neonatal specialist doctors or nurses (Table 2). Five had provided or observed
advanced resuscitation beside the mother. Interviews lasted approximately 20 minutes, and took place in a
private room on the neonatal unit.
Analysis
For the service evaluation, we assessed usability of the trolley based on the range of resuscitation procedures
performed while babies were on it; the feasibility of resuscitation with the cord intact, based on the proportion
who received this; and the acceptability to clinicians based on questionnaire responses. The only anticipated
safety concern was hypothermia. We monitored unexpected safety issues using the Hospital Incident
Reporting System.
The qualitative interviews ended when we achieved data saturation. We used inductive systematic thematic
analysis to identify themes across interviews. Data were managed using NVivo software. We identified five
themes in the parent interviews: (1) reassurance, (2) involvement of the family, (3) staff communication,
(4) reservations and (5) experiences of the trolley. For the clinician interviews, we also identified five themes:
(1) parents’ involvement, (2) reservations about neonatal care at birth beside the mother, (3) practical
challenges in providing neonatal care beside the mother, (4) comparison of the trolley with usual resuscitation
equipment, and (5) training and integration into clinical routine.
TABLE 2 Characteristics of clinicians interviewed
Characteristics n (%) (N= 20)
Profession
Advanced neonatal practitioner 10 (50)
Consultant obstetrician 1 (5)
Consultant neonatologist 2 (10)
Neonatal nurse 1 (5)
Senior house officer (paediatrics) 4 (20)
Midwife 1 (5)
Senior registrar (paediatrics) 1 (5)
Role in providing neonatal care at birth
Observer 2 (10)
Contributor 18 (90)
Trolley experiencea
Used once 9 (50)
Used more than once 9 (50)
a Missing data, n = 2.
Reproduced from Yoxall et al.40 This is an Open Access article distributed in accordance with the terms of the Creative
Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work,
for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
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Key findings
Case report of the first use in clinical practice
Endotracheal intubation was at 7 minutes of age; at 8 minutes, the baby was born, the cord was clamped
and cut and the baby was transferred to the trolley. At 15 minutes of age, the baby was moved to the
standard resuscitation equipment and at 16 minutes the temperature was normal.
Service evaluation
Common delivery room resuscitation procedures were performed successfully for babies on the trolley, and
none was moved to the standard resuscitation platform.161 All resuscitation interventions were performed with
an intact cord, apart from umbilical venous catheterisation, which requires division of the cord. Immediate
neonatal care with an intact umbilical cord was attempted for 61 births and was achieved for 43 (70%). For
18 births (30%), the cord was too short to allow the baby to reach the trolley. Births for which the cord was
judged to be too short were no different in gestation or mode of birth to those with the baby on the trolley
with the cord intact; two-thirds of these births took place during the first half of the study, which included
fewer very low-birthweight babies. As experience increased, the proportion of babies able to receive care on
the trolley with an intact cord also increased.
Only one baby had a temperature of < 36 °C and this baby was born at 30 weeks’ gestation and their
temperature was 36.4 °C at 10 minutes of age on the trolley; therefore, (s)he probably got cold during
transfer to the neonatal unit. No serious adverse events related to the trolley were reported. A reported
practical difficulty was the trip hazard due to hoses connecting the trolley to gas sockets on the wall. A
partial solution was to attach a small size oxygen cylinder to the trolley, reducing the number of gas hoses.
Compared with conventional resuscitation equipment, clinicians rated the trolley as ‘the same’, ‘better’ or
‘much better’ for most aspects of care, and none rated it ‘much worse’. Some rated the trolley as ‘worse’
than conventional resuscitation equipment for ease of access to the baby (15% of clinicians), ease of assessing
the baby (10%) and ease of access to resuscitation equipment (18%). These issues seemed largely due to
difficulty in getting sufficiently close to the operating table at caesarean section. There were also concerns
about maintenance of the sterile field, about the sterile drapes covering the trolley obstructing the view of
the airway management equipment, and that preparing the trolley for use in theatre was time-consuming.
Two-thirds of clinicians rated the trolley as ‘better’ or ‘much better’ for ease of communication with parents,
with a similar proportion rating the overall experience for parents as ‘better’ or ‘much better’.
Parents’ experiences of immediate neonatal care beside the mother
Parents reported that they liked having their baby close by and described feeling reassured by knowing
what was going on.39 At some births the woman was unable to see her baby, but the father (or other
birth partner) could and relayed information about the baby, which reassured her. Parents reported
feeling involved as a family, as they could see and sometimes touch their baby. By watching, parents felt that
they understood what was happening to their baby, felt that they could see that staff were doing the best
that they could, and felt part of their baby’s care. One mother reported that having her baby so close gave
some ‘normality’ and ‘goodness’ to a birth she otherwise experienced as unnatural. Some parents felt that
seeing the initial neonatal care helped staff to communicate with them. Others said that they would have
liked more explanation about what was going on and why, as this might have allayed some of their fears.
Parents whose babies had only low intensity interventions at birth, such as drying or receiving oxygen
by mask, reported no reservations about watching. However, half of them said that they might have
reservations if their baby needed more intensive intervention. No parent whose baby received intensive
intervention, such as intubation or cardiac massage, expressed regrets about watching. These parents
reported feeling scared or finding the intervention unpleasant to watch, but three out of five stated that it
was ‘fine’ or ‘nice’. A few parents suggested that they should be asked beforehand whether or not they
would like to watch their baby’s care at birth. Two were concerned that watching might have an impact
on the staff in terms of adding pressure or distraction.
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Of 11 parents who gave an overall opinion of the trolley, nine were favourable and two were unsure. The
standard resuscitation equipment was also in the room, and some parents thought that this equipment
looked ‘scary’, clinical or like their baby needed a lot of help or would be taken away. Two parents felt
that the standard equipment looked ‘more advanced’.
Clinicians’ experiences of immediate neonatal care beside the mother
Eighteen clinicians mentioned that initial neonatal care at birth beside the mother allowed parents to see
and touch their baby, and to see what the clinical team was doing.40 They felt that this was especially
important for babies subsequently admitted to the neonatal unit, in contrast with usual care, where the
woman might not have been able to see her baby until she visited the neonatal unit. Some clinicians
reported that parents were not able to see their baby at caesarean section because of the screen, or at an
assisted vaginal birth when the trolley was positioned close to the perineum.
Almost half of the clinicians reported positive comments from parents about being close to their baby,
which included one woman whose baby died soon after birth. None mentioned negative comments
from parents. Four clinicians said that they felt that being near to the parents aided or increased their
communication with them, three clinicians felt that being close made no difference, but one clinician
said that communication was an issue of practice, not equipment. One clinician felt that when advanced
resuscitation was required, a member of staff should be assigned to support parents.
Most clinicians had no reservations about being watched by parents, but five thought that staff with less
experience might feel insecure about this. Clinicians varied in their views about the potential impact on
parents of watching neonatal care at birth: five felt that it would be beneficial, four were unsure and two
felt that seeing advanced resuscitation might be upsetting. Two clinicians suggested that parents are asked
beforehand whether or not they wanted to watch.
Practical challenges at caesarean births were that parents were sometimes unable to see their baby and
that scrubbing to enter the sterile field was perceived as a burden that took time out of already busy
work days. Clinicians also noted that the trolley switches and controls were covered by the sterile drapes,
making their use awkward. Other practical issues were: (1) for admission to the neonatal unit, the baby
had to be moved to the standard equipment, and (2) the small platform size limited space for equipment.
Problems with integration into clinical care included not having the trolley routinely available at a birth, or
it not being set up in time. A common concern was that the trolley interfered with other staff members’
space beside the mother. However, three clinicians reported no problems with space for other staff.
Eighteen clinicians gave an overall evaluation of initial neonatal care beside the mother and using the
trolley as positive or conditionally positive.
We also showed that the usual resuscitation equipment can easily be adapted to do this.70,162 Some clinicians,
particularly those with less experience, may find it challenging to conduct neonatal resuscitation in such close
proximity to parents. Although many will appreciate the opportunity this gives to communicate with parents
about their baby, others may prefer to be away from parental scrutiny. Thus, successful introduction of
neonatal care at birth beside the mother requires adequate training and support, and a multidisciplinary
team approach.
Successes
As far as we are aware, the work reported here describes experiences at the first hospital to provide initial
neonatal care beside the mother within routine clinical service. We have shown that all common resuscitation
procedures can be provided this way, with reassurance that this is also safe. Although we used the mobile
trolley designed for this purpose, the same care can be provided using the standard resuscitation equipment,
as happened in the Cord pilot trial.70 Although larger than the trolley, standard resuscitation equipment is
easily moved alongside the mother, the side panel dropped to allow the mattress on which the baby is placed
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to be moved closer to the mother, and the height adjusted. Using standard equipment has the advantages of
being already available in the room or operating theatre, having the usual radiant heater, and requiring no
equipment-specific training as staff are already familiar with its use. Data presented here on initial neonatal
care beside the mother are therefore generalisable to settings in which care is provided using standard
equipment, with the exception of specific practical issues with the trolley.
Although this requires further investigation, the positive view of a woman whose baby had care beside her
and died shortly afterwards has important implications for bereavement.
Challenges
A practical concern about the trolley was the potential trip hazard, especially in the operating theatre,
associated with the hose required for gas supply. Replacing one hose with a small oxygen cylinder fixed to
the trolley has reduced this hazard. Removing the second hose requires a small air cylinder, which was not
commercially available at the time. It is now available, but is not included in the CE mark. A concern about
providing care with the cord intact at caesarean section is the potential to compromise the sterile field.
Maintaining the sterile field and negotiation about space for the neonatal team at the operating table
remain a challenge at caesarean births, especially in an emergency. Our experience is that this becomes
easier as staff become familiar with providing this care.
Generalisability of these data is limited by recruitment of both parents and clinicians from a single hospital
(where the trolley had been developed) with a particular interest in care beside the mother. Other limitations
of the interviews with parents were that participants were not necessarily representative of the wider
population, as they were primarily white, they were either married or living with their partner, the babies
were all alive at the time of interview, and most babies had not required advanced resuscitation at birth.
Parents may have been reluctant to criticise their care, but we mitigated this risk by having an interviewer
who was not directly involved in their care or care of their baby.
Implications for future research
The work presented here should be repeated in other hospitals and should include using the standard
resuscitation equipment as well as the mobile trolley to assess whether or not outcomes, experiences and
costs are similar. Further research should include parents from more diverse backgrounds, those whose
baby required advanced resuscitation and those whose baby died. Further research should also include
follow-up of both parents and infants to assess any long-term impact.
The optimal study design for further evaluation would be a randomised trial comparing outcome for
parents who are offered initial neonatal care beside the mother with the outcome for those offered
traditional care only.
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Work package 4: Cord pilot trial,
a randomised trial of deferred
cord clamping and initial neonatal
care with cord intact versus immediate
cord clamping and initial neonatal care
after clamping for very preterm births
This work package was planned as an assessment of the feasibility of a large randomised trial based onrecruitment for 1 year. As recruitment was extended for a further 11 months, we present outcomes by
allocated group for all participants at hospital discharge and follow-up at 1 year for women and at the age
of 2 years (corrected for gestational age at birth) for the children. In addition, parent and clinician experiences
of the two consent pathways are described.
See Appendices 17–23 for the unpublished and published reports of this work.
Research aims
The aim of the Cord pilot trial was to assess the feasibility of conducting a large multicentre randomised
trial in the UK comparing deferred cord clamping and immediate neonatal care (if needed) with the cord
intact, with immediate cord clamping and with immediate neonatal care after cord clamping for very
preterm births. Recruitment was planned for 1 year and feasibility was assessed based on prespecified
process measures, such as recruitment, compliance, completeness of data collection and participants’ views.
At an interim review, the independent TSC agreed that feasibility criteria had been met and advised that
recruitment continue while funding was sought for the full trial. Recruitment closed in February 2015,
when this funding application was unsuccessful. For the planned full trial, joint primary outcomes were
death before discharge and IVH (all grades), hence these outcomes were considered the primary outcomes
for the extended pilot trial. As the two-stage consent pathway was an important addition to the trial
protocol, we also conducted a qualitative evaluation of the alternative consent pathways.
Methods for data collection
Recruitment to this pragmatic trial was at eight UK tertiary maternity units: five had contributed to earlier
work in the programme and three had not been involved and so were more typical of UK sites. Three
parent representatives were coinvestigators, involved in identifying the research question, securing funding,
and designing and conducting the study. Target recruitment for assessment of feasibility was 100–110
women over 1 year, based on target accrual of 16–18% of eligible births. As we planned this as a pilot,
there was no formal power calculation.
Women expected to have a live birth before 32 weeks’ gestation were potentially eligible. The intervention
was umbilical cord clamping after at least 2 minutes and neonatal stabilisation and resuscitation, if needed,
with the cord intact. Babies were placed onto a firm surface with access to resuscitation equipment; six sites
used their usual resuscitation equipment moved alongside the woman’s bed162 (153 women recruited) and
two sites used the mobile trolley (108 women).69 The control was cord clamping within 20 seconds and
neonatal stabilisation and resuscitation, if needed, after clamping. For both groups, neonatal care was
based on local unit policy and consistent with newborn life support guidelines.57,164
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For the assessment of feasibility we prespecified measures of feasibility. For the planned main trial, joint
primary outcomes were death before discharge and IVH (all grades);165 therefore, these were the main
outcomes for the extended pilot trial. We adjudicated diagnosis of IVH. Secondary outcomes for the babies
included severe IVH (grade 3 or 4),165 a range of measures of neonatal morbidity and neurodevelopment in
early childhood. Secondary outcomes for the women included complications of the third stage of labour,
well-being and satisfaction with care at birth. Follow-up for women was by self-completed questionnaire
at 2–3 months and again at 1 year, and for the children at the age of 2 years (corrected for gestation at
birth) by parent-completed Ages and Stages Questionnaire (ASQ)166 and an assessment at home using the
Bayley Scales of Infant Development III (Bayley-III).167 If no ASQ or Bayley-III data were available, we asked
the site to complete an outcome form using routine clinical data. We agreed the statistical analysis plan for
the extended study before unblinding the data.
Whenever possible, we offered women the usual written consent process (Figure 8). However, if birth was
imminent and the attending clinician considered it appropriate, we offered women a brief explanation of
the study and randomised those who said ‘yes’ (i.e. they gave oral assent). Before discharge from hospital,
these women had an opportunity to discuss the study in detail and to give written consent for participation
in follow-up. This two-stage process was developed in consultation with the NCT and Bliss.
Woman admitted to maternity unit
and meets eligibility criteria
Birth imminent
(Preparing for caesarean section, or in established labour)
Woman gives written
informed consent
Check woman’s eligibility
• Continues to meet eligibility criteria
• Oral confirmation of agreement to
   participate
Randomisation
Information about the trial available to women
in antenatal clinics and antenatal wards
Woman gives oral assent
• If insufficient time for written informed
   consent because the woman is in
   established labour or having an
   emergency caesarean section, assent
   may be orala
FIGURE 8 The two alternative consent pathways. a, Women approached to give oral assent in established labour or
at emergency caesarean section only if the attending clinicians considered it to be appropriate. Women were not
approached if there was insufficient time to give a brief verbal summary of the trial or if they did not speak fluent
English and no translator was available. How long was required for oral assent depended on factors such as how
much the woman already knew about the study, and her knowledge and wishes about care during the third stage.
If recruitment was after oral assent, (1) women were approached before discharge to give written consent to
participation in follow-up and (2) the chief investigator was notified of this within 15 days, and this recruitment was
monitored by the TSC. Derived from Pushpa-Rajah et al.168 © Pushpa-Rajah et al. 2014. This article is distributed under
the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to
the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were
made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/)
applies to the data made available in this article, unless otherwise stated.
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Randomisation was by the attending clinicians, using sealed consecutively numbered opaque envelopes.
Clinical staff were trained, with regular study-specific training provided at each site to as many neonatal staff,
midwives, obstetricians and theatre staff as possible (see Appendix 17). We supported site training with film
clips of simulations for providing immediate neonatal care with the cord intact, and of role-playing to offer
consent via the two pathways. Multidisciplinary teamworking on site was essential for successful trial conduct.
We sent 179 women in the trial an invitation to participate in semistructured interviews. A total of 23 were
interviewed (usual consent pathway, n = 18; two-stage pathway, n = 5). The interview schedule consisted
of open-ended questions42 to explore the women’s views and experiences of being offered participation.
Interviews lasted approximately 30 minutes and took place either at their home or by telephone. We sent
20 clinicians who recruited women invitations for semistructured interviews, and interviewed 17 from seven
sites. The interview schedule consisted of open-ended questions, to explore clinicians’ views and experiences
of offering participation.41 Interviews took place either in a private hospital room or by telephone. They
lasted 20–30 minutes and were audio-recorded and transcribed. Reporting complied with COREQ.154
Analysis
For the assessment of feasibility of a large trial, the prespecified outcomes are presented based on
recruitment at 1 year. For participants in the extended pilot, analyses were based on the groups as
randomly allocated (intention to treat). Women who gave birth after 35+6 weeks were not included in
the analyses, as outcomes for these babies are different from those born very preterm. Where appropriate,
results are presented as RR or risk difference with 95% CIs.
For the qualitative interviews, we used inductive thematic analysis using NVivo version 10 software.
Key findings
Feasibility of a large multicentre trial, based on recruitment for 1 year
Overall, the feasibility objectives were met. During the feasibility phase, we randomised 22% of women
who gave birth before 32 weeks’ gestation (varying from 9% to 43% between sites) (see Appendix 17).
Factors in this variation included availability of the mobile trolley and of trained clinical staff. Sites already
involved in the programme randomised their first participant more quickly than new sites; most sites
randomised the first woman within 1 month of opening, whereas new sites took up to 5 months. Of the
125 women randomised, over one-quarter (29%, 36/125) were recruited using the two-stage oral assent
pathway. Time from randomisation to birth was within half an hour for over one-third of women, and
within 1 hour for over half; three-quarters of women gave birth within 2 hours of randomisation and only
6% gave birth > 1 day after randomisation. Recruitment was across the range of gestational age with
approximately one-third before 28 weeks’ gestation, one-third at 28–29 weeks’ gestation and one-third
at 30–31 weeks’ gestation.
Compliance with the allocated intervention was good. In the intervention group, median time to cord clamping
was 120 seconds (interquartile range 30–135 seconds), compared with 10 seconds (10–15 seconds) in the
control group. Overall, 82% (111/135) of babies in the intervention arm had later cord clamping than the
control arm (< 20 seconds). In the intervention group, the main reason for cord clamping before 2 minutes
was the cord being too short. There were no obvious differences in compliance according to the mode of birth,
or whether the site used usual equipment or the mobile trolley for neonatal care.
Fifteen babies (11%) died before discharge; this included three stillbirths all of whom were extremely
premature and resuscitation at birth was attempted. Nine (60%) deaths (including one stillbirth) were of babies
born < 26 weeks’ gestation. Of liveborn babies, 51 (40%) had an IVH, of whom this was severe for eight (6%).
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Results by allocated group, for all women randomised
Of 945 women approached, 472 (50%) gave consent and 261 (28%) were randomised (Figure 9).71
One-third of women were randomised before 28 weeks’ gestation and two-thirds of women were
randomised before 30 weeks. Just over half were women in their first pregnancy and a similar proportion
had a caesarean birth. Compliance was good, with median time to cord clamping 120 seconds for women
allocated to cord clamping after at least 2 minutes, and 11 seconds for those allocated to cord clamping
within 20 seconds. Neonatal care was comparable between the two allocated groups.
There were no clear differences between the allocated groups in either of the primary outcomes (Table 3).
Three-quarters of infants who died were born before 28 weeks’ gestation. The three stillborn babies were
all born before 28 weeks’ gestation and resuscitation was attempted at birth. There were no clear differences
between the allocated groups for any other outcome for the baby, or in any outcome for the mother.
Qualitative interviews about the consent pathways
Women’s experiences were similar regardless of the consent pathway (see Appendix 20). Few showed a
good understanding of randomisation, but how staff spoke to them when offering participation was
important to women. They appreciated a calm manner, clear information with time to consider participation,
and staff being warm and friendly and not making them feel pressured. Those recruited following oral assent
reported being given less information about the trial, but felt that it was sufficient to make a decision
regarding participation. Irrespective of the consent pathway, there were gaps in women’s understanding of the
trial. Unsurprisingly, the trial was a minor event in comparison to the birth of their baby and, once women had
agreed to take part, often they did not give it further thought. Common reasons for agreeing to participate
were contributing to research, that the trial might help their baby, and that it appeared to be low risk.
Overall, clinicians were supportive of the two-stage consent pathway (see Appendix 19). Over half
discussed the importance of a team approach to inviting participation, regardless of which consent
pathway was used. Clinicians were aware of the tension between the signed consent form as a record
of the consent process and as a legal document proving consent was given. They viewed consent as a
continual process and thought that different consent pathways could be appropriate for different trials.
Some clinicians felt that in time-critical situations, oral assent had advantages over the usual consent
process, as information was provided on a ‘need-to-know’ basis. There was some concern about the
balance between time, information and understanding, for example how much information should be
given for oral assent and how this is understood by women when birth is imminent. However, issues about
the validity of consent applied to both pathways.
Follow-up of women up to 1 year
Response to the women’s questionnaires was 76% (186/244) at 2–3 months, which dropped to 55%
(133/242) at 1 year (see Appendices 21 and 22).169 There were no clear differences between the groups
for any responses, and responses were similar at the two time frames. Scores on the Hospital Anxiety and
Depression Scale170 were lower for depression than for anxiety on both questionnaires, and satisfaction
with care at birth was high. Women were largely positive about their experiences of participation, with
92% answering ‘definitely yes’169 or ‘probably yes’ at 1 year to a question about whether or not they
would participate again in the trial.171 Things women liked about the trial were good information about
the study, caring staff and that their baby or others in the future might benefit from the research.
Suggestions about what could have been improved in the trial including approaching women earlier in
labour, and better communication about the study from staff.
Follow-up of children at the age of 2 years (corrected for gestation at birth)
Overall, data were available for 83% (218/262) of the children included in the follow-up (see Appendix 23).
Children born to women allocated to cord clamping after at least 2 minutes and neonatal care, if required,
with the cord intact had a lower risk of death or adverse neurodevelopmental outcome at the age of 2 years
(corrected for gestation) (RR 0.61, 95% CI 0.39 to 0.96). However, although the response rate for follow-up
was higher among those in the intervention group, neonatal morbidity at hospital discharge was higher for
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Cord clamping after ≥ 2 minutes, neonatal
care with cord intact
132 women and 137 babiesb
• Cord clamping ≥ 2 minutes, n = 80
• Cord clamping 20 seconds – 2 minutes, n = 31
• Cord clamping ≤ 20 seconds, n = 21
• Cord clamping < 2 minutes time not known,
   n = 3
• Time not known,c n = 2
Women approached
(n = 945)
Women randomised
(n = 261)
Women gave consent
(n = 472)
Did not give consent
(n = 473)
Not randomised
(n = 211)
• Declined, n = 193
• Discharged home, n = 144
• Reason not known, n = 30
• Not asked for consent, n = 29
• Not eligible, n = 26
• Birth too rapid, n = 18
• Transferred to another hospital, n = 14
• Language difficulty, n = 8
• Clinical decision, n = 6
• Undecided, n = 3
• Recruitment closed, n = 2
• Written consent, n = 204
   • No longer eligible, ≥ 32 weeks’
      gestation, n = 106
   • Reason not known, n = 44
   • Birth too rapid, n = 16
   • Transferred to another hospital, n = 13
   • Staff not trained, n = 10
   • Clinical decision, n = 8
   • Other,a n = 7
• Oral assent, n = 7
   • No longer eligible, ≥ 32 weeks’
      gestation, n = 4
   • Clinical decision, n = 1
   • Birth too rapid, n = 1
   • Reason not known, n = 1
• Written consent alone, n = 388
• Oral assent + written consent, n = 81
• Oral assent alone, n = 3
Cord clamping after ≤ 20 seconds, neonatal
care after clamping
129 women and 139 babiesb,d
• Cord clamping ≤ 20 seconds, n = 126
• Cord clamping 21 – 35 seconds, n = 8
• Time not known,c n = 4
Included in analysis at discharge
130 women and 135 babies
Included in analysis at discharge
124 women and 134 babiesd
2 women (2 babies) excluded
• > 35+6 weeks at birth, n = 2
5 women (5 babies) excluded
• > 35+6 weeks at birth, n = 4
• Withdrew, n = 1
FIGURE 9 The CONSORT (Consolidated Standards of Reporting Trials) flow diagram for outcome to discharge from
hospital. a, Woman changed her mind (n= 2), intrauterine death (n= 2), equipment failure (n= 1), study closed
(n= 1), randomisation website failed (n= 1). b, Compliance reported by baby. c, Birth at ≥ 36 weeks’ gestation
(all singleton pregnancies). d, One woman and her baby withdrew, data reported for mortality only. Reproduced
from Duley et al.71 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018.
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children with no follow-up data available than for those with outcome data. Hence, this difference no
longer achieved statistical significance after adjusting for missing data using multiple imputation (RR 0.69,
95% CI 0.44 to 1.09).
Successes
We conducted a substantial and successful pilot trial in a difficult clinical area, and demonstrated feasibility
of conducting a large multicentre study. As the study was conducted within existing NHS clinical services,
results are generalisable to similar settings.
A key limitation of previous trials is that they largely excluded babies who were likely to need immediate
resuscitation at birth.172 We developed two successful strategies for recruiting such high-risk infants. First,
for women allocated deferred clamping, neonatal stabilisation and resuscitation was available with the
cord intact. This had the additional advantage that stabilisation was equivalent in the two intervention
groups. Second, if birth was imminent, we could offer women the opportunity to participate using the
two-stage consent pathway. We recruited one-quarter of women using this pathway – women and babies
it would not otherwise have been possible to recruit. Qualitative interviews and questionnaire responses
from the women suggest the two-stage consent pathway was acceptable in the trial.
TABLE 3 Primary outcomes at discharge from hospital for all babies
Clamp ≥ 2 minutes+
neonatal care with
cord intact, n (n= 135)
Clamp ≤ 20 seconds+
neonatal care after
clamping, n (n= 135)a Risk ratio (95% CI)
Death 7 (5%) 15 (11%) 0.47 (0.20 to 1.11)b
Stillbirth 1 2
Early neonatal death 3 7
Late neonatal death 2 5
Post neonatal death 1 1
For babies who died, gestation at birth (weeks)
30 – 31+6 – 1c
28 – 29+6 1 3
26 – 27+6 – 4
< 26 6 7
Any IVH (grade 1–4)d,e 43 (32%) 47 (36%) 0.90 (0.64 to 1.26)
Alive at discharge 38 42
Severe IVH (grade 3–4)d 6 (4%) 7 (5%)
a Includes the baby of one woman who withdrew.
b Excluding death due to congenital malformation gives a RR of 0.50 (95% CI 0.21 to 1.20).
c Major congenital malformation, not known before birth.
d For live births: n = 134, clamp ≥ 2 minutes; n = 132, clamp ≤ 20 seconds.
e IVH diagnosis based on scan adjudication for 81 infants, scan report only for 8, and site data only for 1.
Reproduced from Duley et al.71 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article)
2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article
distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others
to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited.
See: http://creativecommons.org/licenses/by/4.0/.
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Design and conduct of the Cord pilot trial drew on outputs from earlier parts of the programme, and the
experience we developed of working as a multidisciplinary team. In particular, the strong patient and
public involvement in the programme and in the trial was essential for changing the way neonatal care
was provided for very preterm births, and for developing the two-stage consent pathway.
Our study is also the first cord clamping trial to use independent adjudication of cranial ultrasound scans,
thereby reducing potential for bias and improved reliability in ascertainment of IVH.173 Other successes were
being the one of the first deferred cord clamping versus early cord clamping trials at preterm birth to report
outcome for the women, and outcome for the children at 2 years of age (corrected for gestation at birth).
Challenges
Although we demonstrated feasibility and had strong support for the main trial, both from the independent
oversight committees and from clinical sites keen to participate, we were not able to secure the necessary
funding. The reason given by the funding board was that they had concerns over the timing of the study
given other relevant trials that had yet to conclude.
When an external pilot trial is successful, transforming it into an internal pilot by continuing into the full
trial may maximise efficiency and value for money, but our experience demonstrates it is a challenge to
achieve.174 Nevertheless, data from our trial will contribute to the design of any future trials,72 in particular
through the planned prospective meta-analysis and the experience gained in delivering the intervention.
As for many perinatal trials, long-term follow-up of the children was challenging and it required a range of
strategies. The importance of complete follow-up to minimise potential bias is underlined by the apparent
difference between the allocated groups in response to follow-up and that children without follow-up data
in the intervention group were higher risk than those for whom data were available.
Implications for future research
With appropriate planning and training, large multicentre trials of interventions around the time of preterm
birth are feasible within existing maternity and neonatal services in the NHS. To improve the opportunity
for participation, such trials should consider including the two-stage consent pathway. Nevertheless, this
two-stage pathway merits further evaluation in a wider range of studies. Providing neonatal care beside
the mother so that she can see and, if she wishes, touch her baby, also merits further evaluation in a
wider range of clinical settings, and with follow-up to assess any long-term effects for parents or baby.
Since our trial was planned, new research has emerged that should be considered in planning new trials
of timing of cord clamping. This includes work with pregnant sheep which has improved understanding
of the physiology of transition from the fetal to neonatal circulation51,159,175,176 and the publication of
other relevant trials including a large international trial.177 The design of any future trial, including the
interventions to be compared, should therefore be informed by the systematic review and meta-analysis
based on individual participant data (IPD) planned in our final work package.
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Work package 5: a prospective
meta-analysis
P roviding really reliable data on long-term safety and disability-free survival for children born verypremature requires very large numbers. To achieve this, international collaboration is required and,
therefore, we included planning a prospective meta-analysis as the final element of this programme.
Our plan was that the first cycle of this analysis would inform the design of the main trial, should this go
ahead. Although the time scale for this first cycle of analysis has been delayed beyond the end of this
programme, nevertheless it will inform the design of any future large trial.
See Appendices 24 and 25 for the unpublished reports of this work.
Research aims
The aims were to establish a collaborative group of triallists to conduct an IPD meta-analysis to assess
whether timing of cord clamping and other strategies to alter placental transfusion at preterm birth
influence (1) the composite outcome of death or serious morbidity at discharge from hospital and
(2) disability-free survival in early childhood (aged 2–3 years). This work is referred to as Cord Clamping
and Placental Transfusion at Preterm birth (CCPTP). The unexpected rapid increase in small randomised
trials being published led to agreement by the CCPTP collaboration that, if sufficient funding is available,
the planned prospective meta-analysis should be expanded to a retrospective IPD meta-analysis, with a
nested prospective meta-analysis.
Methods for data collection
The CCPTP collaborative group of triallists was established and the protocol (see Appendix 24) discussed
at the annual face-to-face meeting. The PROSPERO registration identifier is CRD42013004405. Following
quarterly searches of trial registries, the chief investigators of studies potentially eligible for the prospective
meta-analysis are contacted and invited to join the collaboration. Studies are included if they are randomised
trials meeting the eligibility criteria and the investigator(s) are blind to outcome data by intervention group at
the time that they agree to the CCPTP protocol.
Eligibility criteria are that participants gave birth (if women were randomised) or were born (if baby was
randomised) before 37 completed weeks’ gestation. Interventions are comparisons of alternative policies
for timing of cord clamping, and other strategies to influence umbilical flow (e.g. lowering the baby
below the level of the placenta, use of uterotonic drugs and umbilical cord milking or stripping). Studies
are included if they compare strategies to maintain ‘physiological’ umbilical flow (i.e. none or minimal
intervention) with strategies that aim to alter umbilical blood flow (e.g. using gravity by lowering the baby,
cord milking or stripping). Studies comparing alternative strategies for influencing umbilical flow without a
‘timing of cord clamping’ arm will also be included.
Planned comparisons are:
1. Early cord clamping (short delay) versus deferred cord clamping (long delay).
2. Early cord clamping (short delay) versus umbilical cord milking or stripping.
3. Deferred cord clamping (long delay) versus umbilical cord milking or stripping.
4. Deferred cord clamping (long delay) plus umbilical cord milking or stripping versus early cord clamping
(short delay).
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As there is no consensus about the definition of ‘early’ and ‘deferred’ cord clamping, early clamping is
defined whenever possible as within 30 seconds, and deferred clamping as after at least 1 minute. Trials
that use different definitions will be included in the analysis.
As outcomes for babies born very preterm (< 32 weeks’ gestation) are different for those born moderately
preterm (32 to 37 weeks’ gestation), separate analyses are planned for these two groups of infants. For
those born < 32 weeks’ gestation, primary outcomes are (1) death or serious morbidity at hospital discharge
(serious morbidity is defined as one or more of severe IVH, necrotising enterocolitis, late onset sepsis, chronic
lung disease and retinopathy of prematurity); (2) chronic lung disease; and (3) neurodevelopmental delay in
early childhood. Secondary outcomes include individual items in the composite outcome and measures of
neonatal morbidity and adverse neurodevelopmental outcome in early childhood.
For infants born at or after 32 weeks’ gestation, the primary outcome is admission to NICU. Secondary
outcomes are measures of neonatal morbidity, iron status in infancy, and adverse neurodevelopmental
outcome in early childhood.
For the women, outcomes are complications of the third stage of labour, postpartum infection,
breastfeeding and postnatal depression.
Analysis
The detailed statistical analysis plan will be developed and agreed before any analysis begins. Planned
subgroup analyses are based on:
l participant-level characteristics – gestation at birth, whether singleton or multiple pregnancy, mode of
birth and whether or not spontaneous onset of labour
l hospital-level characteristics – highest level of neonatal unit available at site, timing of uterotonic drug,
timing of cord clamping, planned position of the baby relative to the placenta with the cord intact, and
whether or not babies needing immediate resuscitation at birth were recruited.
To assess whether or not the results are robust to trial quality and different methods of analysis, the
following sensitivity analyses are planned for the primary outcomes, if there are sufficient data: excluding
studies with a high risk of bias; for comparison of early with deferred clamping, analysis weighted by
observed between-arm difference in mean timing between the groups; analysis weighted by degree of
separation in haemoglobin between the groups.
If a policy of deferred cord clamping appears to be beneficial, additional analyses will therefore explore
the effects based on duration of allocated deferred cord clamping and, if the allocation was clamping
after 20 to 30 seconds, whether or not neonatal care, if needed, was provided with the cord intact.
Successes
Currently we know of 53 trials, involving 11,811 infants (3020 for long-term outcomes). Our success in
establishing the CCPTP collaboration emphasises the international interest in this topic. Annual collaborators
meetings, held alongside neonatal conferences to minimise cost, have facilitated collaboration and biannual
newsletters provide regular updates.
Success of the collaboration between the Nottingham Clinical Trials Unit and the National Health and Medical
Research Council Clinical Trials Centre at the University of Sydney, which jointly support the secretariat for
CCPTP, means that the first cycle of analysis is now planned for 2020 and funding has been secured to
expand this to include a retrospective meta-analysis based on IPD, with a nested prospective meta-analysis
WORK PACKAGE 5: A PROSPECTIVE META-ANALYSIS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
56
(see Appendix 25). The collaboration also changed its name to systematic review and network meta-analysis
with individual participant data on Cord Management at Preterm birth (iCoMP).
Challenges
The main challenge for this project is common to all planned prospective meta-analyses: the time scale for
analysis is unpredictable. Results for the large study planned for inclusion in CCPTP, the Australian Placental
Transfusion Trial, were published later than anticipated,177 as were results for the Cord pilot trial. Hence,
the first cycle of analysis was not possible within the programme time scale. The number of new trials
under way is accelerating, with 29 registered in the past 2 years. Many of these are relatively small and
data analysis may have begun before the investigators agree the CCPTP protocol. Growing numbers being
published risked undermining the relevance of a standalone prospective meta-analysis. Hence, we expanded
the protocol to allow inclusion of a retrospective IPD meta-analysis, with network meta-analysis. Work
commenced on this IPD in 2019.
Implications for future research
Placental transfusion at preterm birth is a current ‘hot topic’, with wide variation in clinical practice. This has
led to a plethora of recent trials largely undertaken in isolation, with little standardisation of the intervention(s)
being tested or the outcomes being collected. Value of these existing trials will be substantially enhanced
by combining and fully utilising the IPD, as planned in CCPTP. Provision of individual participant data by
each trial investigator will provide the required statistical power and enable reliable subgroup analyses to
be undertaken.
Results of these analyses based on IPD from each trial will inform clinical practice and will identify the most
promising intervention(s) for further evaluation. Co-ordinating international efforts in this way will also
help achieve consensus on the most important clinical outcomes to assess in any future trials.
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Conclusions
Our programme aimed to improve the quality of immediate care at very preterm birth, enhancefamily-centred care at birth and improve outcome for infants and their families. To do this, we
conducted 10 projects grouped into five work packages. First, we identified and ranked the top research
gaps for preterm birth. Then, to develop strategies for providing initial neonatal care at birth beside the
mother at very preterm birth, we conducted a survey of practice, assessed parents’ views of initial neonatal
care beside the mother, improved understanding of the physiology of transition from fetal to neonatal
circulation, systematically reviewed strategies for initial care and assessment at preterm birth, and developed
a mobile newborn life support trolley. Finally, to generate the information to enable conduct of a large NHS
trial comparing alternative policies for cord clamping at preterm births, we systematically reviewed ethics
issues in recruiting preterm or sick infants to trials, conducted a feasibility pilot trial and developed the
protocol for a prospective meta-analysis.
The prioritisation process ran in parallel to other work packages, as it was added in response to feedback
from the funding board at stage 1 of the grant application process. Hence, the other work packages were
not dependent on its outcomes. Although cord clamping did emerge as a top priority, we had already
identified this as a priority via an informal process.
Central to the success of our programme was that service user representatives were partners throughout
its planning and conduct. What worked well was being equal partners, rooted in a service user
perspective, and being guided throughout by service user representatives who shared responsibility for the
research. This allowed us to tackle emotive issues, such as immediate neonatal care at very preterm birth,
and consent for participation in a clinical trial evaluating an intervention during labour at very preterm
birth. Our service users came with an understanding of different research methods, but this should not
be a prerequisite as good training could also be included. Our research team included experience and
expertise in working with service users and their representatives. Vital to equal partnership is the support
from those leading the research to specifically include service users who bring their personal experience to
the project. The time commitment required did not prove a problem with this particular programme of
research, but may well be a problem generally. In addition, our qualitative interviews with parents who
had experienced very preterm birth were conducted early in the programme. The experiences these
parents described informed our work, helping to ensure that it remained parent-focused throughout.
Providing care for the mother, her baby and other family members involves complex multidisciplinary teams.
A substantive output from our programme has been to demonstrate that providing initial neonatal care at birth
beside the mother is both feasible within the NHS and acceptable to parents and to clinicians. Our work is
contributing to a shift in culture, for example the World Health Organization now recommends that ventilation
can be started before cutting the umbilical cord, if the attending clinicians have experience in providing
effective positive-pressure ventilation with the cord intact.73 Although further evaluation is required, our data
suggest that, with adequate training, preparation and support, parents and clinicians prefer care beside the
mother rather than moving the baby away from the mother for assessment, stabilisation and resuscitation
at birth.
Although this might seem to be a relatively simple change in practice, achieving it required a change in
culture for care at the time of very preterm birth. When we planned this work, usual practice was to
quickly clamp the umbilical cord and then move the baby either to the side of the room or to another
room nearby. This requires little communication between the obstetric and the midwifery team responsible
for the mother and the birth and the neonatal team responsible for the newborn infant. In contrast,
providing immediate neonatal care beside the mother requires discussion in advance and negotiation
about where to place the resuscitation equipment, who will stand where and who will support the mother
and her partner so they understand what is happening. Parents and clinicians felt that this improved
communication between them. Anecdotally, clinicians involved in the programme also felt that this
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multidisciplinary working enhanced how they interacted with other clinical colleagues on the delivery suite,
with wider benefits in terms of improved quality of care.
Another example of this change in culture is the change in attitude to the role of the mobile trolley. When
we were planning the programme, the neonatologists we consulted were unanimous that developing this
trolley, or a similar device, was essential if they were to provide neonatal care beside the mother. However,
following consultation with the necessary disciplines about providing care beside the mother and with the
umbilical cord intact, and having demonstrated that this is possible in clinical practice, opinion shifted.
Working as a multidisciplinary team, we showed that it was also possible to adapt the existing equipment
to provide neonatal care beside the mother.70 This has the advantages of not needing to purchase new
equipment and that staff are already familiar with its use. For the pilot trial, six out of the eight hospitals used
existing equipment to provide the intervention and two hospitals chose to purchase the new mobile trolley.
Very preterm birth is a difficult time for parents and their experiences of care may differ from those having
a term birth. Our P-BESS questionnaire may be useful to compare views and experiences across hospitals
and differing practices for very preterm birth, whereas individual aspects of the care environment can be
evaluated using the separate subscales.
Conducting randomised trials of interventions around the time of very preterm birth is particularly
challenging, and in the past infants at highest risk have largely been excluded from trials.55 To help ensure
that recruitment to the Cord pilot trial was representative of the total population of very preterm births,
we developed a two-stage consent pathway that allowed women for whom birth was imminent the
opportunity to consider participation. This strategy is now recommended for use in other intrapartum
trials by the Royal College of Obstetricians and Gynaecologists.81 The current informed consent process is
laborious and a major barrier to conducting research on important, but time-sensitive, topics. The two-stage
consent process should help to open neonatology and perinatology to making research participation more
like the everyday clinical care. A similar approach may also be relevant in other emergency trials,178 or in those
for which recruitment is time critical. For example, it has been adapted for use in an acute stroke trial.82
Part of the rationale for including a prospective meta-analysis in our programme was that a large trial was
under way in Australia. That study compared cord clamping after at least 60 seconds and lowering the baby
with clamping within 10 seconds, and results have just been reported for the 1634 babies randomised.177
There was no clear difference in the composite primary outcome of death or serious morbidity at 36 weeks
postmenstrual age, although fewer babies in the intervention group died (6.4% in delayed clamping group
versus 9.0% in immediate clamping).177 In the light of these new data, remaining research questions to
address in future trials include whether or not stabilisation and resuscitation can safely be left until after cord
clamping, even for those with apnoea and the very premature, and what is the optimal time for cord
clamping at very preterm birth.72,179
Our prioritisation process for preterm birth research is already influencing the UK research agenda. For
example, the NIHR Health Technology Assessment programme has funded studies addressing topics in the
top priorities, and Bliss, the charity for babies born premature or sick, has included the priorities in their
strategy for research they support.
Limitations of our programme
Preterm birth is associated with factors such as lower socioeconomic status, ethnicity and maternal age.
For our prioritisation process, despite implementing strategies to reach a representative population,
respondents were primarily white and a relatively high proportion of respondents were homeowners and
were therefore not representative of those most affected by preterm birth. This may limit relevance of the
ranked priorities to other populations.
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For the qualitative work on very preterm birth, limitations of our data were that participants in the
interviews came from two hospitals in the south of England and they were mainly white married women;
therefore, not typical for vey preterm birth. For development of the P-BESS questionnaire, the sample size
was relatively small for a factor analysis and, again, was unrepresentative.
Generalisability of our findings on neonatal care beside the mother is limited by recruitment of parents and
clinicians from a single hospital with a particular interest in care beside the mother, and where the trolley
had been developed. In addition, we were again not successful in recruiting parents for interview who
were representative of the wider population with very preterm birth. Furthermore, the babies were all alive
at the time of interview and most had not required advanced resuscitation at birth.
Finally, although out pilot trial demonstrated feasibility and had strong support for progression to the main
trial, we were not able to secure the necessary funding. Hence, we have not been able to conduct a
definitive trial.
Implications for health care
Providing initial neonatal care at birth beside the mother is feasible within the NHS, acceptable to parents
and to clinicians, and both parents and clinicians felt that it improved communication. Although further
evaluation is required, our data suggest that, with adequate training, preparation and support, parents
and clinicians prefer care beside the mother rather than moving the baby away from the mother for
assessment, stabilisation and resuscitation at birth. This has major implications for maternity services.
Although this is a relatively simple change in practice, implementation of neonatal care beside the mother
at birth requires a change in culture to multidisciplinary teamworking. Care beside the mother can be done
either by adapting the usual resuscitation equipment or by using a mobile trolley specifically designed for
the purpose.
The Cord pilot trial demonstrates that neonatal stabilisation and resuscitation can be provided with the
umbilical cord intact, providing a practical and generalisable strategy for supporting continued umbilical
flow at birth. Results of this trial add to the growing body of data from randomised trials suggesting
that there is no need to rush to clamp the cord at very preterm birth. Although the optimal policy for
cord clamping at very preterm birth remains unclear, waiting 20 to 30 seconds seems prudent.
Only a small proportion of births are very preterm, and parents’ experiences of care during the birth can
differ from those having a term birth. The P-BESS questionnaire was developed to assess experiences
and satisfaction with care during very preterm birth and can be used by hospitals to assess their care,
potentially identifying areas where care can be improved. A total score can be used to compare across
hospitals and differing practices, whereas individual aspects of care can be evaluated using the subscales.
Recommendations for future research
l The 15 top research priorities should guide researchers and funding bodies when planning
new research.
l When planning and funding preterm birth research, it may be relevant to consider not only the top
15 priorities but also the full list of 104 unanswered questions, the top 30 ranked by those affected by
preterm birth and the top 30 ranked by health-care professionals.
l Future prioritisation processes, particularly those with a similar wide range of health-care professionals,
should anticipate potential different perspectives and mitigate any imbalance where possible, and should
report voting separately by ‘service users’ and health-care professionals. Health-care professionals who
are also researchers should declare this potential conflict before participating in the prioritisation
workshop, so that it can be taken into account.
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l Important ‘evidence gaps’ for neonatal care at birth include pharmacological intervention for transition
support or resuscitation of newborn infants, and the effectiveness of new, less invasive forms of airway
management (and related issues regarding surfactant delivery).
l Since our programme started, both timing of cord clamping for very preterm births and providing
neonatal care with the cord intact have become increasingly topical. New research has emerged,
including the work conducted within this programme, which is changing opinion and clinical practice.
Therefore, it would be timely to repeat a survey of practice.
l Further research is needed to replicate our findings about parent experiences at very preterm birth,
and to explore whether or not there is variation for parents from different backgrounds.
l Further studies are needed to test the P-BESS questionnaire in a larger, more representative sample
of parents.
l Fathers of preterm or sick babies are a difficult group to recruit into research. Our work highlights the
importance of including them in research studies to ensure that their perspective is represented.
l Further research is needed to evaluate clinical outcomes, parent experiences and the costs of neonatal
care beside the mother and of care with the cord intact. This should include a wider range of settings
and using the standard resuscitation equipment as well as the mobile trolley. It should involve parents
from more diverse backgrounds, those whose baby required advanced resuscitation, and those whose
baby died. Future studies should also include follow-up of parents and infants.
l The optimal study design would be a randomised trial to compare outcomes (for children and parents)
for parents offered initial neonatal care beside the mother, with outcomes for those offered traditional
care.
l With appropriate planning and training, large multicentre trials of interventions around the time of
preterm birth are feasible within existing maternity and neonatal services in the NHS.
l The two-stage consent pathway should be included in future perinatal trials to increase participation
when there is little time in which to seek consent to participation. It also has potential to increase
participation in other emergency or time-critical trials, but this merits further evaluation.
l Design of future trials comparing alternative policies for cord management should take account of
results from our trial and the planned meta-analysis based on individual participant data from all
relevant trials.
CONCLUSIONS
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Appendix 3 Top research priorities for
preterm birth: results of a prioritisation partnership
between people affected by preterm birth and
health-care professionals
Abstract 
 
Background: We report a process to identify and prioritise research questions in preterm 
birth that are most important to people affected by preterm birth and healthcare practitioners 
in the UK.  
 
Methods: Using consensus development methods established by the James Lind Alliance, 
unanswered research questions were identified using an online survey, a paper survey 
distributed in NHS preterm birth clinics and neonatal units, and through searching published 
systematic reviews and guidelines. Prioritisation of these questions was by online voting 
followed by a decision-making workshop of people affected by preterm birth and healthcare 
professionals.  
 
Results: Overall 26 organisations participated. 386 people responded to the survey, and 636 
systematic reviews and 12 clinical guidelines were inspected for research recommendations. 
From this a list of 122 uncertainties about the effects of treatment was collated: 70 from the 
survey, 28 from systematic reviews, and 24 from guidelines. After removing 18 duplicates, 
the 104 remaining questions went to a public online vote on the top 10. 507 people voted; 231 
(45%) people affected by preterm birth, 216 (43%) health professionals, and 55 (11%) 
affected by preterm birth and also a health professional. Although the top priority was the 
same for all types of voter, there was variation in how other questions were ranked.  
 
Questions ranked as 31-40 were reviewed by the Steering Group, taking into account voting 
preferences of people affected by preterm birth. The top 30 were then taken to the 
prioritisation workshop. A list of top 15 questions was agreed, but with some clear 
differences in priorities between people affected by preterm birth and healthcare 
professionals. 
 
Conclusions: These research questions prioritised by a partnership process between service 
users and healthcare professionals should inform the decisions of those who plan to fund 
research. Priorities of people affected by preterm birth were sometimes different from those 
of healthcare professionals, and future priority setting partnerships should consider reporting 
these separately, as well as in total. 
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Background 
Preterm birth has major impacts on survival, quality of life, psychosocial and emotional stress 
on the family, and costs for health services.1 Improving outcome for these vulnerable babies 
and their families is a priority, and prioritising research questions is advocated as a pathway 
to achieve this.2,3   
 
Traditionally the research agenda has been determined primarily by researchers, either in 
academia or industry, who have used processes for priority setting that lack transparency.4,5 
The James Lind Alliance has developed methods for establishing Priority Setting 
Partnerships between patient organisations and clinician organisations, which then identify 
and prioritise treatment uncertainties in order to inform publicly funded research.6,7 
 
We report the outcomes of a process to identify and prioritise research questions in preterm 
birth that are most important to people affected by preterm birth and healthcare practitioners 
in the United Kingdom and Ireland using methods established by the James Lind Alliance.8 
This partnership differed from previous priority setting partnerships supported by the James 
Lind Alliance in that pregnancy is not an illness or disease, and that it involves at least two 
people (mother and child); in addition preterm birth can have life-long consequences for 
them, their families and for the health services and society. Our aim was first to identify 
unanswered questions about the prevention and treatment of preterm birth from people 
affected by preterm birth, clinicians and researchers. Then to prioritise those questions that 
people affected by preterm birth and clinicians agree are the most important.  
 
Methods 
The Preterm Birth Priority Setting Partnership was convened in November 2011, following 
an introductory meeting in July 2011. The partnership followed the four stages of the James 
Lind Alliance process (see Figure 1).6  
 
Initiation  
Organisations whose areas of interest included preterm birth were informed about the priority 
setting partnership and invited to participate in, or contribute to, the introductory workshop. 
Those who then joined the partnership are listed in Box 1. All participating organisations 
were asked to complete a declaration of interests, including disclosure of relationships with 
the pharmaceutical or medical devices industry. Subsequently a Steering Group was 
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convened, with members of participating organisations who volunteered to take on this role. 
This group was chaired by a representative from the James Lind Alliance (SC). 
 
At the introductory workshop it was clear that many participants felt the scope of the 
partnership should be wider than was initially envisaged. Additional topics proposed for 
inclusion in the scope were uncertainties about the causes of preterm birth, about the 
prognosis following being born preterm, and about treatments long before birth. As widening 
the scope too far would risk leaving the prioritisation unachievable within a reasonable time 
frame and the existing resources, the Steering Group decided the scope would be restricted to 
uncertainties about treatments, to interventions during pregnancy and around the time of birth 
or shortly afterwards (taken up to the time of hospital discharge for the baby after birth).  
 
Box 1: Partner organisations  
Organisations 
representing people 
affected by preterm birth 
Both service 
users’ and 
clinicians’ 
organisations 
Clinicians’ organisations 
 Action on Pre-eclampsia 
 Bliss, the special care 
baby charity* 
 Irish Premature Babies* 
 Multiple Births 
Foundation 
 Cleft Lip and Palate 
Association 
 Irish Neonatal Health 
Alliance* 
 National Childbirth 
Trust* 
 Tiny Life* 
 
 Children's Trust 
 Tommy’s 
 Association of Paediatric 
Anaesthetists of Great Britain and 
Ireland  
 British Academy of Childhood 
Disability*  
 British Association of Paediatric 
Surgeons  
 British Association of Perinatal 
Medicine  
 British Paediatric Pathology Group  
 British Maternal and Fetal 
Medicine Society*  
 Cochrane Neonatal Group  
 Department of Neonatal Medicine, 
Imperial College*  
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 MCRN Neonatal Clinical Studies 
Advisory Group*  
 Neonatal Nurses Association  
 Obstetric Anaesthetists Association  
 Paediatric Intensive Care Society  
 Royal College of Anaesthetists 
 Royal College of Obstetrician and 
Gynaecologists* 
 UCL Institute of Women’s Health* 
* Organisations represented on the steering group 
 
Consultation to gather research questions (treatment uncertainties)  
Research questions were gathered from people affected by preterm birth, clinicians and 
researchers, using methods developed by the James Lind Alliance.7 First, a survey was 
distributed online, including through partner organisations, to ask for suggestions about 
preterm birth experiences, services or treatments which needed to be researched, any why the 
research would be important (see Appendix 1 for paper version of this survey). Respondents 
were asked to say if they were people with personal or family experiences of preterm birth, 
and/or if they were a health professional.  
 
At an interim review of demographic data about home ownership and ethnicity from this 
survey there was concern that the respondents were not representative of the population at 
risk of preterm birth. To try and access a more high risk group, paper copies of the survey 
(see Appendix 1) were distributed at high risk specialist prematurity antenatal clinics at two 
tertiary level hospitals (University College London Hospital and Queen’s Medical Centre 
Nottingham), and to parents visiting their babies in three level 3 neonatal intensive care units 
(University College London Hospital and Chelsea and Westminster Hospital, London; 
Liverpool Women’s Hospital) between March and December 2012. The survey closing date 
was extended to allow time to implement these changes. Respondents were invited to provide 
an email address to be notified about voting to prioritise the questions.  
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In addition, research questions were identified by members of the steering group from 
systematic reviews of existing research and from national UK clinical guidelines (see 
Appendix 2 for the search strategy).  
 
Figure 1: Flow chart of the JLA Preterm Birth Priority Setting Partnership 
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Collation - checking and combining research questions 
With support from an independent information specialist, submissions from the survey were 
formatted into research questions, which were checked against existing reviews and 
guidelines. Those already answered were removed.  The remaining research questions were 
screened by the Steering Group, to remove those answered by a subsequent randomised trial 
or for which a large randomised trial was in progress, and those that were out of scope or 
unclear, and to combine similar research questions (see additional file 2). This left the final 
long list of unanswered research questions which was sorted into similar categories, ordered 
chronologically from before pregnancy to hospital discharge following birth. 
 
Prioritisation of the research questions 
Prioritisation was by a two-stage process using a modified Delphi with individual voting, 
followed by a face-to-face workshop using nominal group technique.7 First, the long list of 
unanswered research questions was made available online for public voting (from September 
to December 2013). Respondents were asked to pick the 10 they considered most important. 
Overall results and results by stakeholder group (people affected by preterm birth, health 
professional) were reviewed by the Steering Group to remove remaining repetition or overlap 
between questions. The final shortlist of 30 unanswered research questions to go forward to 
the prioritisation workshop was then agreed.  
 
The aims of the prioritisation workshop were to agree a ranking for the short list, including 
the ‘top10’, and to consider next steps to ensure that the priorities are taken forward for 
research funding. Participants were invited from across the partnership, and included 
representatives from organisations representing both people affected by preterm birth and 
clinicians, parents of babies born preterm, and adults who were born preterm. Prior to the 
workshop, participants were sent the shortlist of unanswered research questions. 
 
At the workshop (held in January 2014), after an introductory session participants were 
assigned to one of four small groups, each with a facilitator, to discuss ranking for each 
uncertainty. Groups were pre-specified in advance to include a mix of parents, people born 
preterm, clinicians and other health professionals. The groups were provided with a set of 30 
large cards each printed with one shortlisted research question. On the reverse were examples 
of wording from the original submissions, and a breakdown of how people affected by 
preterm birth and healthcare professionals had scored that question in their voting. Following 
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discussion, these cards were placed in ranked order. Over the lunchtime break, rankings from 
the four groups were aggregated into a single ranking order. These aggregate rankings were
presented at a plenary session, to demonstrate where there was existing consensus between
groups, and where there were differences. Participants were then reconvened into three small
groups, again pre-planned so each had a new mix of participants and retained a balance of 
backgrounds, to discuss the aggregate ranking. Similar processes were used as in the earlier 
small groups, with the aim of agreeing the top ten research questions and ranking all 30 
questions. Aggregated ranking from the three small groups was taken to a final plenary
session, with the 30 cards laid out on the floor in ranked order.  Participants then debated and 
agreed the final ranking. 
Results  
Forty two organisations were approached and invited to participate in the priority setting 
partnership (see additional file 1); of these 26 accepted and joined partnership. Ten 
organisations were represented on the Steering Group; four representing those affected by
preterm birth, and six representing health professionals (obstetricians and neonatologists) 
(see Box 1). Some Steering Group members were parents of infants born preterm, or had 
themselves been born preterm. The group also included four non-voting members: two 
researchers who co-ordinated the prioritisation partnership, one a clinical academic with a 
background in obstetrics and the other with expertise in public engagement in research; one 
charity representative, and one PhD student.
When the online survey closed it had been accessed by 1076 people, and completed by 349; 
an additional 37 paper survey forms were completed and returned. Hence a total of 386 
people responded of whom 204 (53%) said that they were affected by preterm birth, 107 
(28%) that they were health professionals, 43 (11%) that they were both affected by preterm 
birth and a health care professional, and 32 (8%) did not answer this question (Table 1). Of
the 247 respondents affected by preterm birth, most 186 (75%) reported they were parents of 
a preterm baby, but some were grandparents and other family members.
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Table 1: Characteristics of respondents to the survey gathering research questions, and to 
voting about priorities 
 
Gathering research 
questions 
n=386 
Voting about 
priorities 
n=507 
 
    
Type of respondent                                  
 affected by preterm birth 204 (53%) 231 (45%) 
healthcare professional 107 (28%) 216 (43%) 
affected by preterm birth + healthcare 
professional 
43 (11%) 55 (11%) 
not known 32   (8%) 5   (1%) 
     
Gender              female 163 (42%) 422 (83%) 
       male 9   (2%) 76 (15%) 
not known 214 (55%) 9   (2%) 
     
Ethnicity                                                   white 159 (41%) 436 (86%) 
Asian 4   (1%) 32   (6%) 
black 9   (2%) 5   (1%) 
Chinese - - 1 (<1%) 
mixed - - 8   (2%) 
not known 214 (55%) 25   (5%) 
     
Home owner* 113 (46%)   
* For people affected by preterm birth only, n=247 gathering research questions 
The 386 responses contained 593 potential research questions. Submissions were formatted 
into research questions, with similar submission combined into one question (see 
supplementary file 2), and screened to remove those already answered, out of scope or 
unclear (see supplemental file 3). Thirty eight submissions were removed as being outside the 
scope of this process. After merging similar questions and removing those that were fully 
answered, 70 unanswered questions were left from the survey.  
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The search of systematic reviews and clinical guidelines identified 540 potentially relevant 
questions. As there was such a large number, the Steering Group agreed a process to 
prioritise which would go forward to the next stage. Each member was asked to select the 
60 questions from systematic reviews they considered to be most relevant and important. 
They then brought their list of 60 to a face-to-face meeting at which questions were only 
considered as potential priorities for the voting stage if they were supported by three or more 
members. This resulted in 28 questions from systematic reviews and 24 from clinical 
guidelines remaining in the process. Overall there were then 122 questions; as 18 of these 
overlapped with other questions they were merged to give a final ‘long list’ of 104 
unanswered research questions (appendix 3).  
 
The 104 questions on the long list were sent for an online public vote, with paper copies 
distributed to the same high risk antenatal clinics and neonatal units. Overall 507 people 
voted (448 online and 59 on paper); 231 (45%) said they had been affected by preterm birth, 
216 (43%) that they were a health professional, and 55 (11%) that they were affected by 
preterm birth and also a health professional (table 1). Type of respondent was not known for 
5 (1%) voters. Of the 271 who said they were a health professional (including those who had 
been affected by preterm birth themselves), 85 said they were an obstetrician, 51 a nurse, 44 a 
neonatologist, 24 a midwife, 4 a general practitioner, 32 were other health professionals and 
31 preferred not to say. Of those who voted, 512 (87%) reported their ethnicity as white, and 
ethnicity was not known for 8 (2%).  Responses were received from the four nations within 
the United Kingdom and the Republic of Ireland. 
 
For public voting, the top priority (which treatments (including diagnostic tests) are most 
effective to predict or prevent preterm birth?) was the same for all three types of respondent 
(table 2), but there was considerable variation in how other questions were ranked. Several 
questions were in the overall top 10 for only one type of voter. Questions ranked overall as 
1-40 in the public vote were reviewed by the Steering Group, taking into account the voting 
preferences of people affected by preterm birth and the overall balance of the topics. Four 
questions were removed: one had already been answered, one was being addressed by an 
ongoing trial, and two were merged with another broader question (all three being about 
infant feeding). A shortlist of the top 30 questions was then taken forward to the prioritisation 
workshop (see table 3).  
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The workshop to prioritise these 30 questions was attended by 34 participants; 13 parents or 
adults who had been born preterm and 21 health professions (neonatology, obstetrics, 
midwifery, speech therapy and psychology). Several of the health professionals also had 
personal experience of preterm birth. In addition, there were four facilitators (two from the 
James Lind Alliance and two non-voting members of the Steering Group), five observers 
(one from the James Lind Alliance, one from a research funding organisation in Canada, one 
from the Institute of Education University of London, and two who were non-voting 
members of the Steering Group). 
 
During the prioritisation workshop, two questions were merged as it was agreed they 
overlapped, and the wording of a few others was modified for clarification. Following the 
first round of small group discussion, there was considerable variation in the top priorities 
between the four groups. Following the second round of small group discussion there was 
agreement about the top few priorities.  During the final plenary discussion about the 
aggregated ranking there was consensus about the top seven questions, less consensus about 
the next three, and disagreement about those ranked as between 10 and 20. As it was not 
possible to achieve consensus about the top 10 questions within the timeframe, a proposal for 
agreeing a top 15 was agreed. Consensus about the top 15 was then achieved (table 3). This 
top 15 had some significant differences to the ranking following public voting. The most 
noticeable was two questions ranked 18 (How do stress, trauma and physical workload 
contribute to the risk of preterm birth, are there effective ways to reduce those risks and does 
modifying those risks alter outcome?) and 26 (What treatments can predict reliably the 
likelihood of subsequent infants being preterm?) at the workshop were ranked 3 and 4 
respectively in the overall public vote (table 3), and 2 and 3 by service users in the public 
vote (table 2).  
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Table 2: For the public vote: top 10 research questions by type of voter (those in italics cells were in the top 10 for one type of voter only)
Type of respondent for public vote 
Service user Health professional Service user & health professional
1 Which treatments (including diagnostic 
tests) are most effective to predict or
prevent preterm birth?
Which treatments (including diagnostic 
tests) are most effective to predict or prevent 
preterm birth?
Which treatments (including diagnostic 
tests) are most effective to predict or
prevent preterm birth?
2 What treatments can predict reliably the 
likelihood of subsequent infants being
preterm?
What is the optimum milk feeding regimen, 
for preterm infants, including quantity and 
speed of feeding and use of donor and 
formula milks? 
What is the optimum milk feeding 
regimen, for preterm infants, including
quantity and speed of feeding and use of 
donor and formula milks? 
3 How do stress, trauma and physical 
workload contribute to the risk of preterm 
birth, are there effective ways to reduce 
those risks and does modifying those risks
alter outcome?
Which treatments are most effective to 
prevent necrotising enterocolitis in preterm
infants?
How do stress, trauma and physical 
workload contribute to the risk of preterm 
birth, are there effective ways to reduce 
those risks and does modifying those risks
alter outcome?
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Type of respondent for public vote 
Service user Health professional Service user & health professional
4 What should be included in packages of
care to support parents and families / carers 
when a premature baby is discharged from 
hospital? 
Which treatments are most effective to 
prevent pre-eclampsia (for example,
progesterone, calcium, garlic etc)?*
What should be included in packages of
care to support parents and families/carers 
when a premature baby is discharged from 
hospital? 
5 What is the optimum milk feeding regimen, 
for preterm infants, including quantity and 
speed of feeding and use of donor and 
formula milks? 
Which treatments are effective in preventing
spontaneous preterm birth in women with
twin and triplet pregnancies, especially in 
those at high risk of preterm birth?*
What type of support is most effective at 
improving breastfeeding in NICU/SCBU/
feeding clinics? 
6 Which treatments are most effective to 
prevent pre-eclampsia (for example,
progesterone, calcium, garlic etc)? 
What methods are most effective to predict 
risk of preterm birth in order to allocate 
service provision?*
What treatments can predict reliably the 
likelihood of subsequent infants being
preterm?**
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Type of respondent for public vote 
Service user Health professional Service user & health professional
8 Can screening of the placenta be effective 
to detect placenta abnormalities associated 
with preterm birth?‡
Is screening in the first trimester effective to 
help prevent preterm birth?†
Which treatments are most effective to 
prevent pre-eclampsia (for example,
progesterone, calcium, garlic etc)? 
9 What is the best way to judge whether a 
baby is feeling pain (for example, by their 
face, behaviours or brain activities)? 
Does screening and treatment for Group B 
Streptococcus help to prevent preterm birth 
and neonatal morbidity and mortality?†
Do preterm babies have better outcomes if
their parents have roomed in?
10 Is screening in the first trimester effective 
to help prevent preterm birth? 
What is the best time to clamp the umbilical 
cord for preterm babies?
How can infection in preterm infants be 
better prevented?
*, **, †‡  these questions had the same number of votes within this type of voter category
7 How can infection in preterm infants be 
better prevented?‡
Is routine transvaginal scanning during 
pregnancy to detect short cervical length, 
and treatment, cost effective?*
Is screening in the first trimester effective 
to help prevent preterm birth?** 
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Table 3: For the prioritisation workshop: final ranking for the 29 research questions (two questions were merged due to overlap) and overall 
ranking from the public vote  
Rank following prioritisation workshop Ranking 
from public 
vote 
1 Which treatments (including diagnostic tests) are most effective to predict or prevent preterm birth? 1 
2 How can infection in preterm infants be better prevented? 8 
3 Which interventions are most effective to prevent necrotising enterocolitis in preterm infants? 9 
4 What is the best treatment for life-threatening lung damage in preterm infants? 20 
5 What should be included in packages of care to support parents and families / carers when a premature baby is discharged 
from hospital? 
6 
6 What is the optimum milk feeding strategy and guidance (including quantity and speed of feeding and use of donor and 
formula milk) for the best long-term outcomes of premature babies? 
2 
7 What is the best way to judge whether a baby is feeling pain (for example, by their face, behaviours or brain activities)? 14 
8 Which treatments are most effective to prevent early onset pre-eclampsia? 5 
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Rank following prioritisation workshop Ranking 
from public
vote
9* What emotional and practical support improves attachment and bonding, and does the provision of such support improve
outcomes for premature babies and their families? 
 25/28*
10 Which treatments are most effective for premature rupture of membranes? 16 
11 What is the best time to clamp the umbilical cord for preterm babies? 19 
12 What type of support is most effective at improving breastfeeding in NICU/SCBU/feeding clinics? 12 
13 Which treatments are most effective to treat necrotising enterocolitis in preterm infants? 22 
14 Does specialist antenatal care for women at risk of preterm birth improve outcomes for mother and baby? 11 
15 What are the best ways to optimise the environment (such as light and noise) in order to improve outcomes for premature
babies?
26 
16 Is screening in the first trimester effective to help prevent preterm birth? 7 
17 Which treatments are effective in preventing spontaneous preterm birth in women with twin and triplet pregnancies, 
especially in those at high risk of preterm birth?
10 
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Rank following prioritisation workshop Ranking 
from public 
vote 
18 How do stress, trauma and physical workload contribute to the risk of preterm birth, are there effective ways to reduce 
those risks and does modifying those risks alter outcome? 
3 
19 Is routine transvaginal scanning during pregnancy to detect short cervical length, and treatment, cost effective? 18 
20 What guidance and information is most useful for parents at risk of having preterm infants? 21 
21 Does screening and treatment for Group B Streptococcus help to prevent preterm birth and neonatal morbidity and 
mortality? 
15 
22 What is the impact of length of orogastric / nasogastric feeding and reflux on early feeding development in preterm 
infants? 
24 
23 What methods are most effective to predict risk of preterm birth in order to allocate service provision? 17 
24 Can screening of the placenta be effective to detect placenta abnormalities associated with preterm birth? 13 
25 What is the best way to encourage Kangaroo Mother Care more by staff in NICU for parents? 23 
26 What treatments can predict reliably the likelihood of subsequent infants being preterm? 4 
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Rank following prioritisation workshop Ranking 
from public 
vote 
27 Do parents of preterm infants benefit from an open approach to notes and ward rounds? 27 
28 Do preterm babies have better outcomes if their parents have roomed in? 29 
29 Which lifestyle changes including gym, bed rest, posture and sexual intercourse are effective to minimise the risk of 
preterm birth? 
30 
*two original questions merged 
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Discussion 
The unanswered research questions relevant to preterm birth identified during this process 
were prioritised in the United Kingdom and Ireland by people affected by preterm birth 
(parents, grandparents, adults who were born preterm, and others affected by preterm birth), 
by a range of health professionals, and by people who were both personally affected by 
preterm birth and a health professional. To our knowledge this is the first such process in 
preterm birth.  People affected by preterm birth and health professionals had many shared 
priorities, but our process demonstrates that on some questions they have different 
perspectives. Priorities may also change over time and in different settings. Hence, although 
the top research priorities from this process should be considered by those who plan and fund 
research in this area, the full list of 104 unanswered questions is also relevant to decision-
making about research funding. This is particularly true if we wish to make research more 
relevant to those whose lives have been affected by preterm birth, and the healthcare workers 
who care for them.   
 
While several of the top priorities for research are broad topics already well recognised as 
important, such as what is the optimum milk feeding regimen for preterm infants and 
prevention of infection, others are indicative of areas previously underrepresented in 
research; for example packages of care to support families after discharge, and what is the 
role of stress, trauma and physical workload in the risk of preterm birth, and are there 
effective ways to reduce this risk and does this influence outcome. This is in keeping with 
findings from previous James Lind Alliance partnerships, which suggests and highlights the 
value of partnership and shared decision making with an inclusive stakeholder group with 
balanced representation of service users and clinicians.9 
 
In line with the literature on consensus development 10, the strengths of this preterm birth 
priority setting partnership include the large numbers of participants in the process, the range 
of stakeholders involved, the formality of the processes, the use of facilitators for face-to-face 
debate to ensure that all options were discussed and all participants had a chance to voice 
their views, providing feedback and repeating the judgement, and ensuring that judgements 
were made confidentially. The first three features applied to both the consultation and the 
workshop; the last applied only to the consultation. The change in priorities between the 
survey and the workshop deserves further investigation. Although the choice of individuals 
APPENDIX 3
NIHR Journals Library www.journalslibrary.nihr.ac.uk
106
within the professional groups represented is unlikely to have made a difference to the 
priorities, 11 difference in status across workshop participants may have. 10
Preterm birth is associated with factors such as lower socio-economic status, ethnicity
(such as African origin), and maternal age (being lower than 18 years or above 35 years).12
Despite implementing strategies to reach a more representative population, our respondents 
remained primarily white and with a relatively high proportion of home owners, hence not 
representative of the population affected by preterm birth. This could limit generalisablity
of these priorities to other populations. A wide range of relevant health professionals 
participated in the public voting, including neonatologists, obstetricians, neonatal nurses, 
midwives, speech and language therapists, psychologists and general practitioners; 
strengthening generalisablity. 
Maintaining balanced representation between people affected by preterm birth and the
different groups of health professionals for the final prioritisation workshop was challenging.
This may have had implications for the final decisions, as happens in guideline development, 
where consensus development research concludes that differences in how groups are 
constituted (but not individual members) leads to different decisions.13 At our workshop 
differences in priorities between the various professional groups contributed to the difficulty 
in achieving consensus for a top 10 list, and to the two ‘lost priorities’ which although ranked 
in the top 5 at the public vote were not included in the final top 15.
The difficulty in agreeing a top 10 underlines the complexity of priority setting for research, 
particularly for topics such as preterm birth which involve mother and baby, as well as their 
wider family. This complexity and the differing priorities of different stakeholders make it
important to publicise the top 30 list, and the full long list of 104 questions, as well as the top 
15 priorities.14 Large changes in ranking following the public vote and the final prioritisation 
appeared to be related to difficulty in the perspective of people affected by preterm birth 
being heard in the large group session, and an imbalance between the different priorities of 
two key types of health professional (neonatologists and obstetricians). This was further 
complicated by some of the healthcare professionals also being researchers. Reporting of the
process for prioritisation is therefore important for transparency, and to identify ways in 
which it could be improved. Future prioritisation processes, particularly those with a similar
wide range of healthcare professionals, should endeavour to anticipate potential different 
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perspectives and mitigate any imbalance where possible, and should report voting separately 
by ‘service users’ and healthcare professionals. Similarly, whilst it may be appropriate to 
include healthcare professionals who are also researchers in prioritisation, this potential 
conflict of interest should be declared and taken into account.  
 
This priority setting was limited to the United Kingdom and Ireland, and is therefore most 
readily generalisable to settings with a similar population and health system.  Previous 
research prioritisation processes for preterm birth15,16 did not include people affected by 
preterm birth and were for low and middle income settings. The most recent neonatal 
prioritisation exercise in the UK did not include people affected by preterm birth and 
considered only medicines for neonates.17 Although unanswered research questions are 
universal, prioritisation of these questions depends on the local values, context and setting. 
Nevertheless, there are common priorities across these different settings and our prioritisation 
process in the UK, such as prevention of preterm birth, postnatal infection and lung damage.  
 
Failure to take account of the views of users of research (i.e. clinicians and the patients who 
look to them for help) contributes to research waste.18 James Lind Alliance priority setting 
partnerships brings together ‘patients, carers and clinicians’ to identify unanswered research 
questions and to agree a list of the top priorities,19 which can then shape the health research 
agenda.20-22 The aim is to ensure that those who fund health research, and also those who 
support and conduct research, are aware of what really matters to both patients and clinicians. 
In our priority setting partnership, people affected by preterm birth and the different groups 
of health care professionals had different priorities. This underlines the importance of this 
paper presenting the full list of 30 questions taken forward to the prioritisation workshop, and 
the respective priorities of people affected by preterm birth and health professionals, as well 
as the long list of 104 unanswered questions sent out for public voting.  
 
Conclusions 
We present the top 30 unanswered research questions identified and prioritised by the priority 
setting partnership, along with the full list of 104 questions. These include treatment and 
prevention as well as how care should be organised and staff training. They should be 
publicised to the public, to research funders and commissioners, and to those who support 
and conduct research.  
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People affected by preterm birth and health professionals sometimes had different priorities. 
Future priority setting partnerships should consider reporting the priorities of service users 
and healthcare professionals separately, as well as in total. Those with a wide range of 
healthcare professionals involved should anticipate potential different perspectives and 
mitigate any imbalance where possible. Healthcare professionals who are also researchers 
should declare this potential conflict before participating in prioritisation, so that it can be 
taken into account.  
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Appendix 4 Consensus development for
tackling technical and emotive challenges: a case study
of the James Lind Alliance Preterm Birth Priority
Setting Partnership
Abstract
Background
Setting priorities for research requires engaging with technical and value-laden issues. 
Guidance developed by the James Lind Alliance (JLA) for priority setting draws on both 
formalised and tacit knowledge held by clinicians and service users. We aimed to assess how 
service users and clinicians interact when making collective-decisions about research, in 
particular how they interact and what makes some messages more persuasive. 
Methods 
An observational study of the Preterm Birth Priority Setting Partnership (PSP), including 13 
meetings (12 steering group, one workshop) and two public consultations from 2011 to 2014. 
We used the Elaboration Likelihood Model of persuasion as a theoretical framework, and 
adopted an ethnographical approach with participant observation and discourse analysis. This 
included transcriptions, field notes and analysis of documentary records of meetings. 
Results
The most frequently used route for persuasion was the ‘central pathway’; health care 
professionals were more likely to use this route while service users were more likely use 
peripheral route pathways. Communication patterns depended on the stage of group 
development. The steering group showed typical stages for group development: forming, 
storming, norming, performing and adjourning. When new participants joined for the
workshop, the group returned to the ‘forming’ stage. This may have influenced quality of the
consensus
Conclusions 
Understanding these interactions may explain differences between public voting and the final 
workshop, and suggests ways to improve prioritisation for research.
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Background
Guidance developed by the James Lind Alliance (JLA) for clinicians and service users 
making decisions collectively about research 2 is unusual in drawing on both formalised 
knowledge about structures, resources and procedures and tacit knowledge about 
interpersonal communication and support.3 We used the experience of the Preterm Birth 
Priority Setting Partnership 4 to assess how participants interacted and influenced each other. 
What we know about how people interact in committees with members from across 
organisational boundaries that make decisions about highly technical matters comes from 
health research, from experimental ‘laboratory’ studies in social psychology, and from 
observations in business administration.5 Larger groups allow greater diversity of 
membership, possibly enhancing the groups’ credibility and acceptance of its decisions.6
Varied membership brings more perspectives, alternatives and better performance. Increasing 
group size may offset the benefit of greater diversity, as reliability declines with more than 
six people, and there are diminishing returns over 12. Status is linked to participation in
larger groups, and to influence in small groups. Formal methods appear to be better than 
informal methods, but the reasons are unclear. The role of the chair or group facilitator links 
to collective performance, being crucial for establishing inclusive practices, and an
atmosphere of openness and trust.6-9 Discussion allows sharing and evaluation of knowledge; 
when time is short, less knowledge is shared and decisions are more the result of negotiating 
between prior preferences.10 When tasks involve judgments, rather than problem solving, 
status within the group influences decisions.6
This evidence is directly relevant to decision-making about research priorities. Two 
additional issues for research prioritisation involving service users and clinicians are i) the
influence of different types of expertise, based on qualifications, experience or problem-
solving skills11, and ii) how arguments are framed and attitudes changed as consensus 
develops.12,13 The roles of logic and emotion in changing attitudes through one-way
communication, such as a broadcasted political campaign or advertisement, have been
investigated with the Elaboration Likelihood Model.14,15 This argues that messages to 
influence others take either a central route or a peripheral route. Central route messages 
include information, rational arguments and evidence. Peripheral route messages rely on 
receivers’ emotional responses to ‘authority’, ‘commitment’, ‘consistency’, ‘liking’, 
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‘reciprocation’, ‘scarcity’ and ‘social proof’.16 This model, adapted for interactive 
communication, offers a framework for analysing group discussion of technical and emotive 
issues in the context of inequalities of knowledge and status. We aimed to use this model to
assess how service users and clinicians in the James Lind Alliance (JLA) Preterm Birth 
Priority Setting Partnership interacted when making collective-decisions about research
priorities. In particular, to determine how they communicated when deciding research
priorities together, and what made some messages more persuasive than others.
Methods
The preterm birth priority setting process took place from March 2011 to March 2014. 
Methods are published elsewhere.17 During this process, the partnership had two workshops 
(initial awareness, and final prioritisation), and 12 steering group meetings (nine face-to-face
and three teleconferences). The study sample comprised those attending one or more of the 
steering group meetings, or the final workshop. We excluded the initial workshop, as it did 
not involve decision-making. The final workshop prioritised the top 30 research questions 
from public voting into a top 15. Meetings took place in either London or Nottingham, and 
involved three types of organisations: academic, clinical and charities. 
This was a semi-ethnographical study18 with participant observation19 and discourse
analysis20 of steering group meetings and the final workshop. We used digital recording and 
transcription of discussions, field notes (for instance of non-verbal communication), and 
analysis of documentary records of meetings and steering group activities. At each event, 
participants were reminded about the recording and all consented. Voice recorded data were
imported into software for qualitative data analysis (NVivo 10), transcribed by an
independent researcher, and coded using an analytical framework based on the Elaboration 
Likelihood Model15 with peripheral cues adapted.16  Analysis therefore sought two different 
pathways of persuasion (central or peripheral) and their cues (authority, commitment, 
consistency, liking, reciprocation, social proof or scarcity). 
Results
Use of central and peripheral pathways at steering group meetings and the workshop
At steering group meetings, members used the central route (n=281) more often than the
peripheral route (n=221). This was consistent (table 1), regardless of timing of the meeting or 
type of discussion, supporting the assumption of the Elaboration Likelihood Model15 that 
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individuals with good cognitive ability (such as these steering group members) employ
central routes for persuasion. Amongst peripheral cues, ‘social proof’ and ‘consistency’ were
the most popular. During the workshop, ‘social proof’ was the most frequent cue (table 1); 
this relies on peer pressure, arguing ‘we do this in our group’.
Table 1: Persuasive pathways used during the steering group meetings and final workshop
Frequency of use 
Steering Group meetings Final workshop
Peripheral route 221 40 
  Authority 18 6 
  Commitment 15 - 
  Consistency 39 5 
  Liking 2 1 
  Reciprocation 10 2 
  Scarcity 23 6 
  Social proof 42 23 
Central Route 281 48 
At the final workshop, health care professionals used central route pathways33 more often 
than people effected by preterm birth (table 2). The association between type of speaker and 
the persuasive pathway was statistically significant (p=0.017, Pearson's Chi-square test). In
other words, health care professionals were more likely to use central route pathways than 
service users, while service users were more likely to use peripheral route pathways. 
Table 2: Association between type of speaker and use of persuasive pathway at the workshop
Persuasive pathway Total
Central Peripheral 
Health care professional 33 17 50 
People effected by preterm birth 15 23 38 
Total 48 40 88 
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At the workshop, for the peripheral route both types of speaker used ‘social proof’ more than
other cues. They used this more often at the beginning of discussion, and more often by
people effected by preterm birth than health care professionals (table 3). Some participants 
used ‘reversed’ social proof to persuade others, using arguments based on ‘we do not do it
normally in our group so we should try it next time’.
Table 3: Peripheral route cues used at the final workshop, by type of speaker
People effected by
preterm birth 
Health care 
professionals
Total
Peripheral route cues
  Authority 3 3 6 
  Commitment - - - 
  Consistency 2 3 5 
  Liking 1 - 1 
  Reciprocation - 2 2 
  Scarcity 2 4 6 
  Social proof 17 6 23 
Total 23 17 40 
Different contexts for discussion 
Preliminary analysis of the first two steering group meetings suggested the patterns of
persuasion differed depending on the context of discussion. When the discussion was about 
medical information (for example, prevalence of pre-eclampsia), participants were easily 
persuaded by information based on evidence. When it was about decision-making based on 
values (for example, the scope of the partnership), participants used different ways of
persuasion. To investigate communication behaviour in different contexts, we needed to look 
at the types of discussion.  It has been argued that there are four types of discussion; 
informational, dialectical, problematical and reflexive.21 During informational discussion, the 
facilitator encourages participants to speak, defers controversy, and lets participants know 
their ideas will not be evaluated. In problematical discussion, a problem-posing query has the 
participants consider the information and/or values needed to address the issue intelligently.
In dialectical discussion, participants are requested to state opponents’ views accurately and 
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sympathetically. In reflexive discussion, participants discuss their own discussion in order to 
learn from the process. 
Based on this classification, we coded transcripts based on whether the discussion was: 
informational, problematical or reflexive. We did not use ‘dialectical’ as it was not clear 
whether participants were taking a position to provoke thoughtful debate, or genuinely 
challenging an opponent’s views. Throughout the partnership process, informational (n=104) 
and problematical (n=169) were the main types of discussion, with problematical increasing
as the partnership developed. For the first 18 months, during the first phase of partnership 
working (up to preparing the long list for public voting), there were no reflexive discussions. 
Reflexive discussions were identified later (n=9), but were few. 
Persuasive pathways used for different types of discussion
For both informational and problematic discussion, people used more central route than 
peripheral route pathways (table 4). When using peripheral route messages to persuade others 
for informational discussion, participants tended to use all the peripheral cues (table 4). For 
problematical discussion, they used mostly ‘consistency’ or ‘social proof’. At steering group 
meetings ‘consistency’ was used more, while ‘social proof’ was used during the workshop. 
‘Scarcity’ was used more frequently during the second phase of the priority setting process, 
when there was more time pressure.    
Table 4: Persuasive pathways and cues, by type of discussion 
Type of discussion
Informational Problematical Reflexive
Central route 85 134 1 
Peripheral route 39 79 3 
  Authority 6 9 1 
  Commitment 3 5 - 
  Consistency 5 23 - 
  Liking - 1 - 
  Reciprocation 5 3 - 
  Scarcity 7 8 1 
  Social proof 4 24 1 
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Final prioritisation workshop
New participants joined the group for the workshop. They required explanation, information, 
time to understand the process of priority setting, and time to ask questions. Steering group
members actively advocated the partnership process. They often responded to queries before
facilitators could do so. As service users and clinicians themselves, steering group members 
were effective at providing credibility to the wider group. Participants at the workshop used 
‘reciprocation’ during the consensus process. For example, for a topic with conflicting views, 
some people wanted to place it at the top of the list while others wanted to put it at the 
bottom. Often the group decided to place the topic in the middle of the list, to compromise. 
It took time for new participants to contribute to discussions. There were four small groups in 
the morning, and three in the afternoon. Facilitators in the small groups began with 
introductions, and reminded participants of the purpose of the prioritisation and invited them 
to express their views. In the morning, for the first 15 minutes participants did not initiate
discussion, they only responded to the facilitator. This was especially so for newly joined 
service users. During this time participants did not express strong views on a particular topic, 
rather they used ‘cushion words’ such as ‘if I understood correctly, […]’ or ‘this is only my
personal experience, […]’, and social proof cues, such as ‘in my charity (or in clinic), we do 
this in this way therefore […]’, appeared more frequently.
Subsequently, participants actively engaged, and often there were lively debates with
conflicting views on a particular issue. When they came back after the lunch break and met 
different people in another small group, participants engaged immediately with the task. They 
were involved more actively in the topics they had failed to persuade others about in the 
morning. They came back with more developed arguments, and often paraphrased their
opponent’s earlier argument. 
Discussion
Throughout the partnership working process, participants were more likely to accept 
messages with a central route than those with a peripheral route. This supports the 
Elaboration Likelihood Model, which argues that if participants are ‘highly motivated’ and 
‘have enough knowledge to understand the information’, messages with a central route are 
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more persuasive. Participants in the partnership were assumed to be ‘highly motivated’ and 
‘have enough cognitive abilities’ to understand the process, as they had experience (either 
direct or indirect) and were willing to advocate for the group they represented. 
The impact of peripheral route message is weak compared to central route messages.15  For 
example, participants might be persuaded for the short term but change their decision change
later;22 hence for a lasting impact, central routes are better than peripheral routes. During the 
final workshop, sometimes participants were assisted to use more central route (or evidence–
based) arguments. For example, in one small group discussion, participants considered ‘how 
can infection in preterm infants be better prevented?’. Initially they decided not to prioritise 
this topic based on the assumption that ‘infection would be limited to the hygiene issues’. 
After clarifying that infection is also associated with brain injury, the group decided to 
prioritise the topic. If a peripheral route message was supported by a central routed message
from another speaker, it became more persuasive. If logical arguments supported the 
peripheral route, it was more likely to be accepted. 
At the workshop, participants had access to information about the public vote for that 
question; overall, and by service user and health care professional. After accessing this 
information, they used more central route arguments, rather than peripheral route ones. 
When participants could clearly state that the topic was an unanswered question, it became 
more persuasive.  For example, questions on ‘Group B Strep’ and ‘environmental issues’
were prioritised within the small group discussions. However, topics such as ‘kangaroo care’
and ‘breastfeeding’ were moved down the ranking because participants thought that they
were (partly) answered or being actively investigated. 
The James Lind Alliance Guidebook highlights the importance of the facilitators’ role.2
Throughout the prioritisation process, facilitators often paraphrased someone’s claims by
using central route expressions, and these claims were likely to be accepted. Facilitators 
focused on the prioritisation process, particularly when time was short. When there was less 
time pressure, facilitators were able to explore further. Participants were able to review the 
outcomes of their collaborative work as they went along, and could ask questions. During
these reflective discussions, participants mostly used central-route pathways. These claims
were more effective, supporting the Elaboration Likelihood Model.
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After the first 15 minutes of discussion, workshop participants were more likely to engage
actively, and used more central-route messages. During the afternoon discussion, many used 
what they agreed in the morning as a cue to justify or support their arguments. In this way,
participants used ‘social proof’ of the morning group. Participants reflected what they
discussed in the morning, although they were reluctant to change the existing order because it
was based on consensus from the small groups.
What factors made arguments more or less persuasive? 
An argument was less persuasive when: a) it lacked a central-route pathway, b) it lacked
urgency, c) broader questions subsumed narrower questions, d) participants thought that they
knew the answer, e) participants did not like the answer they thought might ensue, and f)
when survival was not at stake. An argument without a central-routed pathway was less likely 
to be accepted.  When an argument did not have a central-routed pathway, discussion was 
more likely to move to another topic. 
When the topic (research question) did not address either immediate investigation, or a 
serious health conditions, it was more likely to be rejected. Participants tended to treat 
physical conditions (such as brain injury) as more serious, while they tended to conceptualise 
psychological conditions (such as emotional impact, attachment and bonding) as less serious. 
With similar reasoning, workshop participants combined two questions with themes of 
‘emotional and practical support’, and ‘attachment and bonding’ (table 5). For the first, 
original submissions from the public consultation focused on emotional impact for mothers 
experiencing preterm birth, how to offer them adequate support, and communication between
parents and health care professionals, especially at the time of birth. For the second, original 
submissions were about communication between mother and infant caused by preterm birth, 
which could be related to health care professionals and hospitals, but mostly focused on long-
term problems and consequences. In the public voting these two questions were both 
supported mainly by service users, the first ranked 28/104 and the second 25/104.17 The
merged question was ranked 9 at the workshop (4) ‘What emotional and practical support
improves attachment and bonding, and does the provision of such support improve outcomes
for premature babies and their families?’. Although some service users still argued that the 
two questions differed in nature and origins, other participants were not convinced.
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Table 5: Original submissions for the two questions merged during the workshop
Some workshop participants were more likely to rank a question down if they felt that a 
similar or broader question was already high on the list. For example, screening for the
placenta was considered covered by ‘general prevention’. Others pointed out the risk of de-
prioritising questions because of an overarching question. Participants were more likely to 
move a question down if they personally did not have uncertainty. For example, a health care
professional who argued against support for breastfeeding as a priority used the argument 
their hospital knew what to do and it worked. 
What emotional and practical support
should be included in a care bundle that 
aims to optimise outcomes of preterm 
birth?
Which treatments improve attachment and
bonding and does the promotion of
appropriate attachment and bonding
improve outcomes? 
‘The emotional effects on the mother of 
having a preterm baby’ (mother)
‘More information available to parents 
before the child is born and emotional
support for while the child is in ICU’
(parent)
‘Communication with parents: do parents 
who receive regular communications 
(both written and verbal) feel better 
prepared and supported during the 
hospital stay?’ (father)
‘The only problem I experienced was the 
lack of support for me […]’ (mother of 
twins) 
‘Impact of early parental separation to
emotional development’ (service user)
‘Long term impact of being preterm on 
later communication and feeding 
development - particularly social
communication development long term 
impact on attachment and bonding in
parents with preterm infants’ (carer & 
speech/language therapist) 
‘Lacking in bonding with mother, being left
alone for periods of time without nurture or 
comfort’ (mother)
‘the area in a whole, time spend with family 
just after birth to bond’ (service user)
‘Attachment issues between mother and 
baby during this traumatic experience’ 
(mother)
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Priorities from the public voting ‘lost’ during the workshop
Four research questions ranked in the top 10 after public voting were not included in the final 
top 15 (Table 6). Three (2-4 in table 6) were moved down because participants thought they
were included in the overarching question on prevention of preterm birth (“which treatments, 
including diagnostic tests, are most effective to predict or prevent preterm birth?”), whereas 
the fourth (1 in table 6) was moved down because some participants argued ‘it sounded too 
similar to another question’. For two (1 and 3), participants raised questions about the 
effectiveness or adverse impact of the intervention. For example, arguing that if stress and 
physical work does cause stress, why cause additional stress by raising women’s concern 
about it, and the potential stress of screening. 
Table 6: Ranking during prioritization for questions in the top 10 after public voting which 
finished outside the top 15
Public
voting
Final workshop
am pm final*
1 How do stress, trauma and physical workload 
contribute to the risk of preterm birth, are there 
effective ways to reduce those risks and does 
modifying those risks alter outcome?
3 22 19 19 
2 What treatments can predict reliably the likelihood of 
subsequent infants being preterm?
4 27 27 27 
3 Can screening of the placenta be effective to detect 
placenta abnormalities associated with preterm birth? 
7 16 17 25 
4 Which treatments are effective in preventing 
spontaneous preterm birth in women with twin and 
triplet pregnancies, especially in those at high risk of 
preterm birth?
9 18 18 18 
*final ranking before two questions were merged
The question about ‘stress and physical workload’ remained controversial. Although ranked 
third after public voting, at the final workshop it ranked 22nd in the morning and 19th in the 
afternoon, and was not included in the final top 15. Some participants had difficulty accepting
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this was a ‘research question’ because stress and physical workload do not have conventional 
treatments. Others commented it is difficult to define or standardise ‘stress’ and ‘workload’, 
potentially making research difficult. For example, one service user commented stress would 
be difficult to define as it is different for different people. Others argued that interventions to
reduce physical workload, such as rest, are hard to accept as ‘treatment’.  Some questioned 
whether stress and physical workload are associated with preterm birth. Service users who 
argued against this question referred to their own experiences, arguing either ‘I had stress 
and/or physical workload but I was fine’ or ‘I had preterm birth but did not have physical
workload’. For example, one service user said ‘as a parent, I've been pregnant five times, lost 
the baby, had a miscarriage, had ectopic pregnancy so I can tick all of those things, […], you 
are going to get lots of people saying yeah I had stress, the wider the question more than 
likely to get them voting, so for me, it is, can we identify these physical workload things? 
Having had an extremely stressful time, I still put it further down.’
This tendency to relate to their own experiences risks over-estimating the accuracy of and/or 
relevance of past knowledge potentially leading to ‘hindsight bias’, also known as the ‘knew-
it-all-along effect’.23,24  When someone clarified the issues by offering definitions or methods
for the intervention, or outlining a group who might be high risk, participants tended to rank 
the question higher. 
The final list of priorities combined outcome from two types of public consultation (Delphi
survey, and workshop), designed to counterbalance each other. The ‘lost priorities’ reflect
views from the wider public consultation, which may reflect views from a more
representative population of those at risk of preterm birth than was possible to involve in the 
face-to-face workshop. The top ranked question throughout was an overarching question on 
prevention and prediction of preterm birth. Participants at the steering group meetings and the 
workshop discussed whether to keep this overarching question. The consensus from both 
discussions was to keep it, as it scored so high in the public vote. A consequence was that 
questions about specific interventions tending to be ranked down, based on the argument they 
were covered by this overarching question, contributing to the ‘lost priorities’. 
Delphi versus Nominal Group Technique 
The preterm birth prioritisation used methods2 which combine two iterative techniques for 
achieving consensus: Delphi and the Nominal Group Technique. The Delphi method involves 
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circulating questionnaires to individuals, sharing results with them, and then continuing to re-
circulate and refine responses until consensus is reached.25 The Nominal Group Technique 
prioritises within a group. Usually Delphi is used for forecasting. It takes longer to achieve 
consensus as data are shared over time,26 but allows wide gathering views in different 
geographical areas. It is anonymous, preventing undue influence of individuals. 
Disadvantages were the difficulty of retaining participants, and that it may look less 
transparent than face-to-face meetings. A Delphi can be closed where a single set of
individuals work toward consensus, or open where new people are brought in.25 Nominal 
Group Technique requires members to meet face-to-face, giving opportunity for discussion 
and resolving differences of opinion, and is designed to ensure equal participation.27 It can 
achieve consensus within a relatively short time, with members quantifying their opinions 
numerically. Sometimes smaller teams achieve numerical consensus, and these results are 
compiled.10 Disadvantages are the lack of flexibility in time and geography, and that face-to-
face meetings need planning and resources. 
Public consultation (survey and voting) for this partnership adapted Delphi methods to
perform forecasting, this required time to think and research the topic (i.e. what are the 
research priorities for preterm birth?). The Nominal Group Technique helped the process of 
initiating and developing the steering group, and the final prioritisation. The final workshop 
combined the two methods by using outcomes from the public consultation and bringing new 
participants to the face-to-face meeting. The aim was to maximise the advantages of both 
methods, whilst minimising the disadvantages. However, the ‘lost priorities’ suggest it may 
have weaken the benefits of each method. One factor may have been that in the public voting
the reasons for ranking by participants were not known.
Process of consensus development in the Preterm Birth Priority Setting Partnership
To understand the process of consensus development, we compared the Priority Setting
Partnership to the five stages in the ‘Group Development Model’28: ‘forming’, ‘storming’, 
‘norming’, ‘performing’ and ‘adjourning’. This model argues that every group goes through
these before becoming a self-reliant unit. At each stage, group dynamics change from 
inefficiency and uneasiness through to high performance. The five stages in the James Lind 
Alliance process have similarities to the Group Development Model. In particular ‘forming’ 
in the Group Development Model, is comparable to ‘initiation’, and ‘adjourning’29 is similar 
to ‘reporting’ (Figure 1). 
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Figure 1: Group Development Model versus JLA stages of partnership working
At ‘initiation’ of the partnership, participants had to form a steering group, and define the 
scope, timeframe and methods for priority setting. Steering group members looked outside
for guidance and direction, while some felt anxious and were unsure of their roles. These
characteristics are similar to those in the ‘forming’ or ‘team building’ in the Group 
Development Model.28 Once the group completes ‘forming’, it moves onto ‘storming’ and 
‘norming’.28 During ‘storming’, members feel comfortable expressing discontent and 
challenging other opinions; although this can be unpleasant, the process of challenging is 
necessary for group growth. At ‘norming’, the group have a common goal and mutual plan, 
and take responsibility for success in reaching that goal. In the JLA process, it was difficult to
distinguish ‘norming’ and ‘storming’, as members were repeating ‘storming’ after ‘norming’. 
This ‘re-norming’ is perhaps due to the group having to perform multiple tasks, such as
deciding the partnership scope and preparing the survey.30,31 At ‘performing’ group members 
are competent, autonomous and able to handle the decision-making process; a stage reached
only by high-performing groups28 and similar to ‘prioritisation’ in the JLA process. 
At the final workshop, communication patterns were different between the steering group 
members and new participants. The steering group members had already reached
‘performing’. When new participants joined the final workshop, the group returned to 
‘forming’. Members had to spend time getting to know each other, and defining their roles
Group Development Model
Forming
Storming
Norming
Performing
Adjourning
JLA stages of partnership working
Initiation
Identification
Collation
Prioritisation
Reporting
JLA=James Lind Alliance 
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and tasks. Therefore, those first fifteen minutes, when participants did not express views, can 
be interpreted as the ‘forming’ or ‘norming’ stages necessary for group development. The
Group Development Model relates to task function and dependency of group members 
(Figure 2).1 Initially, participants are scattered and show high dependency, so tasks at this 
stage should be introductory. As the group moves on to ‘storming’ and ‘norming’, it will 
experience conflict and cohesion; then as the group ‘performs’ members manage tasks 
effectively.  Before the final workshop, steering group members had been through the 
‘conflict’ and ‘cohesion’ process and were ‘interdependent’, so at the workshop they could 
work effectively. This caused discrepancy in group development between steering group 
members and new participants, and new participants were given tasks they were not yet ready 
for. This discrepancy may have influenced the quality of consensus at the workshop. 
In conclusion, this study showed the complex issues when tackling research priorities with
service users and clinicians. The Elaboration Likelihood Model helped understanding of how 
they interact and what elements makes some views more persuasive than others. Service
users and clinicians had different priorities and used different communication styles to 
persuade others. Nevertheless, in general, messages using logical arguments (centrally 
routed) were more persuasive than emotional arguments (peripherally routed). While the role 
of facilitators were crucial, participants tended to share more direct messages after the first 15 
minutes of each session. The steering group’s communication patterns were similar to stages 
in the Group Development Model, and this changed with new participants joining.  
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Figure 2: Stages of group development for the steering group and new participants (modified 
from 1)
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Appendix 5 Delivery room transition support for
newborn infants: an overview of Cochrane reviews
Abstract 
Background 
Newborn infants who have delayed establishment of independent respiratory effort after birth 
may require transition support in the delivery room. Cochrane systematic reviews which 
summarise evidence for delivery room interventions are used to inform policy, practice and 
research. Our aim was to identify Cochrane reviews of delivery room transition support 
interventions, appraise their quality, and identify important gaps in the evidence.    
 
Methods 
We searched the Cochrane Database of Systematic Reviews (Issue 6, 2015) for reviews 
evaluating the effects of delivery room transition support for newborn infants. Review quality 
was assessed using the AMSTAR tool.  
 
Results 
Eighteen Cochrane reviews were identified. Broadly, these reviews assessed delivery room 
interventions for airway management, respiratory or circulatory support, supplemental 
oxygen or other drugs, and measures to prevent hypothermia or metabolic compromise. The 
overall quality of reviews was good, but the methodological quality of the included trials 
varied greatly. Most reviews assessed interventions to support the infant airway and 
breathing, and the strongest evidence of effect was for types and timing of surfactant 
replacement. Reviews of oxygen and other drug therapies identified few good quality trials to 
inform practice.   
 
Conclusions 
Existing Cochrane reviews provide good quality evidence to inform the airway and 
respiratory management of newborn infants in the delivery room. They also demonstrate gaps 
in the evidence with the need for further research, particularly with regard to circulatory 
support and pharmacological interventions.  
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Introduction 
One-in-ten newborn infants has delayed establishment of independent respiratory effort after 
birth requiring delivery room resuscitation or transition support. Delivery room interventions 
to support newborn infants include airway, breathing and circulatory support, supplemental 
oxygen or other drugs, and measures to prevent hypothermia or metabolic compromise.1-5  
Increasingly consensus guidelines with recommendations for delivery room transition support 
are informed by evidence from Cochrane systematic reviews.6, 7 The validity and utility of 
guidelines and policy recommendations are dependent on the quality of the included reviews. 
The methodological quality of Cochrane reviews in several areas of health care, including 
perinatal and neonatal, is variable.8, 9 Low methodological quality introduces potential for 
bias. This work package aimed to describe the available Cochrane reviews evaluating 
delivery room interventions for newborn infants, assess their methodological quality and the 
validity of their findings, and identify important research gaps in the evidence.   This chapter 
presents an overview (umbrella review) of systematic reviews evaluating immediate care and 
transitional support at birth for very preterm infants. The results supported guidance for initial 
neonatal care beside the mother, and also provided a context for determining how deferred 
cord clamping might be implemented in the Cord Pilot Trial reported in Chapter 11.  
 
Methods 
We undertook a systematic overview using the standard methods of the Cochrane 
Collaboration and the Centre for Reviews and Dissemination.10, 11 We registered the overview 
on PROSPERO, the international prospective register of systematic reviews (registration 
number CRD42012003038). 
 
Criteria for including reviews  
We searched the Cochrane Database of Systematic Reviews Issue 6, 2015 for reviews 
examining any intervention for delivery room support of newborn infants. We did not include 
(i) reviews of interventions that are more usually or feasibly delivered following admission of 
the newborn infant to the neonatal unit, or (ii) reviews of delivery room interventions 
administered as part of routine practice to all infants. We did not apply any date limits. We 
searched the bibliographies of all relevant reviews for references to other related Cochrane 
Reviews. Two reviewers independently screened titles and abstracts of all records identified 
in the search, and assessed the full texts of any potentially relevant reports.  
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Data extraction  
Two reviewers used piloted data extraction forms to collect information on quality 
characteristics, participants, treatment and control interventions, and outcomes.  
Assessment of methodological quality of included reviews 
Two authors assessed independently the methodological quality of included reviews across 
11 domains used the AMSTAR tool (see box).12, 13 If necessary, we requested additional 
information to clarify methodology and results from the review authors. We resolved 
disagreements in the assessments and data extraction by consensus. 
 
Box 1: AMSTAR questions 
 
1. Was an 'a priori' design provided? 
2. Was there duplicate study selection and data extraction? 
3. Was a comprehensive literature search performed? 
4. Were published and unpublished studies eligible, irrespective of language of 
publication? 
5. Was a list of studies (included and excluded) provided? 
6. Were the characteristics of the included studies provided? 
7. Was the scientific quality of the included studies assessed and documented? 
8. Was the scientific quality of the included studies used appropriately in 
formulating conclusions? 
9. Were the methods used to combine the findings of studies appropriate? 
10. Was the likelihood of publication bias assessed? 
11. Was the conflict of interest stated? 
We rated each criterion as ‘Yes’ (definitely done), ‘No’ (definitely not done), 
‘Unclear’ or ‘Not applicable’ (NA).  Criteria rated as ‘Not applicable’ were 
removed from the denominator, with appropriate adjustment to the ranking. 
 
Risk of bias in the included trials  
For each included trial, we extracted data from the Cochrane reviews’ “risk of bias” tables on 
the risk of selection bias, detection bias and attrition bias.14 
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Results 
We included 18 Cochrane reviews in this overview,15-32 and grouped them by type of 
intervention: airway or respiratory support interventions; surfactant replacement therapy for 
preterm infants with or at risk of respiratory distress syndrome; oxygen and other drugs for 
infants compromised at birth; strategies for timing of cord clamping at preterm birth. 
 
Quality of included reviews  
All of the reviews used methods consistent with those recommended in the Cochrane 
Handbook.10 Four reviews did not have any included trials and therefore could not be 
assessed for the relevant domains.16, 18, 25, 27  The overall quality of the other reviews assessed 
was high, based on the AMSTAR assessment (see Table 1). Most reviews failed to have a 
positive score in just one domain. The only common quality concern was that reviews did not 
explicitly assess the likelihood of publication bias, but most of these reviews did not include 
sufficient trials to allow assessment of funnel plot symmetry or statistical assessment with 
meta-regression.      
 
Search strategy in the reviews 
The reviews all searched the three major bibliographic databases (Medline, EMBASE, and 
The Cochrane Library), and they all described methods for identifying unpublished studies. 
The last search was after 2010 for seven reviews. Three reviews had last conducted searches 
in 2009, and the remainder had not had a search update since 2007 or earlier.  
 
Primary outcomes in the reviews 
The most commonly pre-specified primary outcomes were death, incidence of chronic lung 
disease, and neuro-disability (18 of 20 reviews). Two reviews pre-specified surrogate 
outcomes such as physiological measures (heart rate, temperature) rather than infant-
important primary outcomes. The available trial data provide limited evidence of the effects 
on other outcomes. There are few data on long term neuro-developmental outcomes.  
 
Risk of bias in the included trials  
All the reviews assessed the risk of bias for included trials by assessing the risk of selection 
bias (randomisation sequence and allocation concealment), detection bias (blinding of 
intervention and outcomes assessment), and attrition bias (complete or near-complete 
participant outcomes assessment). Of the 74 trials included in the reviews, 76% were 
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assessed as being at low risk of selection bias, 41% at low risk of detection bias, and 93% at 
low risk of attrition bias (Figure 1). The risk of detection bias and attrition bias was consistent 
across the types of interventions. The risk of selection bias varied; with 96% of surfactant 
replacement trials assessed to be at low risk of selection bias, compared with 45% of trials of 
circulatory, pharmacological or thermal support.  
 
Figure 1: Risk of bias in the 74 trials included in the 18 reviews 
 
Effects of the interventions 
Airway or respiratory support interventions : Four reviews assessed devices and techniques 
for airway support in newborn infants with, or at risk of, respiratory compromise (table 1).15-18
 Of there, two reviews did not find any eligible trials and one included only a single small 
trial.16-18 The fourth review assessed delivery room airway support for infants at risk of 
meconium aspiration, and included four trials with 2,884 participants.15 This review provides 
evidence that routine endotracheal intubation does not reduce mortality or morbidity in 
vigorous term babies with meconium staining compared with standard resuscitation, 
including oro-pharyngeal suction. 
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Table 1: Characteristics of reviews of airway or respiratory support interventions at birth 
Review Last 
search 
Population Intervention Comparison Primary outcomes N=Trials   
(participants) 
Halliday15 2002 Non-
asphyxiated 
term infants 
with meconium 
staining 
Endotracheal 
intubation and 
airway aspiration at 
birth 
 
Routine care 
determined by attending 
clinician 
Death, meconium 
aspiration 
syndrome, air leak  
4 (2884) 
O’Donnell16 2004 Receiving 
positive pressure 
ventilation at 
birth 
PEEP 
 
No PEEP Death, Apgar 
scores 
0 (0) 
Grein17 2004 Requiring 
intermittent 
positive pressure 
ventilation  
Laryngeal mask 
airway for 
respiratory support 
Bag-mask device or 
endotracheal tube for 
respiratory support 
Time to heart rate 
>100/min or device 
inserted, placement 
attempts 
1 (44) 
Schmölzer18 
 
2010 Newborn infants 
who need 
resuscitation 
Respiratory function 
monitoring in 
addition to clinical 
assessment 
Clinical assessment 
alone 
Death 0 (0) 
PEEP = Posive end expiratory pressure 
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Surfactant replacement therapy for preterm infants with or at risk of respiratory distress 
syndrome: Eight reviews assessed the effects of different types of surfactant, different routes 
of administration, and different timing and thresholds for administration in preterm infants 
with or at risk of respiratory distress syndrome (table 2).19-26 Two early reviews, originally 
published in 1997, provide strong evidence that for very preterm infants surfactant 
replacement reduced the risk of death by about 40%.19, 20 A related review provides evidence 
that natural surfactant is more effective than synthetic surfactant for reducing the risk of 
death.21 These reviews are now regarded as “complete” as further trials would be unlikely to 
change their conclusions.  
 
Subsequent reviews examined various modifications of the intervention in the context of 
evolving practice, particularly the use of antenatal corticosteroids to enhance fetal lung 
maturation and the adoption of non-invasive ventilation modalities. The reviews found 
evidence that early surfactant administration with brief ventilation reduces the need for 
mechanical ventilation and associated morbidity, but that prophylactic (delivery room) 
surfactant administration is not more effective than delayed, selective administration when 
infants have prophylactic nasal continuous positive airway pressure support.24, 26 Uncertainty 
remains about the effects of newer synthetic surfactants that contain “surfactant protein 
mimics”, and of novel non-invasive delivery routes.22, 23 
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Table 2: Characteristics of reviews of strategies for surfactant replacement therapy for infants with, or at risk of, respiratory distress syndrome 
Review Last 
search  
Population Intervention Comparison Primary outcomes N=Trials  
(participants) 
Soll19 2009 Preterm infants with 
or at risk of RDS 
Prophylactic protein-
free synthetic 
surfactant 
Placebo or no 
surfactant 
Death, chronic lung 
disease 
7 (1500) 
Soll20 2010 Infants <30 weeks 
gestation  
Prophylactic natural 
surfactant 
Placebo or no 
surfactant 
Death, chronic lung 
disease 
9 (1256) 
Soll21 2000 Preterm infants with 
or at risk of RDS 
Natural (animal 
derived) surfactant 
Synthetic surfactant  Pneumothorax, patent 
ductus arteriosus, 
necrotising enterocolitis 
11 (4657) 
Pfister22 2007 Preterm infants with 
or at risk of RDS 
Protein-containing 
synthetic surfactant 
Natural surfactant Death, chronic lung 
disease 
2 (1037) 
Pfister23  2009 Preterm infants with 
or at risk of RDS 
Protein-containing 
synthetic surfactant 
Synthetic surfactant 
(protein-free) 
Death, chronic lung 
disease 
1 (785) 
Stevens24  
 
2006 Preterm infants with 
or at risk of RDS 
Prophylactic or early 
surfactant, followed 
by early extubation 
“Conventional” 
treatment (surfactant 
administration and 
mechanical 
ventilation) 
Death, need for 
mechanical ventilation, 
chronic lung disease 
6 (1863) 
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Review Last 
search  
Population Intervention Comparison Primary outcomes N=Trials  
(participants) 
Abdel-
Latif25 
 
2010 Infants < 32 weeks 
gestation 
Pharyngeal instillation 
of surfactant before 
the first breath 
Placebo, no treatment 
or intra-tracheal 
instilled surfactant 
Death, chronic lung 
disease, neuro-disability 
0 (0) 
Rojas-
Reyes26  
2011 Very preterm infants Prophylactic 
surfactant 
Delayed (selective) 
surfactant treatment of 
RDS 
Death, chronic lung 
disease 
11 (4756) 
RDS = respiratory distress syndrome 
Oxygen and other drugs for infants compromised at birth: One review compared using air versus 100% oxygen for resuscitation of newborn 
infants at birth (table 3).30 This review identified five trials (three of which were quasi-randomised), but concluded that insufficient evidence 
existed to support a recommendation for using either room air or 100% oxygen for resuscitation of newborn infants.   
Three reviews assessed other drug interventions.27-29 Reviews of using adrenaline or sodium bicarbonate during resuscitation found insufficient 
trial data to determine effects.27,28 The review of naloxone for infants exposed transplacentally to opiate found nine trials but these did not assess 
the pre-specified, infant-important outcomes for the review.29 One review examined interventions to prevent hypothermia in newborn very 
preterm infants.31 This review found evidence that various measures including plastic wraps or bags and warming mattresses reduce the risk of 
delivery room hypothermia in preterm infants, but found insufficient data to assess effects on infant morbidity and mortality. 
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Table 3: Characteristics of reviews of delivery room oxygen and other drugs for infants compromised at birth  
Review Last 
search 
Population Intervention Comparison Primary outcomes N=Trials  
(participants) 
Ziino27) 2010 Newborn with 
extreme bradycardia 
or apparent stillbirth 
Epinephrine 
(adrenaline)  
1. Placebo or no drug 
2. Different doses or 
routes 
Death or severe disability 0 (0) 
Beveridge
28 
2006 Infants resuscitated at 
birth 
Sodium 
bicarbonate  
 
1. Placebo or no drug 
2. Another alkalising 
agent 
Death in the delivery room  1 (55) 
Moe-
Byrne29 
2013 Newborn with opiate 
exposure in utero  
Naloxone  
 
Placebo or no drug Neonatal unit admission, 
breastfeeding not 
established 
9 (316) 
Tan30  2005 Infants receiving 
IPPV at birth 
Respiratory 
support using 
room air initially   
Respiratory support 
using 100% oxygen 
initially   
Death or severe disability 5 (1302) 
McCall31) 2009 Newborn preterm or 
low birth weight 
infants  
Heat loss barriers, 
heated mattresses 
or skin-to-skin 
care 
 
Routine thermal care 
(includes drying, 
wrapping, radiant heater 
or incubator) 
Temperature on admission 
to neonatal unit 
7 (400) 
IPPV = intermittent positive pressure ventilation  
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Strategies for timing of cord clamping at preterm birth: One review assessed alternative 
strategies for timing of cord clamping for preterm births (Table 4).32 This review found 
evidence that deferring cord clamping for 30 to 120 seconds, rather than clamping before 30 
seconds, reduced the need for blood transfusion or circulatory support and reduced the risk of 
intraventricular haemorrhage. Data from 13 of the 15 included trials did not identify a 
statistically significant effect on risk of death. Long-term neurodevelopmental outcomes were 
not reported.  
 
Discussion 
We identified 18 Cochrane reviews evaluating delivery room interventions for infants born 
very preterm: these included strategies for airway or respiratory support, surfactant 
replacement therapy, oxygen and other drugs for infants compromised at birth, and timing of 
cord clamping. Several effective interventions have been identified, particularly surfactant 
administration for preterm infants with or at risk of developing respiratory distress syndrome. 
However, many reviews highlight the paucity of trial data supporting even commonly used 
interventions.  
 
Strengths and limitations of this overview 
In general, the quality of these Cochrane reviews was high, as expected as the editorial 
process includes a published peer-reviewed protocol and a requirement to list all study 
characteristics and assessments. A potential concern is that many had not been updated within 
the past two years, as per Cochrane Collaboration guidelines. Of the 18 reviews, eight had not 
been updated within the past five years. The Cochrane Neonatal Group recognizes the 
challenges in keeping reviews up-to-date, and determines priorities for updating based on 
expert opinion and focused searches. Also, some reviews may be considered as “complete” or 
“dormant”, and no longer be updated as new or modified interventions become established.33 
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 Table 4: Characteristics of reviews of strategies for timing of cord clamping for preterm births 
Review Last 
search 
Population Intervention Comparison Primary outcomes N=Trials  
(participants) 
Rabe32 
 
2011 Newborn 
preterm 
infants 
Early cord clamping 
(< 30 seconds after 
birth) 
Later (delayed) cord 
clamping 
Death or severe disability 
(maternal postpartum 
haemorrhage) 
15 (738) 
 
A
PPEN
D
IX
5
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
144
Quality of the trials included in the reviews was variable. The potential contribution of
methodological weaknesses to bias in trials and systematic reviews is well-described.34 In
particular, quasi-randomised trials and randomised trials with inadequate concealment of
allocation tend to over-estimate effect size estimates compared with randomised trials with
adequately concealed allocation.35,36 For example, the Cochrane review of lower versus
higher oxygen concentrations for delivery room transition support found evidence that high
oxygen (up to 100%) conferred important harms, including a higher risk of death.30 These 
effects were no longer statistically significant when the three trials with inadequate sequence 
generation and concealment of allocation were excluded. For emergency trials, use of quasi-
random methods may not increase selection bias, as assessed by baseline characteristics.37
Trials that report a statistically significant effect are more likely to be submitted and accepted
for publication than studies that do not.38 Few reviews assessed the potential for publication 
bias, but most did not have enough trials for meaningful funnel plot asymmetry or regression 
testing. Prospective registration of trials aims to reduce publication bias and improve the 
quality of the conduct, analysis, and reporting of trials and systematic reviews. 
For several reviews, it was unclear how the scientific quality of the included trials had 
informed the conclusions. No reviews used the GRADE approach to define the quality of the 
evidence with respect to risk of bias, directness of evidence, heterogeneity, precision of effect
estimates and risk of publication bias.39 This may change as the Cochrane Collaboration has 
endorsed use of GRADE.
Implications for future research 
Some reviews identified key “evidence-gaps”. These were mainly related to pharmacological 
intervention for transition support or resuscitation of newborn infants, and the effectiveness 
of new, less-invasive forms of airway management (and related issues regarding surfactant
delivery). 
Although the Cochrane reviews included in this overview in general focussed on clinically
important primary outcomes such as death or chronic lung disease, few trials reported data
for longer-term outcomes. Future trials should therefore assess the potential effects on
disability and impairment. This is particularly important as delivery room interventions for 
newborn infants have the potential to have competing effects, that is, they may reduce 
mortality but with a consequent increase in the risk of disability.
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Table 1: AMSTAR quality assessment of reviews included in the overview 
Review A priori 
design 
provided 
Duplicate 
study 
selection + 
data 
extraction 
Compreh-
ensive 
literature 
search  
Published + 
unpublished 
studies 
included 
List of 
included + 
excluded 
studies 
Characteristics 
of included 
studies 
provided 
Scientific 
quality of 
included 
studies 
assessed 
Quality of 
included 
studies 
applied to 
conclusions 
Appropriate 
methods for 
combining 
studies 
Likelihood 
of 
publication 
bias 
Conflict of 
interest 
stated 
Score 
 
Airway or respiratory support interventions at birth 
       
Halliday14 Yes Yes Yes Yes No Yes Yes Yes Yes NA Yes 9/10 
O’Donnell15 Yes Yes Yes Yes Yes NA NA NA NA NA Yes 6/6 
Grein16 Yes Yes Yes Yes Yes Yes Yes Yes Yes NA Yes 10/10 
Schmölzer17 Yes Yes Yes Yes Yes NA NA NA NA NA Yes 6/6 
Surfactant replacement therapy for infants with, or at risk of, respiratory distress syndrome   
Soll18 Yes Yes Yes Yes* Yes Yes Yes Yes Yes No Yes 10/11 
Soll19 Yes Yes Yes Yes* Yes Yes Yes Yes Yes Yes Yes 11/11 
Soll20 Yes Yes Yes Yes* Yes Yes Yes Yes Yes No Yes 10/11 
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Pfister22 Yes Yes Yes Yes* Yes Yes Yes Yes Yes No Yes 10/11 
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Appendix 6 The ethical issues regarding consent
to clinical trials with preterm or sick neonates:
a systematic review (framework synthesis) of the
empirical research
See Wilman et al.79 https://doi.org/10.1186/s13063-015-0957-x
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Appendix 7 The ethical issues regarding consent
to clinical trials with preterm or sick neonates:
a systematic review (framework synthesis) of the
analytical (theoretical/philosophical) research
See Megone et al.78 https://doi.org/10.1186/s13063-016-1562-3
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Appendix 8 Marked variation in delivery room
management in very preterm infants
See Singh and Oddie.68 https://doi.org/10.1016/j.resuscitation.2013.06.026
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Appendix 9 Barriers to deferred cord clamping in
preterm infants
See Oddie et al.67 https://doi.org/10.1136/archdischild-2014-305968
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Appendix 10 Parents’ experiences and
satisfaction with care during the birth of their
very preterm baby: a qualitative study
See Sawyer et al.36 https://doi.org/10.1111/1471-0528.12104
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Appendix 11 Parents’ first moments with their
very preterm babies: a qualitative study
See Arnold et al.37 https://doi.org/10.1136/bmjopen-2012-002487
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Appendix 12 Measuring parents’ experiences and
satisfaction with care during very preterm birth:
a questionnaire development study
See Sawyer et al.44 https://doi.org/10.1111/1471-0528.12925
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Appendix 13 Measuring placental transfusion at
preterm birth
Abstract 
Background  
The physiology of placental transfusion for preterm births is poorly understood. Optimal 
timing of umbilical cord clamping at preterm birth is uncertain. This study aimed to assess 
the volume and duration of placental transfusion at preterm birth.   
 
Methods  
Women likely to have a healthy livebirth between 32 and 36 completed weeks gestation at 
three maternity units in England were eligible for recruitment. At birth, babies placed on high 
quality pharmacy scales (Mettler-Toledo) with the umbilical cord intact.  The scales 
calculated an average weight twice every second, and were on a trolley beside the women. To 
ensure the baby was no higher than the level of the woman’s abdomen, the bed or operating 
table was raised or lowered as necessary. The baby was monitored using temperature and 
saturation probes. Staff training was with term births. 
 
Results  
Six infants (range 34+4 to 36+5 weeks) were weighed; three were vaginal births and three 
caesarean.  Cord clamping was between two minutes and three minutes 57 seconds. For two 
babies, weight was not well recorded in the first minute while they were dried and probes 
applied. Therefore, an initial 10 seconds ‘hands-off’ period was adopted to obtain the 
baseline weight. Weight change appeared to range from a 20g decrease to a 128g increase.  
Placental flow appeared to continue for at least two minutes for all six babies.  
 
Conclusions  
This study is small, nevertheless, there appears to be variation in the volume and duration of 
placental transfusion, and for some, net flow is to the placenta rather than the baby. For 
preterm births, placental transfusion may continue for longer than at term births.  
 
DOI: 10.3310/pgfar07080 PROGRAMME GRANTS FOR APPLIED RESEARCH 2019 VOL. 7 NO. 8
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Duley et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
167
Background 
At birth, if the umbilical cord is not clamped blood flow between the baby and placenta may 
continue for several minutes.1-4 This umbilical flow is part of the physiological transition 
from the fetal to the neonatal circulation, and for very preterm infants deferring cord 
clamping may improve resilience during this transition.5-7 ‘Placental transfusion’ refers to the 
net transfer of blood to the baby between birth and cord clamping.  
 
Cord clamping before umbilical flow ceases may restrict neonatal blood volume and red cell 
mass, and/or interrupt transition from the fetal to neonatal circulation. For term births, 
umbilical flow usually continues for two minutes, but may continue for over five minutes.2,4 
The mean volume of placental tranfusion at term is 100 ml, which is 29 ml/kg birthweight 
and 36% of neonatal blood volume at birth.4 For preterm births, umbilical flow may continue 
for longer than for term births8 and is incomplete if the cord is clamped in 30-90 seconds.9  
This corresponds with development during gestation, as at term two-thirds of the feto-
placental circulation is in the infant, whilst below 30 weeks a greater proportion is in the 
placenta.1 Also, preterm, the umbilical vein is smaller than at term, uterine contraction less 
efficient, and the transition from fetal the neonatal circulation may be slower.  
 
To improve understanding of the physiology of placental transfusion and assess when might  
be the optimal time to clamp the cord for preterm births, we measured umbilical flow at 
preterm birth.  
 
Methods 
Women likely to have a healthy singleton livebirth between 32 and 36 completed weeks 
gestation at Nottingham City Hospital, Queen’s Medical Centre (Nottingham) or Bradford 
Royal Infirmary were eligible for inclusion. Information about the study was given to women 
considered at risk of preterm birth. Eligible women were invited to participate either before 
labour, during the first stage of labour, or during preparation for caesarean section. Women 
who provided written consent were included. They were free to withdraw from the study at 
any time. 
 
Staff training was with women having a term birth.  Ethics approval required independent 
review of data from five term births before progressing to recruitment of women having a 
preterm birth. Following this review, the data monitoring committee agreed that women over 
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32 weeks gestation could be recruited. Recruitment from 28 weeks was planned, but not 
reached. 
 
Procedure for weighing 
Babies were weighed using digital scales (Mettler Toledo excellence XS precision balance 
Model: XS8001L, Im Langacher, CH-8606 Greifensee, Switzerland), which calculate an 
average weight twice every second, with data stored in a linked computer. Before the birth, 
the scales were zeroed to allow for the weight of any probes being used, a plastic tray and 
two towels (used to wrap the baby during weighing).  
 
At birth, babies were placed on the scales with the cord intact. The attending clinician and 
parents were asked not to touch the baby, the cord, or the scales until weighing was complete. 
If anything was touched or knocked, this was recorded. The scale pan for vaginal births was 
level with either the bed or the woman’s abdomen, and for caesarean births it was level with 
either the bed or the woman’s thighs. Once delivered, the placenta was placed in a funnel to 
drain any residual placental blood. All other aspects of care were at the discretion of the 
attending clinician. The cord was clamped early if requested by the woman or a clinician. 
 
In accordance with the recommendation of the ethics committee, temperature and oxygen 
saturation probes were used to assess temperature and heart rate respectively. For the first 
two preterm births, weight was not well recorded in the first minute while they were dried 
and probes applied. Therefore the temperature probe was no longer used, and the saturation 
probe applied after a ‘hands-off’ period of 10 seconds to establish the baseline weight.  
 
Data collection 
Parity and gestation at birth were recorded. For vaginal births, data were collected on whether 
labour was induced or augmented, the use of analgesia, the mode of delivery and maternal 
position during the second and third stage. For caesarean births, data were collected on the 
indication for caesarean section and the type of anaesthesia. For all women, timing of the 
uterotonic drug, time of cord clamping, maternal blood loss during the third stage, length of 
the third stage and use of controlled cord traction were recorded. For the baby, information 
was collected on the time of birth (delivery of buttocks for cephalic births, and head for 
breech births), temperature after cord clamping, need for resuscitation at birth and whether 
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admitted to the neonatal unit. In addition, a log was kept for each weighing, which included 
events such as the scales being knocked or the cord touched. All data were anonymous. 
 
Statistical analysis 
Characteristics of the women and events during labour were described for women who had a 
vaginal birth and those who had a caesarean birth. The scales were activated to record weight 
as the baby was born, providing the data for each child’s weight against time. Although the 
use of statistical methods to determine the best approximation to the weight gain was 
intended, visual examination and estimation of weight gain was required due to artefacts in 
the data. Two authors (JD, SO) independently assessed the weight change by inspecting the 
graphs, with information on the timing of clamping and when the baby was being handled. 
Differences were resolved by discussion. Due to the small sample, only descriptive statistics 
were used. Volume of placental transfusion was calculated based on 1 ml of blood weighs 
weighing 1.05 g.  
 
Results 
From July 2012 to February 2013, 97 potentially eligible women were approached, 33 of 
whom gave consent. Of these six were included, with gestation from 34+4 to 36+5 weeks 
(Table 1). For the 27 women with consent for whom the baby was not weighed, reasons were: 
pregnancy progressed beyond 36 weeks (n=10); research staff not available at time of birth as 
out of working hours (n = 6); birth too rapid for equipment to be set up (n=5); cord too short 
(n =2); woman withdrew consent (n=2); hardware problem (n = 1; and clinician felt not 
clinically appropriate (n =1).  
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Table 1: Characteristics of the women and events during labour and birth 
n=6 
Primigravid 3 
Gestation at birth (weeks)           36+0 – 36+7 3 
35+0 – 35+7 2 
 34+0 – 34+6 1 
 Induction of labour 2 
Mode of birth 
vaginal 3 
 Caesarean 3 
Third stage of labour oxytocin before cord 
clamping 5 
oxytocin after cord clamping 1 
Estimated blood loss (ml) (median, range) 330 (200, 600)
Manual removal of placenta - 
Residual placental volume (ml) (median, range) 11 (0, 40)
Baby at birth 
Temperature after cord clamping (0C) (mean, SD) 36.3 (0.46)
Resuscitation after clamping 2 
            tact ile stimulation 1 
facial oxygen 1 
Admitted to special care baby unit 2 
Of the six births included, three were vaginal and three caesarean (Table 1). Two of the 
caesarean births were during labour. All births were cephalic presentation. Time from birth to
the baby being on the scales was within three seconds for the caesarean births, but up to 37 
seconds for the vaginal births. The estimated weight change ranged from a 20 gm decrease
to a 128 gm increase. This equates to between a 19 ml decrease and a 122 ml increase.
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An example of weight change over time for one baby born at 35 weeks gestation is shown in 
Figure 1. For the remaining five babies, graphs are provided in the Supplementary material.
The time at which net placental flow appeared to cease was at or after two minutes for all six 
babies (see figure 1, and Supplementary material). For one baby the cord was clamped at two 
minutes but placental transfusion appeared to be continuing, for another weight change was 
static between two and three minutes, and for four babies umbilical flow appeared to continue
for at least three minutes. For two babies net flow during the last minute before clamping
appeared to be from the infant into the placenta. 
Discussion
To assess the volume and duration of placental transfusion at preterm birth we weighed six 
premature infants before clamping the umbilical cord.  Due to difficulties with recruitment
and having research staff available out of hours we were only able to obtain data for a small 
number of births. Nevertheless, these data suggest that for preterm births placental
transfusion may continue for longer than for term births. For five out of six babies weight
change appeared to continue beyond two minutes, and for four beyond three minutes. The 
volume of transfusion was difficult to estimate. Handling the baby at birth to attach oxygen
saturation and temperature probes led to considerable artefact in the weighing data. 
APPENDIX 13
NIHR Journals Library www.journalslibrary.nihr.ac.uk
172
Figure 1: Caesarean section at 35+6 weeks gestation. Weight gain estimated at 51 grams.  
Although we improved on our speed of doing this, and started weighing the baby for 10 seconds 
before siting probes to obtain a better baseline weight, weight change was difficult to judge
As placental transfusion may have a role in stabilising the cardiorespiratory circulation
during transition from the fetal to neonatal circulation, the duration of time the cord is left
unclamped may be as, or possibly more, important than the volume of any net flow.5,7
Despite the limitations of this study, these data helped inform the design of a pilot 
randomised trial of immediate versus deferred cord clamping at very preterm birth.10
This trial compared clamping within 20 seconds with clamping after at least two minutes.11 
Other future trials evaluating deferred cord clamping at preterm birth should consider an 
intervention of two minutes or more, and if necessary providing neonatal care with the 
cord intact. 
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Supplementary Material 
Figure A1: Caesarean section in labour, 35+6 weeks. Weight gain estimated at 14 grams.  
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Figure A2: Induced labour with vaginal birth, 35+4 weeks. Weight gain estimated at 17 
grams. 
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Figure A3: Vaginal birth, 36+1 weeks. Weight loss estimated at 20 grams. 
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Figure A4: Vaginal birth, 36+5 weeks. Weight gain estimated at 128 grams. 
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Figure A5:  Caesarean birth, 34+4 weeks. Weight gain estimated at 63 grams.  
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Appendix 14 Innovation in immediate neonatal
care: development of the Bedside Assessment,
Stabilisation and Initial Cardiorespiratory
Support trolley
See Weeks et al.69 https://doi.org/10.1136/bmjinnov-2014-000017
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Appendix 15 Providing immediate neonatal care
and resuscitation at birth beside the mother:
parents’ views, a qualitative study
See Sawyer et al.39 https://doi.org/10.1136/bmjopen-2015-008495
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Appendix 16 Providing immediate neonatal care
and resuscitation at birth beside the mother:
clinicians’ views, a qualitative study
See Yoxall et al.40 https://doi.org/10.1136/bmjopen-2015-008494
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Appendix 17 Cord pilot trial: assessment of
feasibility of a large trial
Abstract
Objectives
To assess feasibility of a large trial comparing alternatives policies for umbilical cord 
clamping and immediate neonatal care for very preterm births, based on recruitment for one 
year. 
Methods 
Women were eligible if expected to have a livebirth before 32 weeks at eight tertiary 
maternity units. Recruitment was available via two consent pathways. Randomisation (1:1), 
using sealed opaque numbered envelopes, was to either cord clamping after at least two 
minutes and immediate neonatal care with cord intact, or clamping within 20 seconds and 
neonatal care after clamping. Feasibility outcomes were measures of recruitment,
compliance, acceptability and retention. 
Results 
Overall, 125 women were randomised over one year; with 22% (121/550) of births before
32 weeks randomised, of whom one third were before 28 weeks (39/121). Over a quarter of 
recruitment (29%, 36/125) was via the two-stage consent pathway. Compliance with the 
allocated intervention was good, with median time to clamping 120 seconds (IQR 30 to
135 seconds) for the deferred arm and 10 (10 to 15) for the early arm. Neonatal care with cord 
intact was provided for babies using both the mobile trolley (n=32), and the usual equipment 
(n=35).  
Conclusions 
A large multicentre trial comparing cord clamping after at least 2 minutes and immediate 
neonatal care, if needed, with cord intact versus clamping within 20 seconds and neonatal
care after clamping is feasible in the UK.
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Introduction 
We conducted a pilot randomised trial to assess the feasibility of conducting a large 
multicentre randomised trial in the UK comparing alternative policies for timing of cord 
clamping and immediate neonatal care at birth. Having demonstrated feasibility recruitment 
continued beyond the planned one year.1 This paper presents the assessment of feasibility 
based on the first twelve months of recruitment.  
 
Methods  
This was a pragmatic multicentre pilot randomised trial comparing alternative policies for 
cord clamping at very preterm birth. Recruitment was at eight UK tertiary maternity units, 
five of which (in Nottingham, Leicester, Bradford and Liverpool) had contributed to 
development work, and therefore were not necessarily typical of all UK sites.  To ensure an 
adequate assessment of feasibility, we included three sites (in Wolverhampton, London and 
Aberdeen) with no previous involvement.   
 
Ethics approval was by Nottingham REC 2(NRES reference 12/EM/0283). The sponsor is 
Nottingham University Hospitals NHS Trust. Coordination was by the Nottingham Clinical 
Trials Unit (NCTU). The protocol2 and an update3 are published and summarised here.  
 
Participants 
Women were eligible if they were expected to have a livebirth before 32 weeks gestation, 
regardless of mode of birth or whether cephalic or breech presentation.  Exclusion criteria 
were monochorionic twins (from an ultrasound scan) or clinical evidence of twin-twin 
transfusion syndrome; triplets or higher order multiple pregnancy; and known congenital 
malformation.  
 
Interventions  
We compared umbilical cord clamping after at least two minutes and immediate neonatal 
stabilisation and resuscitation, if needed, with the cord intact with usual care of clamping 
within 20 seconds and neonatal care after clamping. For the intervention group, babies were 
placed with the cord intact onto a firm surface with easy access to resuscitation equipment, 
either the usual equipment moved alongside the woman’s bed4 or a mobile trolley designed 
for this purpose.5 At caesarean births the neonatal resuscitation equipment was covered with 
sterile drapes, and the neonatologist scrubbed and gowned. After cord clamping, neonatal 
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care continued either beside the mother or at the usual location (the side of the room or an 
adjacent room), at the discretion of the local clinicians. Until cord clamping, the baby was 
kept at the level of placenta (introitus or mothers’ abdomen or, if a caesarean birth, the 
anterior thigh).  
 
For the control group, babies were dried and/or wrapped at birth with all other neonatal care 
after cord clamping. For both groups other aspects of care, including administration of a 
prophylactic uterotonic drug, were at the discretion of the attending clinicians. Neonatal care 
was based on local unit policy and consistent with Resuscitation Council (UK) newborn life 
support guidelines.6,7 Standard equipment was used according to local practice.  
 
Outcome measures  
Feasibility outcome measures were to: 
 Estimate the number of potential recruits in each centre  
 Measure the recruitment rate 
 Describe reasons for non-recruitment 
 Measure the spectrum of gestational age and neonatal outcome among recruits 
 Measure compliance with the trial interventions and describe factors in non-
compliance 
 Measure the completeness of data collection for main outcomes 
 Record views of parents on randomisation and treatment procedures 
 Measure loss to follow-up after discharge from hospital.  
 
Data collection included clinical outcomes for the women and babies.1 For example, for the 
baby death before discharge; intraventricular haemorrhage; periventricular leukomalacia; 
hypothermia; blood transfusion; other measures of serious neonatal morbidity; and 
neurosensory outcome at age 2 years (corrected for gestation at birth).  For the woman, 
complications of the third stage of labour; wellbeing and satisfaction with care at birth; and 
their about participation in the trial.  
 
Initially, we collected data on intraventricular haemorrhage (IVH) and other brain injury 
using the case report form completed at site. However, as we planned that IVH would be a 
primary outcome for the full trial, we adjudicated cranial ultrasound scan images and 
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compared these with the scan reports, to assess whether this would be necessary for a large 
trial.8 Adjudication was for all babies in the trial, not just those recruited during the first year, 
and is reported in detail elsewhere.9
Recruitment and consent pathways 
Information about the study was available in the antenatal clinics and on antenatal wards. 
Women at risk of very preterm birth were invited to participate. They had the opportunity to
ask questions, and whenever possible had at least 12 hours to consider participation. Those 
who agreed to participate gave written informed consent.
As very preterm birth can be rapid and unexpected, there may be insufficient time for the 
usual consent pathway. Therefore, we developed a two-stage oral assent consent pathway, in
discussion with the National Childbirth Trust (NCT) and Bliss, the special care baby charity.
This complies with recommendations from the Royal College of Obstetricians and 
Gynaecologists.10 If birth was imminent and the attending clinician considered it appropriate,
we offered women a brief explanation of the study and invited participation. Those who said
‘yes’ (i.e. gave oral assent) were randomised. 
Randomisation
Randomisation was by attending clinicians, who took the next sealed consecutively numbered
opaque envelope from a ringbinder folder. Each maternity unit kept a central log of
envelopes. Sequence generation (1:1) was by computer, stratified by site with balanced
blocks of randomly varying size, created by NCTU. On the envelope was a reminder to check 
eligibility criteria, and a label to record the date, time, woman’s initials, her date of birth and 
gestation. Once this label was completed, she was considered randomised, even if the 
envelope was not opened. Inside the envelope was a yellow card instructing when to clamp
the cord, and a ‘Birth Record’ (plus a second for twins) for clinical staff to record information 
about the third stage of labour and neonatal care at birth. Used envelopes and yellow cards
were placed in a locked mailbox, which was emptied regularly and details from each
envelope entered into the online randomisation log. 
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(average annual livebirths per unit 5-6,000) we expected 610 (1.4%)11 livebirths to be before
32 weeks gestation. Target accrual was 16% to 18% of eligible births so we anticipated 100 
to 110 women randomised in one year. As this was planned as a pilot trial there was no
formal power calculation.
Sample size
For the assessment of feasibility it was planned that eight large maternity hospitals would 
recruit for one year. Based on a total of 43,600 livebirths per year at these eight hospitals 
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Figure 1: The two consent pathways   
 
Woman admitted to maternity unit  
and meets eligibility criteria 
Birth imminent 
(preparing for caesarean section, or in established labour) 
Woman gives written  
informed consent  
Check woman’s eligibility 
continues to meet eligibility criteria 
oral confirmation of agreement to 
participate 
Randomisation 
Information about the trial available to women 
in antenatal clinics and antenatal wards 
Woman gives oral assent 
if insufficient time for written 
informed consent, because the 
woman is in established labour or 
having an emergency caesarean 
section, assent may be oral* 
* Women approached to give oral assent in established labour or at emergency caesarean 
section only if the attending clinicians considered it appropriate Women were not approached 
if there was insufficient time to give a brief verbal summary of the trial, or they did not speak 
fluent English and no translator was available. How long was required for oral assent 
depended on factors such as how much the woman already knew about the study, and her 
knowledge and wishes about care during the third stage.  
 
If recruitment was after oral assent: 
women were approached before discharge to give written consent to participation in 
follow up  
Chief Investigator notified within 15 days, and monitoring by Trial Steering 
Committee 
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Site training and initiation 
To prepare for the trial launch, we held a collaborators’ meeting with representatives from 
each site. Key challenges addressed during the meeting were training in deferring cord 
clamping and neonatal care with the cord intact, and in the two consent pathways. Short film 
clips of simulations supported training in deferred cord clamping and neonatal care with cord 
intact.  Roleplaying various scenarios for recruitment, with two actresses playing the women, 
supported training in the consent pathways.  
 
As success of the trial depended on engagement by clinicians, the chief investigator or 
another clinician (obstetrician or neonatologist) accompanied the trial manager (or senior trial 
manager) on site initiation visits.  These included training in the protocol and trial procedures, 
and a walk through of the participant pathway including the antenatal clinic and wards, 
labour suite, obstetric operating theatres, and neonatal unit. This was helpful for integrating 
the trial into local processes, and for raising its profile.  Before opening to recruitment, sites 
were encouraged to agree how they would deliver neonatal care with cord intact for vaginal 
and caesarean births. We suggested training staff using simulation and/or at low risk births. 
To support training we provided film clips of the recruitment scenarios from the collaborators 
meeting, and of simulations for neonatal care with cord intact (both usual equipment and the 
trolley).  
 
As randomisation was by the clinical staff, the local investigator and research nurse provided 
regular study specific training to relevant staff. We encouraged sharing of experiences 
between sites by newsletters, site visits and collaborators meetings.   
 
Statistical analysis  
Continuous data were summarised as mean with standard deviation and/or median with lower 
and upper quartiles.  Categorical data were summarised as frequency counts and percentages. 
We excluded women (and their babies) randomised who gave birth after 35+6 weeks, as 
outcomes for these babies are different from those born very preterm. For each site, the 
number of births before 32 weeks, the number of women approached, consenting and 
randomised were described, along with reasons why women did not give consent or were not 
randomised if they had given consent. Baseline characteristics were described, along with 
compliance with the allocated intervention and reasons for non-compliance. For IVH we 
derived the worst grade for each baby. As this was a feasibility study, no analysis of outcome 
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by allocated group was planned. Analyses were conducted in Stata v13.1.  No formal interim 
analysis was planned. An independent Data Monitoring Committee Data monitored data in 
confidence. 
 
Results 
Recruitment opened in March 2013, and for the feasibility assessment ended after 12 months 
(on 28th February 2014). Four sites randomised women within a month of opening to 
recruitment, two within two months, one within 4 months, and one 5 months. The sites not 
involved in the development work took longer to recruit their first participant. Issues 
contributing to delays included: concerns about having the neonatal equipment close to the 
sterile field at caesarean section (which led to one site largely recruiting vaginal births); 
research staff having limited time as they were running multiple studies; difficulties in 
building the necessary agreement between the neonatologists and obstetricians; and 
engagement of the local investigator.  
 
We randomised 125 women, four of whom gave birth after 32 weeks gestation. This was 
22% of women who gave birth before 32 weeks gestation, varying from 43% to 9% between 
sites. Factors in this variation were whether women having a caesarean birth were offered 
participation, availability of the trolley in the two sites using this equipment, and availability 
of clinical staff trained in the trial.  Four hundred and thirty four women were approached: of 
whom 389 were offered usual consent and 45 the two-stage oral assent consent pathway 
(table 1).  For those offered the usual consent pathway, almost half (184/389, 47%) gave 
consent, of whom almost half (89, 48%) were randomised. For women offered oral assent, 
most (38/45, 84%) gave assent, of whom almost all (36, 95%) were randomised. Thirty five 
women were randomised following oral assent only, as one woman gave written consent 
before randomisation.  Of the women offered participation who did not give consent, almost 
half (101/212, 48%) declined, and a quarter (53/212, 25%) were discharged home (figure 2).  
For the women who gave consent but were not randomised, the main reason was pregnancy 
continuing beyond 32 weeks (63/97, 65%).  
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Table 1: Consent and randomisation for women offered participation, by site
(i) usual written consent pathway
Offered
participation
Consent 
n (%)
Consent & randomised
n (%)
Site 1 65 28 (43%) 10 (36%)
Site 2 58 37 (64%) 18 (49%)
Site 3 63 31 (49%) 12 (39%)
Site 4 66 21 (32%) 11 (52%)
Site 5 21 11 (52%) 6 (55%)
Site 6 92 42 (46%) 24 (57%)
Site 7 12 9 (75%) 4 (44%)
Site 8 12 5 (42%) 4 (80%)
Total 389 184 (47%) 89 (48%)
(ii) two-stage oral assent consent pathway
Offered oral
assent* 
Gave oral
assent**
Oral assent & 
randomised
Written consent 
after randomisation†
Site 1 7 6   6 6 
Site 2 6 6 6 5 
Site 3 9 5 5 5 
Site 4 6 6 6 5 
Site 5 2 2 2 2 
Site 6 9 9 9 9 
Site 7 1 1 1 1 
Site 8 5 3 1 1 
Total 45 38 (84%) 36 (95%) 34 (95%) 
* Declined oral assent only recorded from July 2013
** 1 woman who gave oral assent also gave written consent before randomisation 
† for 2 women written consent after randomisation was not obtained, as the baby died before discharge and 
they did not return for the counselling appointment 
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and 132 babies for analysis (figure 2).  Six sites used their usual resuscitation equipment 
(75 women randomised) and two the trolley (50 women).
The system of randomisation envelopes was popular at sites, and worked well. The only 
incorrect use was when a second envelope was taken in error for a second twin; data are 
presented according to the allocation in the first envelope. Five randomisation envelopes 
were taken from the folder but not used, reasons: second twin (2 women), birth too quick (1), 
gestation 35 weeks (1), and woman did not give birth and was discharged home (1). 
The 125 women randomised gave birth to 135 babies (figure 2). Two women randomised
before 32 weeks gave birth at 38+2 and 39+2 weeks respectively, and were excluded from
analysis. One woman withdrew the use of her and her baby’s data, leaving 122 women 
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Figure 2: Consort flow for the feasiblity assessment based on one year of recruitment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Cord clamping within 20 seconds, neonatal 
care after clamping 
67 women and 74 babies** 
434 women approached 212 did not give consent 
 101 declined 
   53 discharged home  
   13 not eligible 
   14 not asked for consent 
     9 transferred to another hospital 
     9 birth too rapid 
     7 reason not known 
     3 clinical decision 
     3 language difficulties  222 women gave consent 184 written consent alone 
36 oral assent + written 
consent  
2* oral assent alone 
 
125 women randomised 
97 not randomised 
  95 written consent 
    61 no longer eligible, ≥32 weeks  
    10 birth too rapid 
      8 transferred to another hospital 
      6 reason not known 
      4 clinical decision 
      3 staff not trained 
      3 other# 
   2 oral assent 
       2 no longer eligible, ≥32 weeks 
Cord clamping after ≥ 2 minutes, neonatal 
care with cord intact 
58 women and 61 babies 
Included in analysis 
57 women and 60 babies 
11 clamping ≤20 seconds 
12 clamping ≥20 seconds and <2 minutes 
 34 clamping ≥2 minutes 
   3 clamping <2 minutes, time not known 
Included in analysis 
65 women and 72 babies** 
 
68 clamping ≤20 seconds 
  4 clamping ≥20 seconds and <2 minutes 
* baby died before discharge and written consent was not obtained;  
**  1 woman and her baby withdrew, data reported for mortality only;  
#  intrauterine death (n=1), equipment failure (1), randomised after the end of the feasibility phase (1) 
 
 
 
1 woman (1 baby) 
excluded 
   >35+6 weeks  
 
1 woman (1 baby) 
excluded 
   >35+6 weeks  
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Baseline characteristics
The allocated groups were balanced at trial entry (table 2). Time from randomisation to birth 
was within half an hour for over a third of women, and within an hour for over half; three 
quarters of women gave birth within two hours of randomisation and eight gave birth more
than one day after randomisation. Recruitment was across the range of gestational age with
approximately one third before 28 weeks, one third 28 to 29 weeks, and one third 30 to
31 weeks. One women was randomised in error, at 33 weeks. The earliest gestation at 
randomisation was 23+1 weeks.
Table 2: Baseline characteristics for the women 
Clamp ≥2 minutes
+ neonatal care 
with cord intact 
Clamp ≤20 
seconds + neonatal 
care after 
clamping 
n= 57 (%) n=65 (%)
Oral assent 19 (33%) 16 (25%) 
Time from randomisation to birth 
<30 min 22 (39%) 22 (34%) 
≥30 min to <1 hour 12 (21%) 13 (20%) 
≥1 hour to <2 hours 8 (14%) 13 (20%) 
≥2 hours to <5 hours 5 (9%) 7 (11%) 
≥5 hours to <12 hours 3 (5%) 5 (8%) 
≥12 hours to <24 hours 2 (4%) 2 (3%) 
≥24 hours 5 (9%) 3 (5%) 
Gestation at randomisation (weeks) - 
≥32 1 (2%) 
   30 to 31+6 19 (33%) 28 (43%) 
   28 to 29+6 16 (28%) 19 (29%) 
   26 to 27+6 10 (18%) 11 (17%) 
   <26 11 (19%) 7 (11%) 
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Clamp ≥2 minutes
+ neonatal care 
with cord intact 
Clamp ≤20 
seconds + neonatal 
care after 
clamping 
n= 57 (%) n=65 (%)
Age (years),  mean [sd] 30.5 [6.5] 29.4 [6.8]
Primiparous 31 (54%) 41 (63%) 
Twin pregnancy *4 (7%) 7 (11%) 
Pregnancy complications
  prelabour rupture of membranes 22 (39%) 26 (40%) 
  antepartum haemorrhage/placenta previa 5 (9%) 12 (18%) 
  spontaneous onset of labour 12 (21%) 11 (17%) 
  chorioamnionitis 6 (11%) 10 (15%) 
  pre-eclampsia/pregnancy induced hypertension 14 (25%) 10 (15%) 
  CTG abnormalities/fetal distress 12 (21%) 10 (15%) 
fetal growth restriction/small for gestational age 3 (5%) 5 (8%) 
other - **5 (8%) 
In last week received: magnesium sulphate 28 (49%) 20 (31%) 
  corticosteroids 52 (91%) 59 (91%) 
Caesarean section 38 (67%) 36 (55%) 
  before labour   31        28 
  during labour      7          8 
Vaginal birth 19 (33%) 29 (45%) 
  breech presentation     4 5 
* For one woman, one twin known intrauterine death before randomisation. Data for this baby not included in
any tables
**Abdominal pain (n=1), severe asthma (1), pyelonephritis (1), antiphosphate lipid syndrome (1) and 
not known (1).
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clamping before two minutes, for 11 (42%) this was due to the cord being too short. For 
singleton births without a short cord, cord clamping was at two minutes or later for 69%, and 
after 20 seconds for 78%. Compliance in the control group compliance was high; for 68 
babies (94%) cord clamping was within 20 seconds. 
Figure 3: Time to cord clamping (seconds) for babies by allocated group 
* 60 babies allocated to clamp cord after at least 2 minutes, seconds to cord clamping not known for 8 babies. 
** 72 babies allocated to clamp cord within 20 seconds, seconds to cord clamping not known for 8 babies
In the deferred clamping group, there were no obvious differences in time to cord clamping 
according to equipment for providing immediate neonatal care (usual equipment or trolley), 
or whether vaginal or caesarean birth. As sites gained experience, compliance with deferred 
clamping seemed to improve, although numbers are small (data not shown).  Three quarters 
of the babies were positioned level with the placenta. Almost all women (118/122, 97%) 
received a prophylactic uterotonic drug.  Time of administering this, used to derive whether it 
was before or after cord clamping, was not recorded for 37 women.
o = singleton 
1 = twin 1 
2 = twin 2 
Compliance with the allocated intervention 
In the intervention group, cord clamping was after at least two minutes for 34 (56%) babies
and after 20 seconds for 44 (77%) (Figure 3). Of the 27 babies in this group with cord 
APPENDIX 17
NIHR Journals Library www.journalslibrary.nihr.ac.uk
200
Neonatal care was provided beside the mother for 67 babies, of whom 49 (82%) were
allocated deferred clamping (table 3) (some were in the immediate clamping group, for whom
neonatal care was after cord clamping).  The usual resuscitation equipment was used for 35 
babies, and the trolley for 32. 
Table 3: Care given to the babies at birth, beside the mother and at the roomside
Beside the 
mother
At the 
roomside
Location
not known 
   baby in plastic bag/sheet  72* 39 - 
airway suction 23 54 - 
   mask ventilation 44 54 1 
   CPAP 11 22 - 
   intubation attempted, but unsuccessful 12 22 - 
   intubation successful 28 55 - 
   supplemental oxygen 28 48 - 
   surfactant 22 48 - 
   cardiac massage 6 4 - 
   umbilical venous catheterisation 1 5 - 
* some allocated to immediate clamping were placed in plastic bag beside mother, but received all other care at
roomside
Outcomes at hospital discharge 
Fifteen babies (11%) died before discharge; this included three stillbirths born extremely
premature for whom resuscitation was attempted (table 4). Two thirds of deaths were of
babies born before 26 weeks. One baby born at 30+4 weeks died during surgery for an
undiagnosed abdominal mass (congenital anomaly). 
Table 4: Death before discharge from hospital
n=133* (%)
Died before discharge        15 (11%)
   stillbirth 3 
   day 0-6 5 
   day 7-27 6 
≥day 28 1 
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n=133* (%)
Gestational age at birth (weeks)                     30+0 – 31+6 1 
   28+0 – 29+6 2 
   26+0 – 27+6 3 
   <26+0 9 
*  includes one woman who requested her data be removed from the analysis, data reported for death only
Of liveborn babies, 51 (40%) had an intraventricular haemorrhage of whom this was severe
for eight (6%) (Table 5). Only one baby had a temperature below 35°C on admission to the 
neonatal unit. Almost half the babies had a blood transfusion, which was usually for anaemia. 
Table 5: Outcome at discharge from hospital for livebirths 
n=129 (%) 
Brain injury*                       an y IVH (grade 1-4) 51 (40%)
  severe IVH (grade 3-4) 8 (6%)
  periventricular leukomalacia 9 (7%)
other** 10 (8%)
Heart rate < 100 at 1 minute 40 (31%)
   not known 2 (2%)
Temperature on admission to neonatal unit (°C) mean
[sd] 36.8 [0.7]
≤36°C 9 (7%)
    <35°C 1 (1%)
Blood transfusion (any) 61 (47%)
   for anaemia 58 
   for hypotension 3 
other† 8 
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 n=129 (%) 
Jaundice requiring treatment  117 (91%) 
      phototherapy 117 
      exchange transfusion - 
  
Polycythaemia requiring treatment  1 (1%) 
      intravenous fluids   1  
  
Chronic lung disease‡ 42 (36%) 
  
Ventilation 97 (75%) 
  duration (days) median (25th, 75th centile)   3 (1, 10) 
  
Necrotising enterocolitis (≥grade 2) 4 (3%) 
      x-ray with perforation or pneumatosis  4  
      laparotomy  2  
 
Clinical sepsis 71 (55%) 
positive culture + antibiotics ≥5 days 27   
negative culture + antibiotics ≥5 days 44   
  
Treatment for:                               patent ductus arteriosis 18 (14%) 
retinopathy of prematurity ‡†† 6 (5%) 
  
Duration of hospital stay (nights)4 median (25th, 75th 
centile) 56 (36, 82) 
  
Receiving mother’s breast milk at discharge  67 (57%) 
* 124 babies had cranial scan, adjudication results available for 112. For 12 with no scan adjudication, report 
review/CRF was used: IVH (n=6), severe IVH (2)  
** prominent subarachnoid spaces suggestive of atrophy (n=3), ventriculomegaly (2), periventricular 
echodensities (1), increased echogenicity of deep white matter (1), periventricular cyst (1), mega cysterna (1),  
porencephalic cysts (1) 
† thrombocytopenia (n=2), pulmonary haemorrhage (2) NEC clinically unwell (1), internal bleeding (1), 
haemorrhage and clotting anomaly (1), and bradycardia (1) 
‡ for 118 babies who survived to 36 weeks postmenstrual age  
†† information collected at 36 weeks postmenstrual age, discharge or death whichever happened first  
 n=118 alive at discharge 
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Overall, one in ten women had blood loss of 1,000ml or more, and five in ten of 500 ml or
more (table 6).  A quarter had postpartum infection requiring parenteral antibiotics. Most
women whose babies were alive when they were discharged were breastfeeding at discharge. 
Table 6: Outcome at discharge from hospital for the women
n=122 (%)
 Postpartum haemorrhage ≥500 ml 58 (48%)
≥1000 ml 12 (10%)
Blood transfusion 4 (3%) 
For vaginal births (n=48)       manual removal of placenta 2 (4%) 
   length of third stage >30 minutes 1 (2%) 
Postpartum infection treated with parenteral antibiotics 28 (23%)
pyrexia >38°C  5 
Duration of hospital stay (nights)  median (IQR) 4 (2, 6)
Expressing breast milk/breast feeding at discharge* 106 (91%) 
IQR = interquartile range 
* for 117 women whose babies were alive at the time of their discharge 
Overall assessment of feasibility objectives
The independent Trial Steering Group (TSC) assessed progress against the feasibility 
objectives and recommended progression to the full trial (table 7). They felt assessment 
of the feasibility of long-term follow up was not necessary at this point, as this should be
comparable to other similar trials. They advised that recruitment in the pilot sites continue
whilst seeking funding, in order to maximise efficiency and value for money. Progression 
was “strongly supported” by the DMC. 
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Table 7: Feasibility assessment based on one year of recruitment 
Feasibility objective Outcome 
Recruit 100-110 women at 8 sites
over 12 months
Recruitment opened on schedule
125 women randomised across 8 sites
51% women approached gave consent (222/434)
56% women with consent randomised (125/222)
Recruit 16%-18% of women with
livebirth <32 weeks gestation
22% (121/550) births <32 weeks randomised
4 women recruited gave birth >32 weeks 
Describe main reasons for non-
recruitment 
23% approached declined participation (101/434), 
12% discharged home (53/434)
97 with consent not randomised, reasons: 65% 
progressed >32 weeks (63/97), 8% transferred or
discharged (8/97), 10% birth too rapid (10/97), 
and 4% a clinical decision (4/97)
Generalisable spectrum of
gestational age, and outcome 
32% recruited <28 weeks (39/122)
15% recruited <26 weeks (18/122)
11% perinatal mortality 
Compliance with trial 
interventions
Good compliance, endorsed by DMC
Median time (seconds) to clamping 120 (IQR 30, 
135) deferred arm vs 10 (10, 15) early arm 
Neonatal care provided with cord intact, so same 
care in both groups
Describe reasons for non-
compliance 
Deferred clamping: cord too short (11/60), clinical 
decision (7/60), staff error (2/60)
Early clamping: staff error (2/72), baby born
membranes intact (1/72), natural sequence of
events (1/72)
Assess feasibility of oral assent
consent pathway 
Offered to 45 women, 84% (38/45) accepted
2 not randomised, progressed >32 weeks 
36 randomised: 34 gave written consent. 2 not
offered written consent, as baby died and they did 
not return for bereavement counselling 
appointment 
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Feasibility objective Outcome 
Assess acceptability of oral assent 
consent 
 No issues reported in follow up questionnaires  
 Qualitative interviews with women and clinicians 
largely positive 
Completeness of data collection 
for main outcomes 
 100% for death before discharge 
 96% for IVH (124/129 livebirths with cranial 
ultrasound)  
Women’s view of participation   75% (91/122) response to questionnaire at 6-8 
weeks 
 94% (81/86 who completed this section) answered 
‘probably yes’ or ‘definitely yes’ to ‘if time 
suddenly went backwards, and you had to do it all 
over again, would you agree to participate in the 
Cord pilot trial’ 
IQR=interquartile range 
Discussion  
The Cord pilot trial demonstrated feasibility of a large multicentre UK trial comparing 
deferred cord clamping and neonatal care, if needed, with the cord intact versus usual care. 
Nevertheless, we were unsuccessful in our attempt to transform this successful external pilot 
trial into an internal pilot, by continuing into the full trial.12  
 
The trial was multicentre and conducted within existing clinical services, so widely 
generalizable to similar settings. Randomisation close to the time of birth was feasible, with 
over half the women giving birth within one hour of randomisation. We achieved good 
compliance with the allocated intervention. As this is a complex multidisciplinary 
intervention, maintaining compliance required regular training for clinical staff at sites, 
particularly following staff changes and rotations. We anticipate compliance would improve 
in a larger trial as, with sufficient units participating, a growing pool of trainees and other 
staff would have experience of deferring cord clamping and providing neonatal care with the 
cord intact. In addition, the cord being too short, a key reason for clamping before two 
minutes in the intervention arm, becomes less of a problem with more experience.  
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Mortality was 11.3% (15/133. As three babies were stillborn, livebirth mortality was 9.2% 
(12/130), comparable with UK data for 201213 and suggesting a generalizable spectrum of 
babies was recruited. Our two-stage consent pathway allowed recruitment of women for 
whom birth was imminent and was largely supported by parents and clinicians.14,15  
Resuscitation with the cord intact allowed us to recruit babies requiring resuscitation at birth. 
These two strategies mean high-risk women and infants were randomised.  
 
Our independent adjudication of cranial ultrasound scans shows improved reliability of the 
diagnosis of IVH,8 suggesting that for trials where IVH is a main outcome criteria for 
diagnosis should be standardised and adjudication considered. 
 
A practical problem was that babies were sometimes transferred to another hospital not 
participating in the trial. Although we were able to adapt our trial procedures to allow data 
collection for these babies, this was time consuming. For a large trial with many sites this 
would be a less common problem.  
 
In conclusion, this pilot trial demonstrates that a large multicentre trial in the UK would be 
feasible. The two-stage consent pathway merits further evaluation, although our data support 
its use in future trials of cord clamping at preterm birth. Similarly, our data support provision 
of neonatal care beside the mother, although further evaluation of neonatal care with cord 
intact is required. 
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Appendix 18 Randomised trial of cord clamping
and initial stabilisation at very preterm birth
See Duley et al.71 https://doi.org/10.1136/archdischild-2016-312567
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Appendix 19 Clinicians’ views and experiences
of offering two alternative consent pathways for
participation in a preterm intrapartum trial:
a qualitative study
See Chhoa et al.41 https://doi.org/10.1186/s13063-017-1940-5
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Appendix 20 Women’s views and experiences of
two alternative consent pathways for participation in
a preterm intrapartum trial: a qualitative study
See Sawyer et al.42 https://doi.org/10.1186/s13063-017-2149-3
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Appendix 21 Cord pilot trial, comparing
alternative policies for timing of cord clamping
before 32 weeks’ gestation: follow-up for women
up to 1 year
See Bradshaw et al.169 https://doi.org/10.1186/s12884-019-2223-9
DOI: 10.3310/pgfar07080 PROGRAMME GRANTS FOR APPLIED RESEARCH 2019 VOL. 7 NO. 8
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Duley et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
217

Appendix 22 Womens’ experiences of
participating in a randomised trial comparing
alternative policies for timing of cord clamping
at very preterm birth: a questionnaire study
See Bradshaw et al.180 https://doi.org/10.1186/s13063-019-3325-4
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Appendix 23 Randomised trial of cord clamping
at very preterm birth: outcomes at 2 years
See Armstrong-Buisseret, et al.181 https://doi.org/10.1136/archdischild-2019-316912
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Appendix 24 Preterm cord clamping and
placental transfusion prospective meta-analysis:
protocol v1.0, dated 28 January 2013
Background 
The primary objectives are to assess whether timing of cord clamping and other strategies to 
alter placental transfusion at preterm birth influence (i) the composite outcome of death or 
serious morbidity at discharge from hospital, and (ii) disability-free survival in early 
childhood (aged 2-3years). 
 
Methods 
The Chief Investigators of potentially eligible studies will be contacted to invite them to 
collaborate in this prospective meta-analysis.  Eligible trials identified in January 2013 are 
listed in Table 1. The Cord Clamping and other measures to influence Placental 
Transfusion at Preterm birth collaboration (CCPTP collaboration) will undertake this 
prospective meta-analysis using individual participant data according to the methods 
recommended by the Cochrane Collaboration Prospective Meta-Analysis Methods Group.1   
 
Criteria for potentially eligible studies 
Study design: Studies will be included if they are randomised trials. Studies will be included 
if they are individual or cluster randomised. Quasi-random studies will be excluded.  
 
Publication and unblinding of outcome data:  Studies will only be included in the prospective 
meta-analysis if the investigator/s were blind to outcome data by intervention group at the 
time this protocol was agreed (i.e. when the objectives, aims and hypotheses, eligibility 
criteria, subgroup and sensitivity analyses, and main outcomes were agreed). If short term 
data are unblinded by allocation group but follow-up data remain blinded at the time the 
protocol is agreed, only the follow-up data from such trials will be included. 
 
Types of participant: Participants will be women giving birth preterm (before 37 completed 
weeks gestation) and their babies. Studies will be eligible for inclusion if they recruited 
women and their babies, or babies alone. 
 
Types of intervention: Studies will compare early or immediate cord clamping (standard 
care) with deferred cord clamping, with or without other strategies to influence placental 
transfusion (such as position of the baby whilst cord intact, use of uterotonic drugs, and 
umbilical cord milking). Studies will also be included if they compare any alternative 
strategies for influencing placental transfusion without a timing of cord clamping arm. 
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Studies evaluating collection and storage of residual placental blood that is then used for 
transfusion after birth will be excluded. 
 
The comparisons included in the prospective meta-analysis will be: 
1. Immediate cord clamping versus deferred cord clamping (trials with no cord milking 
in either allocated group)  
2. Immediate cord clamping versus deferred cord (with subgroups by whether umbilical 
cord milking) 
3. Immediate cord clamping versus umbilical cord milking 
4. Umbilical cord milking versus deferred cord clamping 
 
There is no consensus about the definition of ‘immediate’ and ‘deferred’ cord clamping. 
Whenever possible immediate clamping will be defined as within 20 seconds, and deferred 
clamping as at least 60 seconds. However, one objective of this PMA will be to explore the 
potential impact of alternative timings of cord clamping.  
 
Types of outcome: Primary outcomes will be for the children: 
 Death or serious morbidity at discharge from hospital. Serious morbidity will be 
defined as one or more of (i) brain injury on cranial ultrasound, (ii) necrotizing 
enterocolitis ≥ Grade 2, (iii) late onset sepsis (>48 hr after birth), (iv) chronic lung 
disease, and (v) retinopathy requiring treatment  
 Disability-free survival at age 2-3 years 
 
 
Secondary outcomes will be: 
For the women: postpartum haemorrhage (blood loss >500ml), any breast feeding, postnatal 
depression 
 
For the children: Death , Brain injury on cranial ultrasound, Necrotizing enterocolitis ≥ Grade 
2, Late onset sepsis (> 48 hr after birth), Chronic lung disease, Retinopathy requiring 
treatment, Blood transfusion, Hypothermia, Jaundice requiring treatment, Long term 
neurodevelopment: cerebral palsy, neurosensory disability, deafness, blindness. 
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Search strategy for potentially eligible studies
We will identify ongoing trials that may be eligible by searching for published protocols in
Medline and Embase, searching online registries of clinical trials, web searches of other 
sources, and personal contacts (for example by asking all collaborators to check conference 
abstracts). The Chief Investigators of ongoing trials will be invited to join the PMA provided
the data remain blind and the study meets the eligibility criteria.
Assessment of study quality 
Potentially eligible studies will be assessed for risk of bias using the criteria described in the 
Cochrane Handbook.  
Planned subgroup analyses
To assess whether the results are comparable for different groups of infants, and for different
levels of intervention, the following subgroup analyses will be conducted for the primary 
outcomes, if data are sufficient, based on:
For all comparisons:
Gestation at birth: <37 completed weeks to 32 weeks; <32 weeks to 28 weeks,
<28 weeks
Type of pregnancy: singleton; multiple
Mode of birth: caesarean; vaginal 
If caesarean birth, by type of anaesthesia: general anaesthesia, regional anaesthesia, 
type of anaesthesia not known
For comparisons of timing of cord clamping 
Timing of uterotonic drug: before cord clamping; after/at cord clamping 
Duration of deferred cord clamping: >30 seconds but  ≤1 minute; >1 minute but
≤2 minutes; >2 minutes 
Whether cord milking: cord milking; no cord milking; not known whether cord 
milking 
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Planned sensitivity analyses
To assess whether results are robust to trial quality and different methods of analysis the 
following sensitivity analyses will be conducted for the primary outcomes, if data are 
sufficient:
excluding studies with high risk of bias
for trials comparing alternative strategies for timing of cord clamping: excluding 
studies where the mean difference between timing in the intervention arms was
<45 seconds, or where the difference is not known 
comparing analyses using fixed effects and random effects models
analysis of outcomes weighted by degree of difference between birth weights in
treatment and control 
Analysis plan
Analysis will include all randomised participants with available data and be based on
intention-to-treat. Missing data will be described and reasons for missing data explored. The 
impact of missing data on conclusions about the comparative effects on the primary outcomes
will be explored where possible (for example by using sensitivity analyses or imputation
techniques). Multilevel models will be considered to examine how much variation in the 
outcomes is attributable by subgroup variables, and to estimate effect sizes with adjustment
for subgroup variables as well as uncountable random effects among individual studies where 
necessary.5 The full analysis plan will be agreed by the Collaboration before any analyses are 
undertaken. 
Project management
Membership of the CORD Collaboration will include representatives from each of the trials
contributing data to the project, plus representatives from the project coordination group, and 
invited experts in IPD prospective meta-analysis. The project coordination group will be
responsible for data management and analysis and communication within the Collaboration, 
including newsletters and email updates. 
Ethics issues
Participants in the individual trials have previously consented to participation in their 
respective trial. The data will be available through an agreement between all Chief 
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Investigators of the included trials, and ethics approval for each of the trials has been given 
by their respective Research Ethics Committees. The trialists remain the custodians of their 
own data and retain the right to withdraw their data from the analysis at any time. Data will 
be de-identified before being shared with the CCPTP Collaboration. 
 
Publication policy 
Each trial has the right to publish the main results of their trial prior to the CCPTP 
Collaboration results being published. When publishing individual study results the authors 
for participating trials will acknowledge within the publication their involvement in the 
CCPTP Collaboration. Before publication of any CCPTP manuscripts, drafts will be 
circulated for comment, revision and approval by a nominated representative of each of the 
participating trials. Publications using these data will be authored on behalf of the CCPTP 
Collaboration, either with specific named authors, or on behalf of the Collaboration as a 
whole and names of other participating Collaborators will be listed in the 
Acknowledgements. 
 
Funding 
Initial funding for the CCPTP Collaboration has been received National Institute of Health 
Research (ref. RPPG060910107): improving quality of care and outcome at very preterm 
birth. The Preterm Birth Programme presents independent research commissioned by the 
National Institute for Health Research (NIHR) under its Programme Grants for Applied 
Research funding scheme (RP–PG–0609-10107). The views expressed are those of the 
authors and not necessarily those of the NHS, the NIHR, or the Department of Health. 
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Table 1: Trials eligible for collaboration in CCPTP at January 2013 
Chief 
Investigator 
Participants Intervention Primary outcome Comparator 
El-Nagare, W 70 infants <31 weeks 
gestation 
Cord  milking - infants in the cord-
milked group will be placed at or 
below the level of the placenta, and 
about 20 cm of the umbilical will 
be vigorously milked towards the 
umbilicus three times before 
clamping the cord 
Systemic blood flow as 
reflected by mean SVC flow 
measured by 
echocardiographic study at 4-6 
hours after birth. 
Immediate cord clamping at 
birth  
Mercer, S  212 pregnant women in 
preterm labour between 
24 and 31.6 weeks  
Delayed cord clamping - at birth, 
the obstetrical provider delays the 
cord clamping for 45 sec while 
lowering the infant. At 45 sec the 
cord is milked once and then 
clamped and cut 
Very low birth weight infants 
in the delayed cord clamping 
group will have better motor 
function at 18-22 months 
corrected age when compared 
with VLBW infants in the ICC 
group.[ Time Frame: 18-22 
months ] 
Immediate cord clamping at 
birth 
Josephsen, J 80 pregnant women in 
preterm labour between 
Cord milking - the neonate will be 
placed below the level of the 
placenta and approximately 20cm 
• To evaluate and compare 
hemoglobin and hematocrit 
concentrations in extremely 
Immediate Cord clamping at 
birth 
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Chief 
Investigator 
Participants Intervention Primary outcome Comparator 
24 0/7 and 27 6/7 
weeks  
of umbilical cord will be milked 
three times over 10-20 seconds 
total from the placental end to the 
neonate before clamping the cord 
low birth weight infants 
(ELVW) after cord milking 
intervention to ELBW infants 
receiving immediate cord 
clamping  
• To evaluate and compare the 
incidence and numbers of 
blood transfusions after cord 
milking  
Katheria, A 60 Infants <32 weeks 
gestation 
Cord milking – the delivering 
obstetrician will hold the infant 
below the mother's introitus at 
vaginal delivery or below the level 
of the incision at caesarean section 
and about 20cm of the cord will be 
milked over 2 seconds and repeated 
two additional times 
Superior Vena Cava Flow. 
Researchers hypothesize that 
infants who receive umbilical 
cord milking (UCM) compared 
to infants who receive 
immediate cord clamping 
(ICC) will have higher SVC 
flow at 6 hours. 
[ Time Frame: 6 hours ]  
Immediate cord clamping at 
birth without milking 
A
PPEN
D
IX
24
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
230
Chief
Investigator
Participants Intervention Primary outcome Comparator
Datta, V 120 infants between
34 weeks 0 days to
36 weeks +6 days 
gestation 
Delayed cord clamping - delayed 
by 30 to 60 seconds 
Short term neurobehavioral 
outcome using N.A.P.I.
(neurobehavioural assessment 
of preterm infant).
Early cord clamping within 20 sec
Mercer, J 212 pregnant women 
between 24 and 
31.6 weeks at risk of 
delivery 
1-Delayed cord clamping - delayed 
30 to 45 seconds while the infant is
held lower than the placenta. 
2-Cord milking -At the end of the 
time, the cord is milked once and 
the cord is clamped. If the 
obstetrician feels he cannot delay 
the cord clamping, then the cord 
can be milked 2 to 3 times. 
• Very low birth weight
(VLBW) infants in the delayed 
cord clamping (DCC) group 
will have less intraventricular 
haemorrhage (IVH) compared
to VLBW infants in the 
immediate clamped (ICC) 
group 
[ Time Frame: December, 2012 ]  
• Very low birth weight infants 
in the delayed cord clamping
group will have less late onset 
sepsis than those in the 
immediate clamping group 
Immediate cord clamping at
birth 
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Chief 
Investigator 
Participants Intervention Primary outcome Comparator 
[ Time Frame: December 
2012 ]  
Hosono, S  566 infants between 24 
and 28 weeks gestation 
Cord milking - Umbilical cord is 
cut and clamped at 30cm from 
infants, baby is placed on a radiant 
warmer. Paediatrician then milks 
the umbilical cord once 
1) the probability of not 
needing transfusion and death  
2) amount of blood transfusion 
within the first 4 weeks  
Early cord clamping within 
30 seconds
Tarnow-Mordi, W  1600 pregnant women 
less than 30 weeks at 
risk of delivery 
Delayed cord clamping - Infant 
held as low as possible below the 
level of the placenta for 60 seconds 
or more before cord clamped about 
6 cm from the umbilicus.  
Composite death and/or major 
morbidity at 36 weeks post 
menstrual age. Morbidity is 
defined by one or more of the 
following: Brain injury on 
ultrasound, Chronic lung 
disease, Severe retinopathy, 
Necrotising enterocolitis, Late 
onset sepsis. Timepoint:
36 weeks post menstrual age
Immediate cord clamping  
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Chief 
Investigator 
Participants Intervention Primary outcome Comparator 
Tarnow-Mordi, 
W 
100 pregnant women 
less than 32 weeks at 
risk of delivery 
Autologous placental transfusion  
1. Cord milking – Cord clamped 
and cut long (3 cm from the 
placenta or the introitus of the 
vagina) then untwisted and milked 
during resuscitation. 
2. Delayed cord clamping -  
Infant place as low as possible 
below the level of the introitus or 
placenta for 30 – 60 seconds then 
cord clamped 6 cm from the 
umbilicus. If the baby is in 
extremis, the previous step is 
omitted and the cord is clamped 
immediately 6 cm from the 
umbilicus.  
Haemoglobin concentration 
will be measured using arterial 
or venous or capillary blood on 
the neonatal intensive care unit 
blood gas analysis machine or 
hospital laboratory using any 
method pragmatically 
available. Timepoint: at 6 
hours after birth   
 
 
 
 
 
 
Immediate cord clamping  
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Chief
Investigator
Participants Intervention Primary outcome Comparator
introitus or the placenta for 30 – 60 
seconds then cord clamped and cut 
long before being handed to
neonatal team. After the delay step, 
cord untwisted and milked during 
resuscitation 
3. Delayed cord clamping plus
milking - Infant held as low as
possible below the level of the 
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Appendix 25 Systematic review and network
meta-analysis with individual participant data on
cord management at preterm birth: study protocol
Abstract 
 
Introduction: Timing of umbilical cord clamping and other cord management strategies may 
improve outcomes at preterm birth. Trials comparing such strategies often recruit at different 
gestations and compare alternative policies, including immediate cord clamping, short (30 
seconds), medium (45 seconds) or long deferrals (up to 5 minutes) and 'milking' the cord. 
Individual participant data (IPD) enables exploration of subgroups to give differential cord 
management recommendations for different groups of participants. Network meta-analysis 
(NMA) methods enable to compare and rank all available interventions using a combination of 
direct and indirect comparisons of multiple treatment options by integrating all the available data. 
Objectives: 1) To evaluate the effectiveness of cord management strategies on neonatal mortality 
and morbidity overall and for different patient characteristics using IPD meta-analysis; and 2) to 
evaluate and rank the effect of different cord management strategies for preterm births on 
mortality using NMA. 
Methods and analysis: Systematic search for all planned, ongoing and completed randomised 
controlled trials that compare alternative cord management policies (such as different timing of 
cord clamping and/or cord milking) at preterm birth (before 37 weeks’ gestation). The trials will 
be identified by searching Medline, Embase, clinical trial registries, and other sources. IPD will 
be sought for all trials. First, deferred clamping and cord milking will be compared with 
immediate clamping in IPD meta-analyses. The primary outcome will be death (at any time). 
Secondary outcomes will include morbidities and harms. Effect differences will be explored for 
pre-specified subgroups of participants. Second, all identified cord management strategies will be 
compared and ranked in an IPD NMA for the primary outcome death, and differential treatments 
depending on participant characteristics will be identified using meta-regression and subgroup 
analyses. Inconsistency and heterogeneity will be explored. 
Ethics and dissemination: Approved by the University of Sydney Human Research Ethics 
Committee (2018/886). Results will be relevant to clinicians, guideline-developers, policy-makers 
and the global research community, they will be disseminated to these groups through 
publications, conference presentations and media releases. 
 
Registration 
 
Keywords: Preterm birth, umbilical cord clamping, umbilical cord milking, placental transfusion, 
individual participant data meta-analysis, prospective meta-analysis, network meta-analysis 
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Introduction 
Preterm birth is an important determinant of adverse outcome for the child, as well as the family 
and health services.1  Each year, 15 million babies are born too soon (before 37 weeks gestation) 
and the number is rising.2-4 Of these, 1.1 million babies die, and preterm birth is now the second 
most common cause of death in children under five years of age.2 Preterm birth is more common 
in low and middle-income countries.2 There are stark inequalities in survival, with 95% survival 
in high-income countries compared to 30% in low-income countries for babies born at 28-32 
weeks gestation.3 Worldwide, preterm birth is a risk factor for half of all neonatal deaths.3 
 
For those born preterm who survive, morbidity and health service costs are high compared to 
babies born at term. In the UK, hospital stay lasts 85 times longer for babies born before 28 weeks 
than for term infants; and 16 times longer for those born at 28-31 weeks.5 Total cost to the UK 
public sector of very preterm birth (before 32 weeks) is estimated at £1 billion annually.6 Of very 
premature infants (<28 weeks) who survive, 5-10% develop cerebral palsy; and 25% develop 
neurosensory disability.1 Those without severe disability have increased risk of developmental, 
cognitive, and behavioural difficulties.7-10 Teenagers and young adults born very preterm report 
poorer physical abilities and more chronic ill health than their peers born at term, although similar 
health-related quality of life.11,12 Prematurity and its sequelae may have a negative psychosocial 
and emotional impact on parents and families.1 Even modest improvement in outcome would be 
of substantial benefit to the children, their families, and health services. 
 
Neonatal transition and blood transfer in preterm infants 
Net transfer of blood from the placenta to the baby is known as ‘placental transfusion’. If the 
umbilical cord is not clamped immediately at birth, blood flow between the baby and placenta 
may continue for a few minutes. Blood flow may continue without any net transfer, however, and 
sometimes net transfer may be to the placenta.13 
 
As the baby is born, umbilical circulation slows and pulmonary vascular resistance falls, rapidly 
increasing pulmonary blood flow volume. Continued flow in the umbilical vein and arteries at 
birth may be part of the physiological mechanisms assisting the baby during this transition from 
fetal to neonatal circulation. For term births, umbilical blood flow may continue for up to five 
minutes or longer.14,15 For preterm births, umbilical blood flow may continue for longer,16 since 
a greater proportion of feto-placental circulating blood volume is still in the placenta (while at 
term two-thirds are in the infant with one third in the cord and placenta).17  
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Time of umbilical cord clamping
Animal and pilot human studies suggest that breathing and lung aeration before cord clamping 
can improve cardiovascular stability and oxygenation and reduce infant mortality, and 
intraventricular haemorrhage.18-21 Other animal and pilot studies suggest that initial respiratory 
support for up to 5 minutes before cord clamping results in improved blood pressure and cerebral 
oxygenation and reduced cerebrovascular impairment compared with immediate cord
clamping.22,23 One potential mechanism of benefit of deferred clamping is allowing time for the 
infant to establish spontaneous breathing whilst still placentally supported, thus avoiding invasive
interventions such as endotracheal intubation in the delivery room. 
Without the assistance of video or extra equipment, clinicians record the time when the cord is
clamped more accurately and consistently than the time when vigorous breathing begins. In 
unpublished data from an earlier study,24 Katheria found that time of onset of breathing in preterm 
infants receiving gentle stimulation is related to time after birth – within a minute over 90% of 
preterm infants had begun spontaneous breathing (r squared=0.91, P<0.001) (personal
communication). Thus the longer after birth the cord is clamped, the more likely is it that breathing 
has begun.
Cord milking 
Cord milking (pinching the cord close to the mother and running the fingers towards the baby, 
usually several times) may be a way to increase preterm blood volume without deferring 
clamping.25 However milking over-rides the infant's physiological control of its blood pressure
and volume and disrupts umbilical flow. Animal data show that cord milking without allowing
placental refill fails to provide placental transfusion, and milking can cause major haemodynamic 
disturbance.26 A recent trial comparing deferred cord clamping with cord milking was stopped 
early in the subgroup of extremely preterm infants (23-27 weeks), as the incidence of severe
intraventricular haemorrhage was higher in the cord milking group.24 Hence, the effects of cord 
milking need further elucidation. 
Other cord management issues 
Initial neonatal care and stabilisation traditionally takes place on a resuscitation platform at the 
side of the room or in an adjacent room, away from the woman. For infants requiring resuscitation 
immediately at birth, this practice means the cord is usually clamped and cut immediately.
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the cord intact beside the woman.27,28 The recent Cord pilot trial29 showed that neonatal stabilisation 
and resuscitation with cord intact is feasible and acceptable to parents and clinicians.28,30-32
Previous reviews of aggregate data 
A 2012 Cochrane Review of timing of cord clamping for preterm births33 included 15 trials, with
738 infants, one of which (with 40 infants) compared cord milking with immediate cord
clamping.34 There was heterogeneity in the timing of cord clamping and gestational age at 
recruitment, and data were insufficient for reliable conclusions about any of the primary outcomes
of the review. A systematic review and meta-analysis published in 2018 (including 18 trials with
2834 participants) compared the effect of deferred (≥30 seconds) vs early (<30 seconds) clamping 
in preterm infants, and found a reduction the primary outcome hospital mortality by 32% (Risk 
Ratio = 0.68, 95% Confidence Interval = 0.52-0.90).35 The main outcomes of this systematic
review are summarised in Table 1. There was heterogeneity in the definition of ‘early cord
clamping’ ranging from immediate or less than 5 seconds to 25 seconds, and ‘late cord clamping,
ranging from 30 seconds to 180 seconds, with most trials clamping after less than 60 seconds.
Recruitment age varied from 22 weeks to 36+6 weeks. Most analyses of infant and maternal 
morbidity were substantially underpowered.35 The review concludes that while there is high
quality evidence that deferred cord clamping improves outcomes, individual participant data
analyses of existing and new randomised controlled trials are urgently needed to further 
understand the benefits and potential harms of different cord management strategies, and to
understand whether differential treatment options are advantageous for key subgroups of infants.35
Current guidelines and practice for cord management at birth 
These uncertainties in optimal cord clamping strategies are reflected in varying guidelines. The 
World Health Organisation (WHO) recommends late cord clamping36 unless resuscitation is
required, the National Institute for Health and Clinical Excellence (NICE) recommends waiting 
for 30 seconds to 3 minutes if mother and baby are stable,37 and the International Resuscitation 
Council (ILCOR) recommends a delay in cord clamping of at least 1 minute. NICE recommends 
positioning the baby positioned at or below the level of the placenta whilst deferring clamping,
whilst WHO and ILCOR make no such recommendations. If the baby is assessed as requiring 
resuscitation (which is the case in many preterm infants),38 WHO recommends immediate 
clamping,[39] NICE recommends to consider cord milking before clamping, and ILCOR 
An alternate strategy is providing immediate neonatal care, including resuscitation if needed, with  
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concludes that there is insufficient evidence to make any recommendations.38 There is little 
information about actual practice for cord clamping.40  
 
The current study 
Overall, there is uncertainty about the optimal cord management strategy which has led to wide 
practice variation. It is also unclear whether there should be differential cord management 
strategies for key subgroups of infants, e.g. those for which resuscitation and/or stabilisation is 
deemed necessary, extremely preterm infants, or those with growth restriction. This uncertainty 
has led to 112 planned, ongoing or published trials (in more than 15,000 preterm babies) that are 
comparing a range of cord management strategies. Individual participant data (IPD) meta-analysis 
is the gold standard for combining such trial data. IPD will provide larger statistical power for 
estimation of treatment effects of rarer secondary endpoints and will enable reliable subgroup 
analyses to examine hypotheses about differences in treatment effect, exploring interactions 
between treatment- and participant-level characteristics.41 A network meta-analysis (NMA) 
facilitates data synthesis when there is a range of interventions available and permits comparisons 
across all interventions, although some interventions may not have been directly compared in 
trials.42 Indirect evidence for these comparisons is obtained by inferring the relative effectiveness 
of two competing treatments through a common comparator.43 Network meta-analysis produces 
estimates of relative effects for each intervention compared with every other intervention in the 
network. These effect sizes can be used to obtain rankings of the effectiveness of the 
interventions.44 Using individual participant data in a network meta-analysis (as opposed to 
aggregate data) can improve precision, increase information, and reduce bias.45  
 
Objectives 
The aims of this study are to:  
1) evaluate the effectiveness of strategies of cord management on neonatal mortality and 
morbidity and to evaluate differential treatment by participant characteristics using 
individual participant data meta-analysis;  
2) evaluate, compare and rank the effect of different cord management strategies for preterm 
births on mortality using network meta-analysis. 
 
Methods and analysis 
We will conduct a systematic review of randomised trials with individual participant data pairwise 
and network meta-analysis, and a nested prospective meta-analysis. The lead investigator for all 
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potentially eligible studies will be contacted and invited to collaborate and join the individual 
participant data Cord Management at Preterm birth (iCoMP) Collaboration. Eligible trials 
identified up to August 2018 are listed in Table 2. The Collaboration will undertake this project 
according to the methods recommended by the Cochrane Collaboration Individual Participant 
Data, Cochrane Multiple Interventions Group, and Prospective Meta-Analysis Methods 
Groups.41,46,47 The protocol is registered at PROSPERO, the International Prospective Register of 
Systematic Reviews.[48] PRISMA-IPD and PRISMA-NMA statements will be followed for 
reporting. 
 
Eligibility criteria 
Types of studies 
Studies will be included if they are randomised trials, quasi-random studies will be excluded. 
Studies must compare at least two of the interventions of interest (defined below). 
 
Trial participants 
Participants will be women giving birth preterm (before 37 completed weeks’ gestation) and/or 
their babies. Individually randomised studies will be eligible for inclusion if the unit of 
randomisation was either the woman, or the baby. Women and babies will be included regardless 
of whether mode of delivery was vaginal or Caesarean, and whether the birth was singleton or 
multiple. Babies will be included regardless of whether or not they received immediate 
resuscitation at birth. 
 
Types of interventions and comparators 
Part 1: individual participant data pairwise meta-analysis 
For the pairwise meta-analysis we will include all trials that compare an intervention to enhance 
umbilical blood flow or allow more time for physiological transition to the comparator immediate 
cord clamping. This includes interventions assessing cord management strategies for timing of 
cord clamping, and other strategies to influence umbilical flow and physiological transition (such 
as lowering the baby below the level of the placenta whilst cord intact, and umbilical cord milking 
or stripping).  Studies will be included if they compare strategies to maintain ‘physiological’ 
umbilical flow (i.e. none or minimal intervention) and placental transfusion, and if they examine 
strategies that aim to alter umbilical blood flow and placental transfusion (such as using gravity 
by lowering the baby, or cord milking or stripping).  Trials will be included regardless of whether 
initial neonatal care is provided with the umbilical cord intact, or not. 
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Different strategies (i.e. cord clamping and milking) will be analysed in separate subgroups to 
assess comparability between the groups by assessing subgroup effects and heterogeneity. They 
will then be collapsed into one ‘cord management intervention’ group if they are deemed 
comparable based on the previous subgroup assessments. If they are deemed non-comparable they 
will be analysed and interpreted separately.  
 
Part 2: individual participant data network meta-analysis 
For the network meta-analysis we will include as interventions of interest cord management 
strategies for timing of cord clamping, and other strategies to influence umbilical flow and 
placental transfusion. 
Thus, interventions of interest include: 
 Immediate cord clamping (within 30 seconds) 
 Short deferral of cord clamping (>30 to ≤ 45 seconds) without  milking 
 Medium deferral of cord clamping (45 to ≤  90 seconds) without  milking 
 Long deferral of cord clamping (> 90 seconds) without  milking 
 Umbilical cord milking or stripping before cord clamping 
 Umbilical cord milking or stripping after immediate cord clamping 
 Umbilical cord milking or stripping after deferred cord clamping 
 Physiological clamping after onset of breathing 
 
If we identify other interventions not listed above we will include them if they are addressing cord 
management or related strategies to influence umbilical flow and placental transfusion.  Again, 
trials will be included regardless of whether initial neonatal care is provided with the umbilical 
cord intact, or not.  Studies evaluating collection and storage of residual placental blood that is 
then used for transfusion after birth will be excluded. All possible comparisons between eligible 
interventions are displayed in Figure 1.  
 
Nodes that specify different timings of cord clamping were defined according to what timing is 
classified as immediate clamping, short deferral, medium deferral or long deferral according in 
the literature to date (as shown in Table 2), and after discussion with clinicians. Different timings 
are commonly compared in head-to-head comparisons, hence, their classification as different 
intervention nodes. Similarly, nodes that specify cord milking were classified after a review of 
current milking techniques described in the literature and after discussion with clinicians. 
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If insufficient data are available, categories will be collapsed where possible. For instance, milking 
before and after cord clamping could be collapsed into one single cord milking category, or 
medium and long delay could be collapsed into a medium to long delay category. We consider 
the interventions of interest to be jointly randomisable (i.e. a participant could, in principle, be 
randomised to any one of the interventions of interest). 
 
Types of outcome measures 
Included trials must report at least one of the clinical outcomes included in this review as specified 
in the ‘measures’ section below to be included. 
 
 Figure 1. Network of possible comparisons between cord management interventions 
  
Eligibility for nested prospective meta-analysis 
Studies are only included in the nested prospective meta-analysis if the investigator/s were blind 
to outcome data by intervention group at the time the main components of the protocol (i.e. 
objectives, aims and hypotheses, eligibility criteria, subgroup and sensitivity analyses and main 
outcomes) were initially agreed in January 2015. Other planned or completed eligible trials will 
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be included in the first cycle of this IPD meta-analysis if their expected last participant enrolment 
is before end March 2019. 
Information sources and search strategy
The search strategy to identify potentially eligible studies will include a search of the register of 
trials developed and maintained by the Cochrane Collaboration Pregnancy and Childbirth Review
Group. The Cochrane Pregnancy and Childbirth Group’s Trials Register contains trials identified
from: monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);
weekly searches of MEDLINE (Ovid); weekly searches of Embase (Ovid); monthly searches of 
CINAHL (EBSCO); hand searches of 30 journals and the proceedings of major conferences; and 
weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email
alerts. Details of the search strategies for CENTRAL, MEDLINE, Embase and CINAHL, the list 
of hand searched journals and conference proceedings, and the list of journals reviewed via the 
current awareness service can be found in the ‘Specialized Register’ section within the editorial 
information about the Cochrane Pregnancy and Childbirth Group.49 We will identify ongoing 
trials that may be eligible by searching for published protocols in Medline and Embase, searching 
online registries of clinical trials, and personal contacts (for example, by asking collaborators to
notify any unregistered studies they are aware of). The Chief Investigators of eligible trials will 
be invited to join the iCoMP Collaboration. They will also be asked if they know of any further 
planned, ongoing or completed studies. 
Selection of studies for inclusion in the review 
Two members of the iCoMP Secretariat (see project management section below) will
independently assess all the potentially eligible studies identified for inclusion. Disagreements
will be resolved by discussion or, if required, by consulting a third member. Studies that are not
willing or able to provide IPD will be will be synthesised where possible using aggregate data.
Data collection, management and confidentiality 
Data receipt 
De-identified, individual participant level data for each randomised participant will be provided 
by each participating trial. These data will be backed-up and stored in a secure, centralised
database. 
DOI: 10.3310/pgfar07080 PROGRAMME GRANTS FOR APPLIED RESEARCH 2019 VOL. 7 NO. 8
© Queen’s Printer and Controller of HMSO 2019. This work was produced by Duley et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
243
Data checking: Range, internal consistency, consistency with published reports and missing items 
will be checked for each trial. Trial details such as randomisation methods and intervention timing
will be cross-checked against any published reports, trial protocols and data collection sheets. 
Integrity of the randomisation process will be examined by reviewing the chronological 
randomisation sequence and pattern of assignment, as well as the balance of prognostic factors
across treatment groups (taking into account stratification factors). Inconsistencies or missing data 
will be discussed with the individual trialists and any problems will be resolved by consensus.
Each trial will be analysed individually and the resulting analyses and trial data will be sent to the 
trialists for verification before inclusion in the iCoMP database. All trial specific outcomes
generated from the individual participant data will be cross-checked against published information 
via a series of crosstabs.
Data re-coding: The outcome data may have been collected in different formats within the 
different trials. Therefore, the de-identified data collected from each of the participating trials will
be extracted and re-formatted into a commonly coded dataset. 
Data transformation and collating: Once the data from each of the trials are finalised, it will be
combined into a common dataset, but a trial identifier code for each participant will be retained. 
New variables will be created from the combined dataset as required to address the hypotheses to
be tested. 
Risk of bias assessment and quality of evidence appraisal 
Eligible studies will be assessed for risk of bias using the criteria described in the Cochrane
Handbook:50 random sequence generation; allocation concealment; blinding of participants and 
personnel; blinding of outcome assessment; incomplete outcome data; selective reporting; and 
other bias. The quality of evidence will be assessed using the GRADE approach51 for the pairwise
comparisons, and the rating approach suggested by Salanti and colleagues for network meta-
analysis that is implemented in the CINeMA application.52
Data processing
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born moderately preterm (32 to 37 weeks), separate analyses will be conducted for these two 
groups of infants for the secondary outcomes.  Where possible, definitions will be standardised, 
otherwise outcomes will be used as defined by the trialists. Secondary outcomes will include 
measures of neonatal and maternal morbidity, and health service use. There will be efficacy 
outcomes that cord management strategies, compared with immediate clamping, may improve 
such as death, late onset sepsis and severe intraventricular haemorrhage, and there will be safety 
outcomes reflecting potential risks of not clamping immediately such as postpartum haemorrhage, 
hypothermia and polycythaemia. 
 
Covariates and subgroups 
Subgroup analyses will be conducted for the primary outcome of death and key secondary 
outcomes, if sufficient data are available. All included covariates and subgroups are listed in Table 
3. The comparative effects of alternative cord management strategies may vary depending on key 
infant risk factors, but also depending on the level and type of neonatal care available at the 
hospital of birth. Thus, there will be subgroup analyses based on participant-level characteristics 
and based on hospital-level characteristics. If data are insufficient for subgroup analysis, 
categories will be collapsed. 
 
Table 3. Measures for individual participant data pairwise meta-analysis 
Outcomes 
For all infants  
Primary 
outcome 
 Death (at any time for follow-up duration of the included trials) 
For infants born before 32 weeks gestation 
Key secondary 
outcomes  
 Death (within 7 days) 
 Severe intraventricular haemorrhage on cranial ultrasound (grade 3-4) 
 Necrotizing enterocolitis ≥ grade 2 (or trialist definition) 
 Late onset sepsis (where possible defined as clinical sepsis > 72 hour after birth) 
 Patent ductus arteriosus requiring treatment (medical and/or surgical) 
 Chronic lung disease (at 36 weeks postmenstrual age or trialist defined) 
Other secondary 
outcomes  
 All grades of intraventricular haemorrhage on cranial ultrasound 
 Respiratory support (mechanical ventilation, CPAP, low flow oxygen)  
 Duration of respiratory support 
 Retinopathy of prematurity requiring treatment (medical and/or surgical) 
 Drug treatment for hypotension 
 Blood transfusion (volume) 
 Hypothermia on admission to neonatal unit 
Measures 
Part 1: individual-participant data pairwise meta-analysis 
Outcomes 
All outcome measures are listed in Table 3. The primary outcome will be death of the baby at any 
time. As outcomes for babies born very preterm (before 32 weeks gestation) are different to those 
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Polycythaemia, haemoglobin, haematocrit 
Jaundice requiring treatment 
Birthweight 
Length of stay in NICU
Long term developmental disability (assessed using the Bayley III, or similar tools): 
o cerebral palsy (severe, moderate, mild) 
o neurosensory disability (severe, moderate, mild) 
o deafness (severe, moderate, mild) 
o blindness (severe, moderate, mild)
For infants born at or after 32 weeks gestation
Key secondary 
outcome
Death (within 7 days) 
Admission to Neonatal Intensive Care Unit (NICU)
Other secondary 
outcomes
Length of stay in NICU 
Duration of respiratory support (mechanical ventilation or CPAP)
Chronic lung disease (receiving supplemental oxygen at 36 weeks postmenstrual 
age)
Late onset sepsis (> 72 hour after birth)
Patent ductus arteriosus requiring treatment (medical and/or surgical)
Drug treatment for hypotension
Blood transfusion 
Hypothermia on admission to neonatal unit or postnatal ward
Long term developmental disability (assessed using the Bayley III, or similar
tools): 
o cerebral palsy (severe, moderate, mild) 
o neurosensory disability (severe, moderate, mild) 
o deafness (severe, moderate, mild) 
o blindness (severe, moderate, mild)
For all women
Secondary 
outcomes
Maternal death 
Postpartum blood loss ≥500ml
Postpartum infection requiring antibiotics
Manual removal of placenta 
Retained placenta (>30 minutes)
Not breast feeding when baby discharged from hospital 
Postnatal depression
Blood transfusion 
Covariates/ Subgroups
Based on participant-level characteristics
Gestation at birth: <37 completed weeks to 32 weeks; 28 to <32 weeks; 26 to
<28 weeks, <26 weeks 
Type of pregnancy: singleton; multiple
Mode of birth: caesarean before onset of labour; caesarean after onset of labour;
vaginal
Spontaneous onset of labour: spontaneous onset or prelabour ruptured membranes;
not spontaneous onset or prelabour ruptured membranes; not known whether 
spontaneous onset of labour or prelabour ruptured membranes 
Time of breathing onset (seconds or before/after cord clamping/milking)
Assessed as needing resuscitation and/or stabilisation (yes/no)
Gender (male, female, uncertain/other)
Intrauterine growth restriction: yes, no (trialist defined)
Suspected maternal antenatal/intrapartum sepsis (trialist defined): yes/no 
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Based on hospital / trial-level characteristics
Highest level of neonatal unit available at site: neonatal intensive care unit, 
neonatal unit (some capacity to provide ventilation), special care baby unit (no 
ventilation available), no neonatal unit or special care baby unit
Type of uterotonic drug (if any)
Planned timing of uterotonic drug: before cord clamping; after/at cord clamping; 
timing mixed or not known
Planned position of the baby relative to the placenta whilst cord intact: level with
placenta (between level of woman’s bed and her abdomen/anterior thigh); more
than 20 cm below level of placenta; position mixed or not known
Need for immediate resuscitation at birth: infants requiring immediate 
resuscitation at birth excluded; infants requiring immediate resuscitation at birth 
included; unclear whether infants requiring immediate resuscitation at birth 
included or excluded 
Type of consent 
Part 2: individual participant data network meta-analysis
Outcome
The primary outcome for the network meta-analysis will be death of the baby at any time (during 
the follow-up duration of the trials).
Covariates and subgroups
All variables listed in Table 3 will be considered as covariates to improve consistency of the NMA 
model. There will be subgroup analyses comparing babies born before and after 32 weeks, and 
comparing babies in need of immediate resuscitation versus not in need of immediate
resuscitation.
Data analysis
The full, detailed Statistical Analysis Plan will be agreed on by the Collaboration before any 
analyses are undertaken. Analyses will include all randomised participants with available data,
and the primary analyses will be based on intention-to-treat without imputation of missing data. 
Missing data will be described and reasons for missing data explored. The impact of missing data
on conclusions about the comparative effects on the primary outcomes may be explored in
sensitivity analyses if appropriate. 
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Part 1: individual-participant data pairwise meta-analysis
For each outcome, a one-stage approach to analysis will be employed to include individual
participant data from all eligible trials in a multilevel random or mixed effects regression model.
Aggregate data will be included were individual participant data is unavailable. Heterogeneity of 
treatment effects across trials will be estimated using confidence and prediction intervals, with
further inclusion in secondary models of participant-level and trial-level covariates to explain the 
sources of heterogeneity. Forest plots will be presented by trial for each of the primary outcomes, 
and for any secondary outcomes where there is evidence of heterogeneity across trials. 
We will use a generalised linear modelling framework, with the choice of outcome distribution 
and link function dependent on outcome type. For example, binomial with log link will be used
to estimate risk ratios for the binary primary outcome of death or serious morbidity, and Gaussian
with identity link for differences in mean duration of ventilation, with log-transformation of the 
data if appropriate. We will follow a similar approach for secondary outcomes. For estimation of 
subgroup effects on the primary outcomes, we will present forest plots of pooled treatment effects
according to pre-specified subgroup variables, and estimate effects by including appropriate 
interaction terms between subgroup variable and treatment arm in the regression models. The 
results of all comparative analyses will be presented using appropriate estimates of treatment
effect along with 95% confidence intervals and two-sided p-values. 
Part 2: individual participant data network meta-analysis
We will calculate a two-step random-effects network meta-regression model to compare and rank 
all available treatments using direct and indirect comparisons using a Bayesian model and 
assuming an independent interaction between treatment effects and covariates. We will obtain 
probability rankings of the effect of all interventions on the primary outcome death and for key 
secondary outcomes if data permits. If there are statistically significant interactions between
covariates and treatment effects, we will provide probability rankings of intervention effects by
subgroup for these covariates. Heterogeneity will be measured by the heterogeneity parameter τ2. 
Residual inconsistency will be measured by comparing effect estimates between the direct and 
indirect comparisons. A judgement of excessive heterogeneity or inconsistency would prevent the 
interpretation and reporting of the network meta-analysis.
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Assessment of compliance with the allocated intervention
Compliance with the interventions will be described for each trial. For studies of early versus
deferred cord clamping this will be based on i) the time to cord clamping in each allocated group 
and ii) the difference in time between early and deferred clamping. For studies comparing cord 
milking with no milking, this will be based on i) time to cord clamping in the allocated groups ii)
reported compliance with cord milking in both groups. 
Adjustments for multiple testing (to be added)
Planned sensitivity analyses
To assess whether results are robust to trial quality and different methods of analysis the following
sensitivity analyses will be conducted for the primary outcome, if data are sufficient:
Excluding studies with high risk of bias, defined as those assessed as high or unclear risk
of bias for sequence generation and/or concealment of allocation, and/or high risk of bias
for loss to follow up for pairwise and network meta-analysis; 
For trials comparing early cord clamping with deferred clamping: analysis of outcomes
weighted by degree of separation between groups (observed between-arm difference in
mean timing of clamping) for pairwise meta-analysis;
Analysis of outcomes weighted by degree of separation in haemoglobin (at 24 hours) 
achieved between intervention and control groups for pairwise meta-analysis (as a 
surrogate for net placental transfusion); 
For trials with deferred cord clamping, we will perform an additional dose-response 
analysis assessing intended time of cord clamping deferral as a continuous variable; 
An exploratory analysis will be based, not as intention-to-treat, but on actual timing of 
cord clamping for individual participants for pairwise and network meta-analysis.
Project management
Membership of the iCoMP Collaboration will include representatives from each of the trials
contributing data to the project, the Secretariat, and invited experts in individual participant data
systematic reviews, network meta-analysis and prospective meta-analysis who will form an
Advisory Group. The Secretariat will be responsible for data management and analysis and 
communication within the Collaboration, including newsletters and email updates.
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Ethical issues
Participants in the individual trials have previously consented to participation in their respective
trial. The data will be available through an agreement between all Chief Investigators of the 
included trials, and ethics approval for each of the trials has been given by their respective
Research Ethics Committees. The trialists remain the custodians of their own data and retain the 
right to withdraw their data from the analysis at any time. Individual participant data will be de-
identified before being shared with the iCoMP Collaboration. Ethics approval for this project has 
been granted by the University of Sydney Human Research Ethics Committee (Project number: 
2018/886).
Publication policy <will be updated>
The key methods for this meta-analysis protocol were agreed by the iCoMP Collaborators in
January 2015, before unblinding of any outcome data from the studies included in the nested
prospective meta-analysis. This manuscript was discussed at the first iCoMP Collaborators 
meeting held at the Pediatric Academic Societies meeting in San Diego, in April 2015. At this
meeting it was agreed the protocol should be expanded to a retrospective systematic review and 
individual participant data and network meta-analysis with a nested prospective meta-analysis.
The protocol was then revised based on further discussion, and circulated to members of the 
collaborative group for further comment and agreement prior to submission. 
Participating trialists in the prospective meta-analysis, when reporting results from their own 
trials, will endeavour to include a statement that their trial is part of this prospective meta-analysis 
in any published manuscripts or conference abstracts. Any reports of the results of this meta-
analysis will be published either in the name of the collaborative group, or by representatives of 
the collaborative group on behalf of the iCoMP Collaboration, as agreed by members of the 
collaborative group. Reports will be circulated to the collaborative group for comments and 
approval before submission for publication.
Discussion
There is an urgency to conduct this systematic review and individual participant data pairwise and 
network meta-analysis so we can make sense of the many small trials now being undertaken, 
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inform clinical practice and identify the most promising interventions for further evaluation. This
meta-analysis offers an opportunity to reliably test important hypotheses that cannot be resolved
by any of the individual trials, either alone or in simple combination. Coordinating international 
efforts in this way will help achieve consensus on the most important substantive clinical
outcomes to assess in any future trials. Unequivocal synthesized results, together with the 
identification of key determinants (e.g. effect modifiers) will be critical for translating evidence 
from the results of this meta-analysis into practice.  Figure 2 gives an idea of the network of direct 
comparisons available from the trials that we have identified to date. We plan to complete study 
identification and individual participant data collection by mid-2019, and conduct the analysis
and disseminate the results by end-2020.
This study is only possible because trialists around the world have agreed to collaborate to share 
the individual participant data from their cord management trials. This collaborative approach will
enable us to move beyond the traditional ‘one-size-fits-all’ approach in medicine, towards
precision medicine to find the optimal treatment from a range of treatment options for each 
individual woman and her baby, based on their individual characteristics and risk factors. 
Figure 2. Illustration of network of currently available trials comparing different cord
management strategies. 
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Table 1: Fogarty review35 of immediate versus deferred cord clamping for preterm births 
 
Outcome Numbe
r of 
trials 
Number of 
participant
s 
Risk 
ratio 
95% 
confidence 
interval 
 
All infants born <37 wk 
    
Hospital mortality 18 2538 0.68 0.52 to 0.90 
Apgar score     
               <4 at 1 minute 2 1600 0.82 0.67 to 1.00 
               <8 at 5 minutes 3 1683 1.03 0.91 to 1.17 
Cardiorespiratory support at resuscitation 10 748 0.89 0.71 to 1.11 
Intubation in the delivery room 6 532 0.96 0.82 to 1.13 
Temperature on admission  (°C, mean)   11 2317 -0.02Š  -0.07 to 0.3Š  
Intraventricular haemorrhage      
 any (grade 1 to 4)) 19 2871 0.87 0.75 to 1.00 
 severe (grade 3 or 4) 11 2300 0.87 0.59 to 1.27 
Periventricular leukomalacia   8 1977 0.71 0.39 to 1.27    
Combined periventricular leukomalacia 
or porencephaly or echodense 
intraparenchymal lesions or 
ventriculomegaly 
6 1920 0.77 0.56 to 1.06 
Mechanical ventilation 9 686 0.95 0.84 to 1.07 
Chronic lung disease ≥ 36 wk 7 1951 1.02 0.93 to 1.12 
Patent ductus arteriosus 12 2397 0.96 0.84 to 1.09 
Necrotising enterocolitis 12 2397 0.88 0.65 to 1.18 
Late onset sepsis 10 2146 0.95 0.80 to 1.13 
Severe retinopathy of prematurity 5 1893 0.74 0.51 to 1.07 
Peak haematocrit % 2 1587 2.73Š  1.94 to 3.52Š  
Blood transfusion 13 2595 0.81 0.74 to 0.87 
Polycythemia (haematocrit >65%) 13 2529 2.65 1.61 to 4.37 
Partial exchange transfusion 4 1743 0.14 0.01 to 2.74 
Serum bilirubin peak (mean) 15 2358 4.43Š  1.15 to 7.71Š  
 
All infants born ≤28 wk gestation 
    
Hospital mortality 3 996 0.70 0.51 to 0.95 
Severe (grade 3 or 4) intraventricular 
haemorrhage 
3 967 0.80 0.51 to 1.25 
Chronic lung disease ≥ 36 wk 3 869 0.99 0.91 to 1.09 
Necrotising enterocolitis 4 977 0.87 0.61 to 1.24 
Late onset sepsis 3 925 1.07 0.87 to 1.31 
Severe retinopathy of prematurity 2 839 0.72 0.47 to 1.09 
Blood transfusion 2 941 0.91 0.85 to 0.97 
 
Š   mean difference 
SCBU=Special Care Baby Unit 
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Table 2: Eligible randomised trials to date for the pairwise and network meta-analysis with individual participant data on Cord Management at 
Preterm Birth (iCoMP) February 2019 
Trial Country 
(PI) 
Publication 
year 
Start year/ 
completion 
year 
Sample 
size 
Participants Intervention Comparator Primary outcome/s 
Argentina53 
(Carroli)  n/a 2016/2020 700 24-30 weeks GA DCC – at 90 sec Early cord clamping <30 sec 
Sepsis (proven and very 
probable) 
Australia54 
(Badurdeen)  
n/a 2018/2020 120 (not all 
preterm) 
Infants greater than 
32 weeks GA* 
DCC: at least 1 minute ICC Average heart rate between 
60-120 seconds after birth 
Australia55 
(McDonnell) 1997 1994/1994 46 26 to 33 weeks DCC: 30 sec ICC Venous haematocrit 
Australia56 
(Kamlin)  
n/a 2014/2015 27 (not all 
preterm) 
32-42 weeks GA* 
Arm 1: DCC -  at 90-180 sec 
Arm 2: DCC – 10 sec after 
crying and breathing 
established 
Early cord clamping <60 sec 
Heart rate 90 sec after birth 
(measured by pulse oximetry 
and digital microphone 
enabled stethoscope) 
Australia57 
(Tarnow-Mordi)  
n/a 
(Pilot for 
Tarnow-Mordi 
2017) 
2009/2010 100 <32 weeks GA 
Arm 1:  Cord milking - cord 
cut long (3 cm from placenta/ 
introitus), milked during 
resuscitation 
Arm 2: DCC – at 30-60 sec 
infant below level of 
introitus/placenta. If baby in 
extremis, immediate 
clamping. 
Arm 3: DCC at 30 – 60 sec + 
milking 
Immediate cord clamping 
within 10 sec 
Haemoglobin 6 hours after 
birth 
Australia58 
(Tarnow-Mordi)  2017 2010/2019 1634 <32 weeks GA 
DCC - ≥60 sec, baby 
positioned below placenta ICC within 10 sec 
Composite: Mortality or 
major morbidity (IVH, 
chronic lung disease, ROP, 
NEC, late onset sepsis) at  
36 weeks 
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Trial Country 
(PI) 
Publication 
year 
Start year/ 
completion 
year 
Sample 
size Participants Intervention Comparator Primary outcome/s 
Austria59 
(Urlesberger)  
n/a 2018/2021 80 (not all 
preterm) 
>=28 weeks* 
DCC 30 cm, cord milking 
after long clamping at 30cm, 
1x 10cm/sec 
Standard care (cord cutting) 
Cerebral blood volume 
(CBV) (within 15 min after 
birth) 
Changes in CBV (ml/100g 
brain) 
Bangladesh60 
(Yasmeen)  
2015 2012/2013 40 
Neonate delivered at 
less than 37 weeks of 
GA 
DCC: cord clamped at 3 
minutes 
DCC: cord clamped at 1 
minute 
Haemoglobin (Hb), iron and 
ferritin 
Canada61 
(El-Naggar)  2019 2011/2018 73 24-31 weeks GA 
Cord  milking x3, at or below 
the level of the placenta, ~20 
cm milked, before clamping 
ICC 
Systemic blood flow 
(Superior vena cava flow at 
4-6 hours) 
Canada62 
(Murphy)  
n/a 2007/2010 296 Singletons, 24-32 
weeks GA 
DCC – at 30-45 sec ICC Composite: IVH or late onset 
sepsis 
China63 
(Dai)  
2014 n/a 31 Preterm infants Wait until cord pulsation 
ceased 
ICC: 5-10 sec NA 
China64 
(Dong)  
2016 n/a 90 <32 weeks DCC: 45 sec ICC: <10 sec 
Routine blood test results, 
total amount of red blood cell 
transfusion, blood gas 
parameters, mean arterial 
pressure, bilirubin peak, total 
time of phototherapy, 
incidence rates of necrotizing 
enterocolitis, late-onset 
sepsis, intracranial 
haemorrhage, retinopathy, 
and bronchopulmonary 
dysplasia 
China65 
(Hao)  n/a 2018/2019 48 
Preterm infants with 
GA of 30 to 31 + 6/7 
weeks 
UCM DCC Cerebral haemodynamics 
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Trial Country 
(PI) 
Publication 
year 
Start year/ 
completion 
year 
Sample 
size Participants Intervention Comparator Primary outcome/s 
China66 
(Hu) 
2015 (master’s 
thesis) n/a 120 
28-35 weeks GA 
Vaginal birth 
1. DCC 30 sec 
2. DCC 60 sec 
3. DCC 120 sec 
ICC < 10 sec 
Haematocrit and haemoglobin 
levels at 24 hours and 1 week 
after birth 
China67 
(Hua)  2010 2009/2011 
176 (49 of 
those 
preterm) 
Any GA* 
Normal birth 
Arm 1: DCC – wait until cord 
ceases pulsing 
Arm 2: DCC – at 90 sec 
Asphyxia 
Arm 1: DCC – wait until cord 
ceases pulsing, resuscitate on 
bed site with cord intact 
Normal birth 
Immediate clamping <10 sec 
Asphyxia 
Immediate clamping <10 sec, 
resuscitate after on irradiation 
table 
Haemoglobin 1 month after 
birth 
China68 
(Li)  2018 2017/2017 102 
Neonates who were 
delivered vaginally 
between 28 0/7 and 
36 6/7 week and 
complicated by 
premature prolonged 
rupture 
of membranes 
UCM: milked four times at a 
speed of 10cm/sec, then 
clamped 
ICC: clamped and cut 
immediately 
Incidence of certain or 
probable infection in neonates 
China69 
(Liu)  n/a 2019/2019 
948 (not all 
preterm) 
Neonates with GA 
between 34 weeks 0 
day and 38 weeks 6 
days* 
DCC: 60 sec ICC: within 10 sec Rate of respiratory distress within 24 hours after birth 
China70 
(Shi)  2017 n/a 
60 preterm 
(and 460 
term) 
Single foetus 
deliveries* DCC ICC 5-10 sec 
Hemoglobin (newborn cord 
blood &after 24 h), neonatal 
complications, bleeding 
volume, third labour time, 
incidence of placental 
adhesion and peeling 
China71 
(Xie)  
n/a 2017/2019 300 Singletons, <34 
weeks GA 
UCM: X2-3, 25cm/2 sec, 
below placenta level, before 
clamping 
ICC 
Concentrations of 
Haemoglobin &Haematocrit, 
serum ferritin level (48 hours 
after birth)
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Trial Country 
(PI)
Publication 
year
Start year/ 
completion
year
Sample
size Participants Intervention Comparator Primary outcome/s 
Egypt72
(Allam) n/a 2018/2019 210
Premature babies at
30-34 weeks GA ECC: first 5 sec 
DCC: until cord stops pulsing
or 1-2min
Fetal haemoglobin, neonatal
death 
Egypt73
(Nour 2017a) 
n/a 2017/2019 90 Preterm infant  
<34 weeks GA
UCM: cord milked three 
times at 10cm/sec 
ICC Peripheral venous CD34 at
admission 
Egypt74
(Nour 2017b) n/a 2017/2018 90 
Preterm infant  
<34 weeks GA
Group A: ICC, with placental 
insufficiency 
Group B: DCC, with
placental insufficiency
Normal placenta with DCC:
60 sec 
Peripheral venous CD34 at
admission 
Germany75
(Nelle) 1998 n/a 19 PT <1500g*
DCC: 30 sec, 30 cm below 
placenta ICC 
Mean Blood Pressure
(mmHg, Dinamap), left
ventricular output (LVO,
ml/kg/min), mean cerebral
blood flow velocity (CBFV)
in the Arteria carotis interna 
(ACI, m/s; Doppler-
ultrasound), hemoglobin (Hb, 
g/dl), hematocrit (Hct, %),
systemic and cerebral 
hemoglobin transport(HbT), 
systemic vascular resistance
(SVR; mmHg/kg/min-1) 
Germany76
(Rabe 2011) 2011 2006/2008 40 <33 weeks DCC: 45 sec DCC: 20 sec 
Feasibility, effects on post-
partal adaption and anaemia 
of prematurity 
India77
(Agarwal) 
2018 2013/2014 100 <34 weeks GA DCC: at 120 sec ICC ≤30 sec 
Hyperbilirubinemia and 
polycythemia within first
7 days
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Trial Country 
(PI)
Publication 
year
Start year/ 
completion
year
Sample
size Participants Intervention Comparator Primary outcome/s 
India79
(Aghai 2018) n/a 2018/2020
1400 (not
all preterm)
Depressed neonates
born between  
35-42 weeks*
UCM: milked four times,
milking 30cm over 2 sec ICC: immediately after birth 
Number of infants with
moderate to severe HIE or
death 
India80
(Anusha) 
n/a 2017/2019 148
Neonates with birth 
weight less than
1500g*
DCC: 30 sec ICC: within 10 sec 
Haemodynamic stability,
haematological status, serum 
ferritin, and requirement of
blood transfusion 
India81
(Bhriguvanshi)
n/a 2017/not 
specified
236
Neonate > 28 weeks 
GA, requiring
resuscitation*
UCM: milked three times 
towards baby at 10cm/sec,
then clamped 
ICC: within 30 sec Haemoglobin (Hb) and 
hematocrit (Hct) 
India82
(Chopra)
2018 2013/2015 142
growth retarded
babies (IUGR)born at
and above 35 weeks 
of GA* 
DCC: 60 sec ICC: 10 sec Hemoglobin and ferritin
levels
India83
(Datta) 2017 2012/2013 120 34-36 weeks GA DCC: at 30-60 sec ICC: <20 sec 
Neurobehavioural
Assessment of Preterm Infant
(NAPI) at 37 weeks post-
conceptional age 
India84
(Dhaliwal)
2014 n/a 300 34-37 weeks GA DCC: 60 sec ICC: <10 sec 
Risk of neonatal mortality & 
abnormal neurological
examination at 40 weeks GA
India85
(Dipak) 2017 2013/2014 78 27-31 weeks GA
1. DCC: 60 sec 
DCC 60 sec with
intramuscular ergometrine 
ICC: 10 s Hematocrit 4 h after birth 
India78
(Aghai 2014) 2018 2014/2016
101 (not all 
preterm) 
>35 weeks GA, baby
depressed*
UCM: X3 before cord
clamping, below placenta 
level 
ICC 
Feasibility (Number neonates 
cord milking), resuscitation 
efforts (ventilation, intubation, 
chest compression), short term 
resuscitation outcomes (5 min 
Apgar, severity Hypoxic 
Ischemic Encephalopathy, 
blood gas 1 hour)
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Trial Country 
(PI)
Publication 
year
Start year/ 
completion
year
Sample
size Participants Intervention Comparator Primary outcome/s 
India86
(George/Isac) n/a 2017/2018
180 (not all 
preterm) 
Mothers with a period
of gestation between
34 and 40 6/7 * 
UCM: milking whole length 
at 10cm/sec, three times, then
clamped 
ICC: no details 
Infant haemoglobin (Hb) and 
hematocrit (Hct) 
India87
(Gupta)
n/a 2018/2020 110
Preterm newborn 
babies born at  
<34 weeks 
DCC ICC Ferritin and PCV 
India88
(Ram Mohan) 2018 2014/2015 54 
Preterm, requiring
resuscitation 
UCM: 20-25 cm umbilical 
cord x3, within 30 sec of birth No milking Haemoglobin at 6 weeks 
India89
(Ranjit)
2015 2010/2010 100 30-366 ICC DCC:  >2min Hematocrit and serum 
ferritin, at 6 weeks 
India90
(Kumar Mangla/
Thukral)
n/a 2016/2016 84 (not all 
preterm) 
Late preterm and term
neonates* 
Deferred UCM: cord clamped 
at 60 sec 
UCM: Cord milking in 10 sec Venous haematocrit at  
48 hours of life 
India91
(Upadhyay 2010) 
2013 2010/2011 170 (not all 
preterm)
>35 weeks GA* UCM Non UCM Haemoglobin and serum 
ferritin at 1 and 1.5 months
India92
(Upadhyay 2013) 2015 2013/2014 200
32-36 weeks GA, 
vaginal or caesarean UCM: X3, 10cm/sec ICC: <30 sec 
Haemoglobin and ferritin at
1.5 months
India93
(Varanattu) n/a 2018/2019 250
Preterm infants  
<32 weeks GA 
UCM: milked three times 
over 20 sec period towards 
infant at 20cm/2sec with  
2 second pause between.  
ICC: clamped immediately 
Haemoglobin levels at birth 
and IVH (incidence and 
severity) 
India94
(Venkataseshan) 2018 2012/2013 434 30-33 weeks GA
DCC: 60 sec below placenta. 
If baby depressed, immediate
clamping keeping cord long, 
milked x3 during 
resuscitation  
ICC: within 10 sec 
Mortality and/or abnormal
neurological examination at
40 weeks postnatal age 
Iran95
(Armanian) 2017 2015/2015 60 ≤34 weeks GA DCC: at 45 sec ICC: <10 sec Time of cord clamping
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Trial Country 
(PI)
Publication 
year
Start year/ 
completion
year
Sample
size Participants Intervention Comparator Primary outcome/s 
Iran96
(Haghshenas) 2017 2014/2015 54 
<32 weeks GA, 
caesarean, birth 
weight < 1500g
DCC: at 30-45 sec ICC: <10 sec 
IVH (days 3 to 7), survival
infant (up to 28 days) 
Iran97
(Hemmati) n/a 2012/2013 114 26-34 weeks GA DCC: at 30-45 sec ICC: 10-15 sec IVH, 3-4 and 7-10 days
Iran98
(Mirzaeian) n/a 2017/2018 160
Neonates with a GA
of 28 to 34 weeks 
UCM: milked three times in
20 sec ICC 
Amount of transfused blood, 
bilirubin levels
Iran99
(Sekhavat) 2008 n/a 52 
Infants born 26-34 
weeks GA DCC: 30-60 sec ICC: 10-15 sec 
higher blood pressure (BP), 
hematocrit (Hct) and blood 
glucose (BS)
Iran100
(Shahgheibi) n/a 2017/2018 90 
Women with preterm 
labour DCC: 180 sec DCC: 30 sec 
Blood parameters, weaning 
from ventilator, NICU
discharge time
Ireland101
(Dempsey) n/a 2015/2016 45 <32 weeks GA
Arm 1: DCC – at  60 sec on
mobile resuscitation trolley 
at/below placenta level 
Arm 2: UCM – Cord stripped
3 times at 20cm/2 sec 
at/below placenta level 
ICC: <20 sec 
Neonatal: Brain activity (6 & 
12 hours post-partum, EEG 
and NIRS) 
Maternal: hemoglobin at 
24-36 hours post-partum 
Israel102
(Kugelman) 2007 2004/2005 65 <35 weeks GA DCC: 30-45 sec ICC: 5-10 sec 
initial serum complement  
(C3 and C4) and 
immunoglobulins (IgG, IgM)
Japan25
(Hosono 2008a) 
2008 2001/2002 40 24-28 weeks GA, 
singletons
UCM: 20 cm of the cord, 
2-3x, before clamping, 
20cm/2sec
ICC 
Probability of not needing 
transfusion, determined by 
Kaplan–Meier analysis number 
of RBC transfusions
Japan103
(Hosono 2008b) n/a 2008/2016 566 24-28 weeks GA
UCM: cord cut 30 cm from
infant, cord milked x1 ICC: <30 sec 
1) Probability needing 
transfusion and death 
2) Amount of blood 
transfusion first 4 weeks  
A
PPEN
D
IX
25
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
272
Trial Country 
(PI)
Publication 
year
Start year/ 
completion
year
Sample
size Participants Intervention Comparator Primary outcome/s 
Korea104
(Song) 2017 2012/2015 66 
Neonate delivered 
between 24 0/7 and 
32 6/7 weeks 
UCM: milked four times at
speed of 20cm/2sec, with
2sec pause between
ICC: immediately after 
delivery
Short term safety: Apgar 
score, prevalence of
hypothermia, early intubation, 
initial blood gas analyses, 
bilirubin levels, duration of
phototherapy, use of cross-
transfusion, and respiratory 
distress.
Nepal105
(Andersson)
2017 2014/2017 540 (not all 
preterm) 
34-41 weeks GA* DCC: at ≤180 sec ICC: ≤30 sec Haemoglobin at 8±1 months
Nepal106
(Ashish KC) 
n/a 2016/2016 1510 (not
all preterm)
Singletons,  
≥33 weeks GA* 
DCC: at ≥180 sec ECC: <60 sec 
Neonatal heart rate
continuously until 10 min 
after birth and at 1,3&5 min 
Netherlands107 
(Te Pas) n/a 2019/2020 660 <30 weeks GA
Physiology-based cord
clamping (PBCC): 
Resuscitation with cord
intact, clamp when infant is
stable (heart rate >100 bpm, 
oxygen>80%, supplemental 
oxygen <40%) 
DCC: 30-60 sec, clamping 
before resuscitation 
Intact survival at NICU
discharge (without cerebral
injury (IVH ≥ grade 2 and/or
PVL ≥ grade 2 and/or
periventricular venous
infarction) and/or NEC (Bell 
stage ≥ 2)
Netherlands108
(Ultee) 2008 n/a 37 34 to 36 weeks GA DCC: 3 min ICC: <30 sec 
haemoglobin and ferritin 
levels (at 10 weeks)
Pakistan109
(Malik) 2013 2009-2009 80 30-37 weeks GA DCC: 120 sec DCC: 30 sec Hematocrit
Saudi Arabia110
(Al-Wassia) n/a 2017/2019 180
Preterm infants  
<32 weeks GA
UCM: milked 20cm segment 
over 2-3 sec three times DCC: 60 sec IVH 
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Trial Country 
(PI) 
Publication 
year 
Start year/ 
completion 
year 
Sample 
size Participants Intervention Comparator Primary outcome/s 
Saudi Arabia111 
(Gomaa) n/a 2016/2018 200 
Infants 23 to 34 + 6/7 
weeks GA 
DCC: 45-60 sec before 
clamping, with baby at level 
or below placenta 
UCM: milked 4-5 times from 
maternal end of cord to baby 
abdomen,  2 sec pause 
between milking 
Haematological parameters of 
neonates - hematocrit (Hct) 
level 
South Africa112 
(Hofmeyr 1988) 1988 n/a 38 <35 weeks DCC: 1 min & ergometrine ICC PVH/ IVH 
South Africa113 
(Hofmeyr 1993) 1993 n/a 86 <2000 g birthweight* DCC 1-2 min ICC PVH/ IVH 
South Africa114 
(Tiemersma)  2015 2012/2012 
102 (not all 
preterm) 
Birth weight <2500g 
± 500g* DCC: at 2-3 minutes ICC: within 30 sec Haemoglobin at 2 months 
Spain115 
(De Paco 
Matallana) 
n/a 2011/2014 100 24- 34 weeks GA DCC: at 45-60 sec ICC: <10 sec 
Neonatal haemoglobin, 
haematocrit and bilirubin 
levels (within 7 days after 
birth) 
Spain116 
(Domingo 
Puiggrós) 
n/a 2014/2016 40 <34 weeks GA, 
caesarean 
UCM: X3 at 20 cm/2sec DCC: 30 sec Haemoglobin (at 1 and  
24 hours) 
Spain117 
(Leal) 
2019 n/a 138 24 + 0/7 until 36 + 
6/7 weeks 
UCM ICC Red blood cell transfusion, 
phototherapy 
Spain118 
(Socias) n/a 2014/2017 150 26-32 weeks GA DCC – at 30-60 sec ICC: <30sec 
Red blood cell transfusions 
(number & volume), IVH, 
postpartum haemorrhage 
Switzerland119 
(Baenziger) 2007 1996/1997 39 24-32 weeks 
DCC: 60-90 sec, below 
placenta ICC: <20 sec Cerebral oxygenation 
Taiwan120 
(Shen) n/a 2015/2019 100 
Preterm infants born 
at less than 30 weeks 
GA 
UCM: milked one time, 20cm 
section at speed of 10cm/sec 
and clamped at 2-3cm.  
ICC and no milking 
Neonate's hemoglobin, 
hematocrit, and mean arterial 
pressure at admission 
Thailand121 
(Chamnanvanakij) 2017 2015/2016 46 25-34 weeks GA 
UCM: X3-4 , 30 cm, before 
clamping DCC: at 60 sec 
Haematocrit level  (2 hours 
after birth) 
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 Trial Country 
(PI) 
Publication 
year 
Start year/ 
completion 
year 
Sample 
size Participants Intervention Comparator Primary outcome/s 
Thailand122 
(Jomak) n/a 2018/2018 110 
Singleton preterm 
pregnancy at 24 
weeks to 36 + 6 /7 
weeks GA 
ICC DCC Hematocrit (Hct) 
Thailand123 
(Mungkornkaew) 2015 2014/2014 
200 (not all 
preterm) 
Singleton, GA 34-42 
weeks* DCC: 2 minutes DCC: 1 minute 
Fetal hematocrit, hemoglobin 
and microbilirubin 
Thailand124 
(Panichkul) n/a 2015/2016 170 34-36 weeks GA DCC: at 60 sec ICC: at 10 sec 
Haematocrit 2 hours after 
birth 
Thailand125 
(Ruangkit)  
2019 2016/2017 100 Multiples, 28-36 
weeks GA 
DCC: at 30-60 sec ECC: <10 sec Haematocrit level at birth 
Thailand126 
(Salae) 
2016 2014/2015 86 34-36 weeks GA DCC: at 2 minutes  ECC: within 30 sec Haematocrit at 48 hours 
Thailand127 
(Tanthawat) n/a 2016/2016 40 <32 weeks GA 
UCM: Cut cord at 30cm, cord 
milking x1, 10cm/sec. ECC: <10 sec 
Haemoglobin and 
Haematocrit level at 
admission 
Turkey128 
(Alan) 
2014 2011/2013 44 ≤32 weeks GA 
≤1500 g 
UCM: at 25-30 cm,X3, 
5cm/s, below placenta level  
ICC: <10 sec 
Packed red blood cell (PRBC) 
transfusion and hematologic 
and hemodynamic parameters 
Turkey129 
(Gokmen) 2011 2008/2009 42 <32 weeks GA DCC: 30-45 sec ICC: 5-10 sec 
peripheral hematopoietic 
progenitor cells (HPCs) and 
haematological parameters 
Turkey130 
(Kilicidag) 2015 2012/2013 54 PT ≤ 32 weeks GA 
UCM: X4 before clamping 
(20cm/2sec) ICC 
absolute neutrophil counts 
(ANCs) and the neutropenia 
frequency 
Turkey131 
(Silahli) 2018 2015/2016 75 <32 weeks GA 
UCM: at 20 cm, 3x, before 
clamping ICC <10s Thymic size 
UK132 
(Aladangady) 2006 n/a 46 24-32
6 weeks GA 
DCC: 30-90 sec, below 
placenta, oxytocic agent, with 
ventilation/ resuscitation if 
necessary 
ICC Infants’ blood volumes. 
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Trial Country 
(PI) 
Publication 
year 
Start year/ 
completion 
year 
Sample 
size Participants Intervention Comparator Primary outcome/s 
UK133 
(Duley) 2017 2013/2017 260 <32 weeks GA DCC: after at least 2 min ECC: <20 sec 
Feasibility: Recruitment, 
compliance, retention, 
completeness data, patient 
views 
UK 
(Holland) 
Not published 1998/2001  <33 weeks’ gestation DCC 40-90 s ICC (?) 
Median arterial/alveolar PO2 
ratio over the first 24 hours of 
life 
UK134 
(Kinmond) 1993 n/a 36 
27-32 weeks GA, 
vaginal delivery 
Conventional management 
(ICC): 10 sec median 
DCC 30 sec, 20 cm below 
placenta 
Initial packed cell 
volume, peak serum bilirubin 
concentrations, red 
cell transfusions, respiratory 
impairment 
UK135 
 (Rabe)  2011 2006/2008 58 
Singletons, <34 
weeks GA UCM 
DCC: Slight deferral in cord 
clamping time 
Acceptability of cord 
clamping methods 
UK136 
(Weeks) n/a 
n/a 
(protocol, not 
funded/started to 
date) 
7242 (not 
all preterm) All births* 
DCC: clamped once it has 
stopped pulsating or at least 5 
minutes after birth 
ICC: within 30 sec of birth 
Developmental delay and/or 
behaviour problem 
USA137 
 (Backes) 2016 2009/2013 40 22.5-27.6 weeks 
DCC: 30-45 sec, 
Below placenta ICC: 5-10 sec 
Safety, feasibility, 
haematological and 
circulatory outcomes 
USA138 
(Bauer) n/a 2014/2019 400 24-29 weeks GA 
Arm 1: DCC – at 45 sec and 
indomethacin within 6hrs 
Arm 2:  DCC – at 45 sec and 
placebo within 6hrs 
Arm 3: ICC and 
indomethacin 
Arm 4: ICC and placebo 
Survival at 38 weeks with no 
severe IVH (grades 3/4) or 
PVL  
USA139 
(Berens) n/a 2018/2019 
100 (not all 
preterm) >35 weeks GA* DCC: 60 sec ECC: <15 sec 
Neonatal bilirubin level 
[ Time Frame: 24 hours after 
birth ] 
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Trial Country 
(PI) 
Publication 
year 
Start year/ 
completion 
year 
Sample 
size Participants Intervention Comparator Primary outcome/s 
USA140 
 (Bienstock) n/a 2011/2013 22 24 - 32 weeks GA UCM: X4 over 10 min ICC 
Haemoglobin (within 24 
hours of birth and through 
NICU stay) 
USA141 
 (deVeciana)  2013 2009/2011 113 
Singletons, 24-28 
weeks GA 
UCM: 10cm, immediately 
after delivery ICC 
Red blood cell transfusion 
(within 28 days of life) 
USA142 
(Driggers) n/a 2011/2013 2 
Infants delivered at 
24 to 28 + 6/7 weeks 
GA 
DCC: 30 sec 
UCM: milking four times in 
10 sec 
ICC 
Adverse neonatal event: 
composite of 
bronchopulmonary dysplasia, 
NEC, grade 3 or 4 IVH or 
PVL, or death  
USA143 
 (Elimian) 
2014 2006/2011 200 Singletons, 24-34 
weeks GA 
DCC: at 30-35 sec ICC: <5 sec Need for blood transfusion 
USA144 
 (Garg) 
n/a 2016/2018 5 <32 weeks GA UCM: X2, before clamping ICC 
Cerebral oxygenation and 
function (first 24 hours of 
life) 
USA145 
 (Josephsen) n/a 2012/2016 64 24-27 weeks GA 
UCM: below level of placenta 
and ~20 cm cord milked x3 
over 10-20 sec before 
clamping 
ICC 
Haemoglobin and haematocrit 
concentrations (within 4 hrs 
birth) 
Incidence and number blood 
transfusions until discharge 
USA146 
(Katheria 2011) 
2014 2011/2013 60 <32 weeks GA 
UCM: milking X3, below 
placenta, about 20 cm of cord 
over 2 sec 
ICC Superior vena cava flow at 6 
hours 
USA147 
 (Katheria 2013) 2015 & 2017 2013/2018 197 23-31 weeks GA UCM: X4 at 20 cm/2 sec DCC – at 45-60 sec 
Superior vena cava flow at 
<12 hours 
USA 
(Katheria 2017) n/a 2017/2022 1200 
Infants 23 to 32 + 6/7 
weeks GA 
UCM: milking four times at 
20cm/2sec DCC: at least 60 sec Incidence of IVH or death 
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Trial Country 
(PI)
Publication 
year
Start year/ 
completion
year
Sample
size Participants Intervention Comparator Primary outcome/s 
USA 
(Katheria 2019) n/a 2019/2020
1000 (not
all preterm)
Non-vigorous
newborns born
between 35-42 weeks 
GA* 
UCM: milking four times,
entire umbilical length over  
2 sec.
ICC: average 20 sec Admission to NICU
USA148
(Kattwinkel)
n/a 2016/2021 940 23-28 weeks GA
Assisted Ventilation (face 
mask, Continuous Positive
Airway Pressure or Positive
Pressure Ventilation) prior to
DCC at 120 sec 
DCC: 30-60 sec, assisted
ventilation only after cord
clamping
IVH on head ultrasound 
(7-10 days) 
USA (Krueger) 2015 2012/2013 67 
Singletons, 22-316 
weeks GA
DCC: (30 sec) with cord
milking 
DCC: (30 sec) without cord
milking 
Initial fetal hematocrit
USA149
 (Martin) n/a 2012/2014 72 
Singletons, 23-37 
weeks GA
Arm 1: DCC – at 60 sec 
Arm 2: DCC – at 40 sec ECC: 20 sec 
IVH number and severity
(15 months) 
USA150
(Mercer 2003a) 2003 1998/2001 32 24 to 32 weeks GA DCC: 30-45 sec ICC: 5-10 sec Initial blood pressure
USA151
(Mercer 2003b) n/a 2003/2006 58 
Singletons, <34 
weeks gestation 
DCC: 30-45 sec, below 
placenta ICC 
Acceptability of cord
clamping methods 
USA152
(Mercer 2006) 2006 2003/2004 72 <32 weeks GA DCC:30-45 sec ICC: 5-10 sec 
bronchopulmonary dysplasia 
(BPD) and suspected NEC 
(SNEC)
USA153
 (Mercer 2008)
2011 & 2016 
& 2018 2008/2014 211 24-31 weeks GA
DCC & UCM - 30 - 45 sec,
below placenta level, cord
milking x1 at end of time, 
before clamping. If clamping 
cannot be deferred, cord
milked x2-3
ICC: <10 sec IVH, late onset sepsis
USA154
 (Oh) 2011 2000/2001 54 
Singletons, 24-27 
weeks GA DCC: at 30-45 sec ICC: <5 sec 
Number of infants enrolled in
the pilot within 6 months
USA155
 (Perlman) n/a 2015/2019 150 28-34 weeks GA DCC: at 60 sec DCC: at 30 sec Haematocrit 1 hour after birth 
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Trial Country 
(PI) 
Publication 
year 
Start year/ 
completion 
year 
Sample 
size Participants Intervention Comparator Primary outcome/s 
USA156 
(Smith) 
n/a 2014/2018 240 23-34 weeks GA UCM: X4, before clamping, 
below placenta level 
DCC: at 30 sec, below 
placenta level 
Haemoglobin & Haematocrit 
in NICU (~50 days) 
USA 
(Strauss) 2008 n/a 158 
Neonates ≤36 weeks 
GA  DCC: 60 sec ICC 
Red blood cell volume/mass, 
per biotin labelling 
USA 
(Yared/Young) n/a 2015/2016 39 
Very low birth weight 
(500 to 1500 grams)* DCC: at 60 sec DCC: at 30 sec 
IVH (during NICU admission 
up to 6 months) 
Thailand 
Pongmee 2010 2010 (abstract)  43 <35 weeks GA 
Milking 2x along 30 cm after 
cutting ICC 
Initial haematocrit, need for 
blood transfusion, morbidity 
Medina 2014    Premature neonates DCC  Haemodynamic parameters 
* only those born <37 weeks gestation eligible 
NEC = necrotising enterocolitis; GA = gestational age; DCC = deferred cord clamping; ROP = retinopathy of prematurity; IVH = 
intraventricular haemorrhage; PVL = periventricular leukomalacia; EEG = electroencephalogram; NIRS = near-infrared spectroscopy; cm = 
centimetres; sec = seconds, NICU = Neonatal intensive care unit; UCM = umbilical cord milking; ECC = early cord clamping; ICC = immediate 
cord clamping 
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